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Abstract
This study aims to investigate the biological responses induced by silver nanoparticles
(AgNP) following oral exposure. The commonality of AgNP in consumer goods
highlights the need for a thorough investigation into the interaction with and subsequent
responses evoked in living systems following exposure. Firstly, the potential interaction
with and effect of biofluid components, namely cholic acid (CA), deoxycholic acid
(DCA) and ursodeoxycholic acid (UDCA), on AgNP toxicity was investigated. Two
cell lines corresponding to organs related to the biofluid components, HepG-2 a
hepatocellular carcinoma derived from liver tissue and Hep2 an epithelial cell line, were
employed. Physicochemical and cytotoxic screening was performed and the ability of
biofluid components to modify AgNP cytotoxicity was explored. No alteration to the
physicochemical characteristics of AgNP by biofluid components was observed;
however their addition resulted in altered AgNP toxicity. Greater reactive oxygen
species (ROS) induction was noted in the presence of CA and DCA. UDCA
demonstrated no modification of toxicity in HepG-2 cells however significant
modification was observed in Hep2 cells. It was concluded that biofluid components
can modify AgNP toxicity but is dependent on the biofluid component itself and the
location where it acts.
As inhalation is the most common route of nanoparticle entry and given the close
proximity to the GI tract, the tendency of cross exposure between the two is prevalent.
As such the next line of investigation involved the potential toxicity of AgNP to A549
alveolar epithelial carcinoma cells and the influence of a major component of lung
surfactant dipalmitoylphosphatidylcholine (DPPC) on toxicity. This follow up
investigation revealed that exposure generated low levels of oxidative stress and a
reduction in cell viability. While the presence of DPPC caused no influence on viability
studies its presence increased ROS formation and significantly modified the
inflammatory response generated by AgNP exposure. These findings suggest a possible
interaction between AgNP and DPPC causing particles to become more reactive thus
increasing oxidative insult and inflammatory response within A549 cells.
The final investigation in this report was on the biological effects of AgNP on the innate
immune response of circulating white blood cells. This study determined the ability of
i

AgNP to induce an inflammatory response in THP-1 monocytes by measuring AgNP
stimulated gene expression of the pro-inflammatory cytokines interleukin-1 (IL-1),
interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α). A further study on
monocytes extracted from a cohort of blood samples, was carried out to compare the
inflammatory response to THP-1 monocytes. Finally ELISAs were performed on
supernatants of THP-1 monocyte cultures to test for the activation of pro-IL-1β a key
mediator of the inflammasome complex. The findings clearly demonstrate AgNP can
significantly up-regulate pro-inflammatory cytokine gene expression in THP-1 and
primary human blood monocytes, with IL-1β release by inflammasome involvement
indicating AgNP can result in an immunologically active state.
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Chapter 1

Introduction and Overview

1.1 Introduction to Nanotechnology
The origins of modern nanotechnology begin with the physicist Richard P. Feynmen
and his lecture in 1959 entitled “There’s Plenty of Room at the Bottom”. In the lecture
Feynmen described that it was not the laws of physics which prohibited the
manipulation of atoms or molecules but the methods and tools available at that time
(Feynmen 1959). Despite Feynmens conjecturing, it was not until 1974 that Norio
Taniguchi first used the term nanotechnology stating that “Nanotechnology mainly
consists of the processing, separation, consolidation and deformation of materials by
one atom or one molecule” (Taniguchi 1974). From that time the definition of
nanotechnology has been expanded and changed. In October 2011, the European
Commission published a report which defined a nanomaterial as;
“A natural, incidental or manufactured material containing particles, in an
unbound state or as an aggregate or as an agglomerate, and where for 50% or
more of the particles in the number size distribution, one or more external
dimensions is in the range 1-100nm
In specific cases and where warranted by concerns for the environment, health,
safety or competitiveness the number size distribution threshold may be replaced
by a threshold between 1-50%
By derogation from the above, fullerenes, graphene flakes and single wall
carbon nanotubes with one or more external dimensions below 1nm should be
considered as nanomaterials.”
This recommendation of a definition for a nanomaterial was to be used for materials that
require special provisions such as risk assessment (European Commission, 2011).
While this definition aimed to encompass a general nanomaterial definition, there are
numerous definitions detailing the parameters of what classifies a nanomaterial within
certain sectors such as cosmetics, food and biocides. This in itself presents a lot of
1

confusion regarding the definition of a nanomaterial as the context in which the
nanomaterial is presented must be taken into account (European Commission, 2009;
2011; 2012).
This EU Commission definition has generated a lot of controversy and was considered
too broad by some industries, too narrow by others and used inappropriate thresholds.
As a result this definition is currently under review as to whether the size number
distribution threshold of 50% should be increased or decreased. This review is due to
conclude in 2016 following consultation with stakeholders regarding its findings
towards the end of 2015 (European Commission, 2015).

1.2 Potential of Nanotechnology
Nanotechnology has often been described as a new frontier of this century with many
different applications in various fields including textiles, electronics, medicine,
cosmetics and food, demonstrated graphically in figure 1.1 (Sozer & Kokini, 2008;
Bouwmeester et al, 2009). Between March 2006 and February 2008 the number of
consumer products containing nanoparticles had tripled with more than a thousand
commercial products identified (Powell et al, 2010). It was discovered during this time
that over 200 manufactures marketed their products as “nano-products” and of these 9%
were food and beverage while health and fitness accounted for 60% (Sozer & Kokini,
2008). A recent report stated that the global nanotechnology market was worth an
estimated $26 billion in 2014 and is predicted to reach approximately $64.2 billion by
2019 (McWilliams, 2014). The inventory of consumer products currently on the market
in 2015 using nanotechnology has increased substantially to 1,628 a 24% increase from
2010. This inventory allows the public to browse the products currently available and
also provides details on the companies behind these nano-products. Of the 1600+
products listed, 117 accounts for food and beverage based products with health and
fitness making up the largest number of products at 907. Silver proves to be the most
popular nanomaterial of choice with 483 of the 1628 products are listed as containing
nano-silver (Nanotechproject, 2013). This exponential growth in nano-based products
and increased consumer exposure will only continue to grow and highlights the need not
only for strict regulation but also for a complete risk assessment on the impact of
exposure. This work will examine the biological effects of exposure to nanoparticles on
2

humans, ultimately contributing to an on-going project into the development of a
complete and detailed risk assessment of the potential harm resulting from exposure to
nanoparticles. While there are a number of different routes of entry, this project will
focus on the oral route of exposure and thus will focus on the applications of
nanotechnology where oral exposure to nanoparticles is a requirement or a concern.

Figure 1.1 Applications of Nanotechnology and some examples of the nano-enabled
products available

1.3 Application of nanotechnology in areas of industry where oral exposure is
essential or a concern
The applications for nanotechnologies are numerous and the likelihood of exposure to
humans is becoming increasingly significant. Their inclusion into a variety of everyday
products only increases the incidence of contact and raises questions regarding potential
hazards of exposure. While their inclusion can provide various benefits there is the
potential to produce undesirable biological effects. Oral exposure provides one of the
3

easiest routes of nanoparticle entry be it through food additives, drug delivery
(ingestion) or products such as deodorants, fabrics and bedding (inhalation), and
highlights this route as one of the most common entry points and one in which any risk
assessment regarding nanoparticle safety must be focused (Sekhon, 2010; Boisseau &
Loubaton, 2011; Cerkez et al, 2012).

1.3.1 Application of Nanotechnology in the Food Industry
Nanotechnology is nothing new to the food industry with certain well established
products employing a form of nanotechnology to reduce fat content of for example
mayonnaise by emulsifying fat droplets in nano-sized water droplets without effecting
taste. More recent uses of nanoparticles include food supplements, additives, novel
foods, flavourings and packaging (Smolkova et al, 2015). The presence of nanoparticles
in food can be unintentional as well as intentional with nanoparticles used in all aspects
of the food industry from use as pesticides or fertilizers to veterinary drugs. The
presence of nanoparticles in food packaging as a means of detecting food spoilage or
monitoring temperature and moisture, present another route of unintentional
nanoparticle presence in food through leaching. Nanoparticles such as titanium dioxide
(TiO2) are added to powdered food as anticaking agents in products such as powdered
milk and sugar as well as its use as a white colouring for confectionary and white
coloured sauces and dressings (Lomar et al, 2002; Smolkova et al, 2015). Silver
nanoparticles (AgNP) are used as antibacterial agents in food products and can be used
as a detection method for food spoilage known as “e-noses”. Another aspect is the use
of AgNP in gels to coat food such as vegetables preventing water loss and their
incorporation into cellulose pads to prevent microbial growth when placed in contact
with meat products including beef (Tung et al, 2014; Smolkova et al, 2015).
One of the most important aspects of nanotechnology in food is the ability to allow
delivery of certain labile bioactive compounds such as antioxidants and vitamins. The
encapsulation of such compounds in solid lipid nanoparticles can potentially increase
their bioavailability and stability, and protect from degradation by various enzymes and
acids in the GI tract. This application has the potential to improve overall health and can
be applied to pharmaceuticals as well as natural bioactive compounds (McClements,
2013; Weiss et al, 2008; Yao et al, 2015).
4

A recent extensive research of nanotechnology in the food sector by the European Food
Safety Authority (EFSA) revealed 633 nanotechnology applications with product
names, related suppliers and described the physio-chemical characteristics of
nanomaterials in the food, agriculture and feed sectors. 55 types of nanomaterials were
identified and the most common applications were found to be in food additives or food
contact materials (Peters et al, 2014).

1.3.2 Application of Nanotechnology in Drug Delivery
Nanotechnology is well established in drug delivery as an intelligent method of delivery
maximising the targeted control of compounds while minimizing side effects. The
application of nanotechnology in drug delivery aims to improve bioavailability of drug
compounds, prolong their residence time in the body and allow for targeted delivery to
affected sites while sparing healthy cells. Engineering polymeric nanoparticles is a
growing area of drug delivery research and shows promise as a method of targeted drug
release. These polymers can be produced to be biocompatible and are often
biodegradable, allowing intelligent controlled release of a drug product while producing
non-toxic by-products following degradation that are then easily eliminated from the
body (York et al, 2008). Dendrimers are also a popular choice for drug delivery with
drug molecules either encapsulated within the dendrimer or covalently attached to the
surface. A number of characteristics including easy manipulation of size and attached
functional groups, high penetration of cell membranes and a lack of immunogenicity
make them a popular delivery vehicle (Yang et al, 2009; Siewiera & Labieniec-Watala,
2012; Safari & Zarneger, 2015).

Oral delivery of chemotherapeutic drugs is a growing area of interest in order to
maintain a constant high level of exposure of chemotherapeutics to cancer cells while
also improving patient comfort. This could provide a breakthrough in the available
cancer treatments given intravenously which result in peaks above the maximum
tolerable concentration and fast excretion from the circulation, thus limiting the
therapeutic effects and resulting in serious side effects typically associated with current
cancer treatment (O’Neill & Twelves, 2002; Feng et al, 2011; Jia et al, 2013; Mei et al,
2013). Dendrimers have been highlighted for potential oral delivery due to their ability
to permeate intestinal epithelium enhancing drug absorption (Wiwattanapatapee et al,
5

2000). Polymeric micelles are another means of delivery providing increased solubility
of drugs and improving oral bioavailability (Gaucher et al, 2010). Liposomes have also
been highlighted as a possible carrier due to their potential protection of encapsulated
drugs from intestinal degradation while increasing absorption (Moutardier et al, 2003;
Mei et al, 2015). This method of cancer treatment provides many challenges in its
design with numerous factors to be considered both physiologically and the particular
properties required of the carrier. The treatment of cancer through oral drug delivery
may not be too far off and highlights how the application of nanotechnology can be
used to improve the treatment of diseases such as cancer and improve the quality of life
of those affected.

1.4 Concerns of Nanotechnology
Everyday consumer products containing nanomaterials are becoming more widely
available and easily accessible. As a result it is important to consider various questions
raised regarding the health and environmental risks associated with these products.
Together with potential risks, the concerns of the public must be addressed regarding
these products. In the past not acknowledging the public view has led to problems with
the introduction of new technologies, in particular regarding the introduction of
genetically modified (GM) products (Gaskell et al, 1999).With the continued growth of
nano-based products, it is important to take into account the public concerns at the
beginning of product development in order to avoid a backlash similar to that observed
with the introduction of GM products. Studies have been carried out in order to gauge
public perception of nanotechnology and have concluded that general knowledge on this
topic is very limited with many not understanding the term nanotechnology and what it
implies. A study into the general public’s perception on new food technologies
including nanotechnology highlighted that consumer acceptance of a new technology
cannot be assumed, and that consumers reactions to new technologies and the likelihood
of acceptance varies with each individual and each technology. The main observations
from this study indicated that stakeholders must carefully consider the methods
involved in introducing new technologies well in advance of market launch and that
transparency is paramount in building consumer confidence and acceptance of new
technologies (Henchion, 2012). This study has highlighted that there is still clearly a
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need for a detailed and complete risk assessment into the applications of
nanotechnology, particularly nano-silver to build consumer confidence in the area.
The need for proper and strict regulation guidelines and testing are only now coming to
the forefront with the exponential growth in the industry over the past couple of years.
In April 2015 the US Environmental Protection Agency (EPA) was forced to stop the
sale of two nano-silver based products for use in hospitals as sterile agents due to
unsubstantiated claims made by the company that these products “can swiftly eradicate
all micro-organisms and keep surfaces free of colonization for up to a full year” (Nano
Defence Solutions Inc). Under new federal law filed by the Center for Food Safety any
product that contains a pesticide as an active ingredient must be registered with the EPA
and determined to be risk free when used as per the labels instructions. The EPA now
acknowledge nano-silver antimicrobial products should be regulated as new pesticides
and that products must be regulated and safety tested by independent experts in order to
safeguard the public from unregulated nano-products on the market (Center for Food
Safety, 2015).

1.4 Nanosilver
Bulk silver is a white and brilliant metallic element that has been utilized for thousands
of years due to its antimicrobial activity, high thermal and electrical conductivity and its
low contact resistance (Nordberg et al, 1988). Usage of silver in its bulk form has a
long history dating back thousands of years. Its use for the preservation of food and
purification of water in ancient times has been well documented with large silver
vessels used for the storage of wine and water. During World War I silver was used to
treat wounded soldiers and prevent infection prior to the discovery of antibiotics
(Russell & Hugo, 1994; Chen & Schluesener, 2008). Although it has well described
healing and preservative properties, prolonged exposure to silver has been associated
with irreversible pigmentation of the skin known as argyria (Rosenman et al, 1972;
Marshall & Schneider, 1977; Gulbranson et al, 2000; White et al, 2003). Apart from
this condition silver was believed to be relatively non-toxic and in the advent of
nanotechnology, manufacture of silver on a nano-scale has become a rapidly expanding
area of development.
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Nanosilver is probably one of the most highly used nanomaterials on the market today
with applications ranging from antibacterial textiles and medical devices to food
packaging, cosmetics, water treatment and electronics. Compared to bulk silver,
nanosilver displays different physicochemical properties and can exhibit different
biological activities (Zhai et al, 2006; Dawy et al, 2012; Greulich et al, 2009). Probably
the most important property of nanosilver and the one that makes it so appealing is its
antimicrobial activity. Its ability to inhibit microbial growth has made its use in the
medical sector invaluable with dressings, bandages and catheters to name a few
embedded or coated with nanosilver to prevent infection and sepsis (Cheng et al, 2004).
This antimicrobial property has now been applied to everyday consumer products from
laundry detergents and water purificants to paints and even clothing. It has been
reported that the antimicrobial effect of AgNP result from their ability to interfere with
membrane permeability and redox-cycling in the cytosol of bacteria by attaching to the
cell membrane, causing accumulation of intracellular radicals and if small enough,
eventually entering the cell causing DNA damage (Liang et al, 2010). Staying within
the medical sector nanosilver also has uses diagnostically. In the area of bio-imaging
and bio-sensing the plasmonic properties of nanosilver are used to improve diagnostic
mechanisms. The attachment of nanosilver to biosensors reduces the interference of the
buffer solution it is suspended in and produces greater resolution. For bio-imaging
compared to the fluorescent dyes commonly used, nanosilver can be detected by
numerous microscopy techniques and can be used to monitor dynamic biological events
for extended periods of time due to its photostable property (Sotiriou & Pratsinis, 2011).

1.5 This Thesis
This study focuses on AgNP, commonly used across a variety of industries due to their
antimicrobial properties. The reason being that while there are benefits which have led
to growth and innovation within the area of nanotechnology, there is still a lack of
regulation and a gap in the knowledge regarding the fate of AgNP following exposure,
the interaction with biological entities and how this can ultimately affect the responses
produced. It is important to establish the interaction with and potential toxic effect on
biological systems in order to produce a complete and detailed risk assessment, not to
hinder the development of the industry but to provide knowledge so that further
innovation utilizing AgNP can be carried out in an informed, regulated and safe manner.
8

This study is part of an on-going Science Foundation of Ireland (SFI) funded project
with the overall aim to develop a risk assessment for oral exposure to silver
nanoparticles from food products. From the work performed over the last four years it is
hoped that the knowledge gained can actively contribute to this risk assessment and
provide insight into the effects of nanoparticle exposure on living systems, furthering
the understanding of the toxic profile of AgNP.
Specifically this thesis aims to establish nanoparticle interaction with biological entities,
namely biofluids, associated with the GI tract and the lung, two organ systems affected
by oral exposure and how this interaction may affect the response produced. This study
does not end here, as nanoparticles do not remain in initial exposure sites, but have the
ability to translocate through the body moving to different biological compartments
eventually reaching circulatory system. The final part of this investigation is to
determine the immunological significance of AgNP on circulating white blood cells and
whether their presence can induce an innate immune response. An overview of the
thesis is summarized in figure 1.2, and highlights the thought process of the thesis
design, following the route of AgNP from initial oral exposure to eventual absorption
into the bloodstream.

9

Figure 1.2 Summary diagram of thesis outline highlighting the main focus points
following the potential route taken by AgNP following oral exposure. Arrows indicate
areas of interest throughout the study

Before any toxicity studies can be performed it is first essential to carry out full
physicochemical characterisation of the tested AgNP. This will provide important
information and give insight into how AgNP will interact with different cells of the
body following internalisation. This characterisation will be presented in chapter 4.
Investigations in to how AgNP interact with various biofluid components present in the
body, such as bile acids and lung surfactant will be assessed. Their ability to modify the
toxic profile of AgNP in the liver, larynx and lung all areas associated with oral
exposure will be presented in chapters 5 and 6. In doing so this study aims to mimic real
life exposure scenarios and determine the influence of certain biological entities, in this
case components of biofluids, on the biological response induced following AgNP
exposure. Following this an investigation into the effects induced by AgNP exposure
following absorption into the circulatory system will be investigated. The potential
effect of AgNP on the innate immune response of circulating white blood cells will be
explored. First a monocyte cell line was used to determine pro-inflammatory cytokine
gene expression induced by AgNP exposure, indicative of an inflammatory response. A
further study on human monocytes extracted from a cohort of human blood samples was
10

carried out to compare the AgNP response with that observed in the monocyte cell line,
all detailed in chapter 7.
The key research questions that are considered over the PhD are as follows:


What are the physicochemical characteristics of AgNP and does the addition of
biofluid components alter them?



Are AgNP toxic to cells associated with oral exposure and does the addition of
biofluid components modify the observed toxicity?



Can AgNP exposure result in up-regulation of pro-inflammatory cytokine gene
expression in THP-1 monocytes?



Can AgNP exposure result in up-regulation of pro-inflammatory cytokine gene
expression in primary human monocytes and how does this response compare to
the response in THP-1 monocytes?



Does AgNP exposure result in cleavage and activation of pro-IL-1β, indicating a
role for the inflammasome complex in AgNP response in circulating blood
cells?

11
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Chapter 2

“Nanotoxicology”

2.1 Introduction
The previous chapter highlighted the potential of nanotechnology and its benefits as a
technology across a wide range of industries, including medical, cosmetics and food
with a focus on AgNP. Although it continues to be marketed as an advantageous
technology improving the quality of products in the areas of health, food, technology
and agriculture a number of concerns are being raised as to the impact of this
technology on the environment and human health. The rapid growth of this industry and
apparent lack of regulation has led people to question the possible harm associated with
this technology. This chapter will discuss some of the issues associated with
nanomaterial and nanoparticle exposure, the various routes of exposure and the risk
associated with exposure to AgNP. It should be noted however that the benefits of
nanotechnology greatly outweigh the negatives and so any risk assessment must be
balanced so as not to stifle innovation and development.

2.2 Nanoparticle interactions with Biological Systems
The relationship between nanoparticles and biological systems is complex, with a
variety of factors including physicochemical characteristics of the particle and the
position within the body as well as the variety of proteins and biological entities present
influencing the types of interactions and responses produced.
These intermolecular forces apart from dictating the biological response evoked by
nanoparticle exposure are fundamental to life itself. Intermolecular interactions are
required for the basic functioning of cells. Proteins, a fundamental components of cells,
are formed by the formation of peptide bonds which link a number of amino acids
together resulting in the production of a protein. Protein folding is important in
determining function and occurs through several types of weak molecular interactions;
hydrogen bonds, ionic bonds and van der Waals forces. Although weak, a large number
of these bonds form allowing protein folding to occur and form a stable conformation.
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A fourth force is also involved. Clustering of the non-polar hydrophobic side chains of
the polypeptide towards the inside of the molecule will allow these side chains to avoid
the aqueous cell environment thus further affecting protein shape (Alberts et al, 2002).
In addition to protein formation and folding, intermolecular forces are required to allow
proteins to carry out functions including binding specifically to ligands in order to carry
out specific functions, for example antibody binding to specific bacterium marking it for
destruction and removal from the body.
In addition to proteins, attractive forces are essential to DNA structure with hydrogen
bonding between base pairs producing the distinctive double helical shape of the DNA
molecule (Guerra et al, 2000). Haemoglobin is a complex protein structure made up of
multiple protein subunits that requires the formation of covalent bonds such as
disulphide bridges and hydrogen bonds to maintain stability following folding (Cooper,
2000; Berg et al, 2002). From the basic formation of the cell to construction of proteins
to the reversible binding of oxygen to heme for transportation around the body,
molecular interactions are essential for living systems and form the basis of life itself.
While it is clear that intermolecular forces are vital to life, forming the basis of cellular
structure and function, it is important to consider the interaction between nanoparticles,
cells and other biomolecules. As intermolecular interactions are fundamental to living
organisms and dictate various processes, the same focus should be put on nanoparticlebiomolecule interactions as these may also dictate biological outcome following
exposure.
The interaction between nanoparticles and various biomolecules including proteins has
become an important topic in understanding the behaviour of nanoparticles following
exposure. Not only is the type of biomolecule or location within the body a factor, but
also the physicochemical characteristics of the nanoparticle can dictate the type of
response induced (Lynch et al, 2009; Ehrenberg et al, 2009). Following entry into living
systems a dynamic layer of biomolecules adsorb onto the nanoparticle surface and this
coating is what cells “see” and interact with. Nanoparticles may become coated with
proteins, lipids, sugars and other molecules impacting not only the properties of the
nanoparticle itself but also the adsorbed biomolecules (Cukalevski et al, 2011; Bailes et
al, 2012; Lesniak et al, 2012). Biological interactions have been shown to vary as a
nanoparticle moves from one biological environment to another, subsequently changing
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the composition of the surface coating with evidence suggesting the same nanoparticles
can elicit different responses based on the particular composition of the surface coating
(Maiorano et al,2010; Lundqvist et al, 2011). With the variety of biomolecules present
and the number of additional factors involved in nanoparticle-biomolecule interactions,
it is becoming apparent that a need for mapping the surface coatings of nanoparticles in
the relevant biological and cellular compartments, in order to understand the various
interactions and possibly predict the responses produced is required (Lynch et al, 2007;
Byrne et al, 2013).
It is safe to say that with the literature available nanoparticles will not exist as noninteracting entities within biological systems but will quickly become associated with a
layer of biomolecules following entry and this surface coating will vary depending on a
number of factors relating to the nanoparticle itself, the biological location and types of
biomolecules encountered. It is this interaction that provides vital information into
predicting nanoparticle behaviour and biological outcome, both of which must be
addressed in toxicological research.

2.3 Exposure Routes
When considering the risks associated with contact to nanoparticles and nanomaterials
one of the aspects to be identified first is exposure routes to the body. There are three
main routes of entry that must be considered;
1. Skin
2. Inhalation
3. Oral Exposure

2.3.1 Skin
Dermal exposure to nanoparticles is becoming increasingly common particularly in the
area of drug delivery where nanoparticle formulations have been incorporated into
topical creams and lotions. The skin represents the main protection barrier of the body
and provides first line defence against infection and environmental hazards. The barrier
function of the skin is provided by the stratum corneum which is composed of highly
differentiated keratinocytes. These keratinocytes contain a natural moisturising factor
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which keeps the skin hydrated and are held together by a lipid lamellae layer preventing
water loss and providing barrier permeability (Cork et al, 2009). While it has been
previously demonstrated that titanium dioxide (TiO2) and zinc oxide (ZnO)
nanoparticles do not penetrate the skin, it has been noted that metallic nanoparticles of
10nm and less could penetrate the skin and deposit in the deepest layers of the stratum
corneum (Baroli et al, 2007; Pflucker et al, 2001; Shulz et al, 2002; Cross et al, 2007).
In relation to the penetration of AgNP into the skin, it was demonstrated that particles of
30nm and less can penetrate the skin eventually reaching the deepest layers of the
stratum corneum and that in damaged skin this permeation is increased (Larese et al,
2009). It was suggested that a certain amount of particles dissolve and diffuse through
the skin as elemental silver, this hypothesis is similar to a mechanism observed for
nickel penetration where stratum corneum diffusible compounds are formed by the
oxidation and solubilisation of particles on the skin surface and enter by an intracellular
route (Hostynek et al, 2001).

2.3.2 Inhalation
Nanoparticle exposure via inhalation is probably the most common entry point for
nanoparticles and because of this, targeted and controlled drug delivery via the lungs
has become a popular area for development. Inhalation provides an easy entry route for
engineered nanoparticles in nano-carrier systems for drug delivery, allowing an easy
route for targeted, controlled and non-invasive delivery. Liposomes in particular have
been the nano-carrier of choice in the development of improved and intelligent drug
delivery systems (Varez-Lorenzo et al, 2009; Shum et al, 2001). A number of
investigations into the mechanisms of nanoparticle uptake in the lung have provided
information into the methods required for the formulation of potential carriers to induce
uptake and the various access points. Entry may occur via a transcellular mechanism
mediated by specific receptors, paracellular uptake or through mucus penetration with
the characteristics of the nanoparticle often dictating the route of entry as well as the
biological response induced (Prakash & Matalon, 2014). A summary of these potential
entry methods are highlighted in figure 2.1. While inhalation provides an alternative
method of pharmaceutical delivery, improving both the treatment and comfort of
patients, it can be a double edged sword providing an easy access route for undesirable
nanoparticles. A number of studies have been undertaken to explore lung entry of
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various nanoparticles and their subsequent distribution around the body. Cerium oxide
(CeO2) nanoparticles have been shown to cause acute toxicity in the lungs following
exposure. It was postulated that this could lead to chronic inflammation days after the
exposure period, with particles deposited in the lungs as they penetrate through the
alveolar wall into the systemic circulation (Srinivas et al, 2010; He et al, 2010). AgNP
exposure in the lung has also been shown to induce cytotoxicity along with other
nanometals including ZnO and TiO2. The induced toxicity may result in knock-on
effects including excessive secretion of certain biological agents causing dysfunction in
the cytokine network, thus reducing the efficiency of the respiratory immune system
(Liu et al, 2013).

Figure 2.1 Potential routes of absorption of nanoparticles following inhalation and the
response induced, dependent on both nanoparticle characteristics and host factors. ASM
Airway Smooth Muscle, ROS Reactive Oxygen Species (Prakash & Matalon, 2014)
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2.3.3 Oral exposure
Oral exposure is the main exposure route associated with this study. Indeed the
probability of nanoparticle exposure via ingestion is high with the advent of
nanoparticle use in drug delivery and also their incorporation into food products, to
increase the health benefits and assist in adequate nutrient delivery. In terms of drug
delivery the oral route is the easiest and most acceptable to patients but due to the
various obstacles associated with delivery such as degradation by stomach acid and
elimination by the first-pass effect, the stability and final concentration of the drug
reaching the systemic circulation comes into question. Nanoparticle systems offer a
solution to the problems associated with ingestion of pharmaceuticals. An example of
nanoparticle use in oral drug delivery is the use of chitosan nanoparticles. These
nanoparticles are biocompatible, non-toxic, have muco-adhesive properties and can
open tight junctions in the intestinal tract facilitating their residence time in the
gastrointestinal (GI) tract and transport across the gastric epithelium. When loaded with
insulin chitosan nanoparticles have been shown to increase the bioavailability and
absorption of insulin therefore reducing blood glucose levels in in vivo diabetic rat
models (Chen et al, 2013; Lin et al, 2007).
As well as ingestion of nanoparticles due to drug delivery, nanoparticles are used in
food products to prolong shelf-life and also to increase the nutritional value of foodstuff
by increasing the bioavailability of nutrients.

2.3.3.1 Ingestion
Throughout evolution humans have ingested various nano and microparticles including
nutrients such as ferritin, thus demonstrating how the GI tract has adapted to facilitate
nanoparticle uptake. This naturally occurring nanoparticle, ingested both in meat and
plant based food, appears to be only partially digested in the GI tract and it has been
suggested that it may be endocytosed and utilised by epithelial cells in the gut as a
source of dietary iron. This process highlights that nanoparticle uptake in the gut can
occur and that in some cases it may be beneficial (Powell et al, 2010). Once food is
partially digested by chewing in the oral cavity, dissolution begins in the stomach due to
acidic conditions and the release of various enzymes. Following release from the
stomach the food is then exposed to bile salts which will emulsify any fats and
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hydrophobic compounds present (Acosta, 2009). Although there are a number of
digestion processes nanoparticles will be exposed to, their sub-cellular size can
dramatically increase their residence time in the gut. They can achieve this because of
the large surface area available to interact with biological entities and their size can
contribute to a decreased rate of clearance by intestinal mechanisms. Nanoparticles can
efficiently deliver bioactive compounds to various targets in the body because they can
pass through fine capillaries, penetrate deep tissues, cross the epithelial lining
fenestration and are usually taken up efficiently by cells (Chen et al, 2006). Along the
inner surface of the small intestine microvilli coat the surface of epithelial cells. These
structures are fundamental for nutrient absorption and the layer of mucin covering the
surface of the microvilli represents a key component involved in nanoparticle uptake
(Acosta, 2009).
The GI tract has been noted as a major area of AgNP deposition coupled with
pathological responses. A number of studies have demonstrated damaged microvilli and
intestinal glands, abnormal pigmentation and an increase in intestinal goblet cells
following oral administration of AgNP in rats (Hadrup & Lam, 2014; Shahare &
Yashpal, 2013; Jeong et al, 2010; Kim et al, 2010). The liver in particular is an
important site of nanoparticle deposition following ingestion with reports of high
concentrations of AgNP reported in mice 24 hours after exposure. Inhalation also
provides a route to the liver. Mucocilliary clearance of nanoparticles can result in entry
to the GI tract and deposition in the liver. Accumulation of AgNP can lead to liver
toxicity including bile duct hyperplasia and inflammation (Kim et al, 2008; Nemmar et
al, 2002). The liver has also been identified as a one of the main pathways involved in
nanoparticle excretion. Hepato-biliary secretion is believed to be a main route of
intestinal secretion of nanoparticles with evidence of gold and polystyrene nanoparticle
excretion by this route. Accumulation of nanoparticles within bile canaliculi is
suggestive of the important role of bile in the intestinal secretion and elimination of
nanoparticles in faeces (Zhao et al, 2014; Johnston et al, 2010; Semmler-Behnke et al,
2008).
There are four main pathways by which nanoparticles can cross the gastrointestinal
mucosa; transcellular uptake by enterocytes, M-cell uptake, persorption and paracellular
uptake. The primary function of enterocytes is to absorb and transport nutrients
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systemically, but data has shown that these cells can also take up particulate material
(Acosta, 2009).

1) Transcellular uptake
The transcellular transport of particulate material across enterocytes is known as
transcytosis. This process begins at the apical cell membrane whereby an endocytic
process transports particles through the enterocytes or the M-cells in Peyers patches and
releases them at the basolateral side of the epithelium (Des Rieux et al, 2006; Magnuson
& Bouwmeester, 2011). There are two methods of transcytosis, one involves the direct
diffusion of particles through the enterocyte, this is a passive mechanism and the other
requires specific receptors for the transport of particles. This active process uses
receptors to capture nanoparticles with specific surface chemistry and internalise them
(Acosta, 2009; Des Rieux et al, 2006).

2) M-cell uptake
Although enterocytes represent 90-95% of the epithelial cells in the intestine it is
through M-cells that is the most common route of uptake for nanoparticles (Powell et al,
2010). M-cells are a specialised, differentiated group of epithelial cells located in the
Peyer’s patches of the lower intestine (Powell et al, 2010; Acosta, 2009). They can
transport material intact from the lumen to adjacent mononuclear cells and their location
is thought to be at important immune inductive sites (Powell et al, 2010). M-cells
primary function is to sample potential antigens in the intestine and this role provides a
mechanism of continued pathogen and antigen surveillance (Powell et al, 2010; Acosta,
2009). Although M-cells are more permeable than enterocytes it would seem that these
cells are an ideal entry point for nanoparticle absorption, however M-cells represent less
than 1% of the total intestine area making delivery of particles more difficult. To
overcome this issue there are currently developments to incorporate specific ligands on
nanoparticles for M-cell delivery. Due to their antigen monitoring role, M-cells have
developed specific receptors to capture various antigens and pathogens coated with
glycoproteins and it is this principle that is being explored as a possible method for the
targeted delivery of nanoparticles (Acosta, 2009).
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3) Paracellular uptake
Another route for nanoparticle uptake in the intestine is through the interstitial space
between epithelial cells known as paracellular uptake. However due to the space
between the cells ranging from 0.3-1nm, the paracellular route is considered the least
effective of the four mechanisms. For the majority of nanoparticles the space between
the epithelial cells is just too small to permeate (Acosta, 2009). Although the tight
junctions between epithelial cells are extremely efficient at preventing even the smallest
nanoparticles to permeate, there are a number of physiological conditions that can affect
the integrity of these junctions (Acosta, 2009; Des Rieux et al, 2006).

Various

situations including disease, calcium chelators and epithelial cell metabolism can affect
tight junctions allowing the influx of very small nanoparticles (Acosta, 2009). In
addition to physiological conditions a number of synthetic peptides can also modulate
the influx of nanoparticles through tight junctions. One such peptide is an E-cadherinderived peptide that expands tight junctions between the endothelium by acting on the
aqueous filled pores of the paracellular pathways causing expansion (Magnuson &
Bouwmeester, 2011).

4) Persorption
Finally the route of persorption or passage through “gaps” has also been described as a
mechanism of nanoparticle uptake. This occurs when enterocytes are shed into the gut
lumen from the villous tip leaving a hole in the epithelium through which nanoparticles
as well as large particles including starch can be translocated (Acosta, 2009). A
summary of all methods of nanoparticle transport across the GI tract is illustrated in
figure 2.2.
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Figure 2.2 Summary diagram of methods of nanoparticle transport in the GI tract

Nanoparticles can be modified to protect from metabolism and local degradation. As a
result they can enter intact into the blood and lymphoid circulation from the
gastrointestinal epithelium and from here be further distributed to other tissues in the
body. Once in the blood nanoparticles can interact with blood components which may
influence their distribution and subsequent excretion. There are a number of organs
where nanoparticles have been identified including the liver and spleen. It has been
revealed that the smaller the nanoparticle the more diverse the distribution within the
body with some nanoparticles identified in the bone marrow and brain (Bouwmeester et
al, 2009).
The method of nanoparticle uptake is influenced by a number of characteristics of the
specific nanoparticle. Absorption depends not only on the physicochemical properties of
the nanoparticle but on the properties associated with the GI tract. Whether a particle is
absorbed or not depends on its initial contact with enterocytes, its ability to access and
diffuse through mucus, cellular trafficking and post-translocation events (Medina et al,
2007). The transcellular uptake of nanoparticles can be influenced by specific particle
26

characteristics such as particle size, surface charge, attachment of ligands or coating
with surfactants, shape, physical and chemical stability (Magnuson & Bouwmeester,
2011). Different properties of particles can affect not only if they are absorbed but the
rate at which they are so. One important factor appears to be charge and studies have
shown that anionic nanoparticles can reach the epithelial surface and diffuse across the
mucus layer whereas cationic particles become trapped in negatively charged mucus
(Magnuson & Bouwmeester, 2011). Size also appears to be a key factor as it has been
shown that the smaller the particle diameter the faster particles diffuse through the GI
tract and reach the colonic enterocytes (Medina et al, 2007).

2.4 GI Tract Defences
As mentioned, oral exposure is the main focus of this report and can include inhalation
as well as ingestion. While separate these systems function only millimetres apart and it
is possible a certain amount of nanomaterial will enter the lung during ingestion in the
oral cavity where both the oesophagus and trachea begin. While this report will include
data on nanoparticle toxicity exposure to the lungs it is mainly toxicity due to ingestion
and the effects on the GI tract that will be investigated.
On a daily basis the GI tract is exposed to numerous potentially harmful agents, and
with a total surface area in the range of 200m2, without an adequate defence system
harmful pathogens and toxic agents would gain easy access to associated organs and the
systemic circulation. While protective mechanisms must be in place for prevention from
infiltration of unwanted agents, a balance must be maintained between the defences
keeping potentially harmful agents out and normal functions such as exchange of
nutrients and ions. As a result the GI tract has a number of defence mechanisms in place
that constantly monitor the substances within the intestine. These include commensal
gut microflora, the epithelial surface of the intestine, intestinal macrophages and
mucosal B cells all of which provide the GI tract with a multi-layered defence system
(Schenk & Mueller, 2008).
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2.4.1 Commensal Gut Microflora
The microflora that are resident in the gut provide a number benefits including
facilitating the digestion of nutrients such as cellulose. The most important function by
far is that these bacteria occupy ‘space’ within the intestine that would otherwise
become occupied by other unwanted disease causing pathogens. While in some
instances such as in immunocompromised patients the commensal bacteria may become
pathogenic, in the normal healthy individual the relationship is mutually beneficial with
microflora providing a barrier defence by maintaining the epithelial villi (Hooper et al,
2001; Schenk & Mueller, 2008).

2.4.2 The Epithelial Surface
Within the intestinal epithelium are specialised cells known as goblet cells. Their
primary function is to secrete mucus onto the surface of the epithelium which adds to
the physical barrier (Mueller & Macpherson, 2006). This complex mix of glycoproteins
ensures commensal bacteria remain in the intestinal lumen and do not penetrate the
epithelium. Another group of cells called Paneth cells, secret antibacterial enzymes such
as lysozyme upon exposure to invading pathogens, another component preventing
access to the intestinal mucosa (Ayabe et al, 2000).

2.4.3 Intestinal Macrophages
Bacteria that bypass the aforementioned intestinal barriers and gain access to the
mucosa can be phagocytosed and destroyed by intestinal macrophages. These
macrophages are also involved in maintaining tissue homeostasis by phagocytosing
dead cells and do not display potent inflammatory cytokine production. This feature
prevents an overstimulation of the immune system to commensal bacteria if they gain
access to the mucosa (Sansonetti & Braesco, 2001; Smith et al, 2001; Schenk &
Mueller, 2008).

2.4.4 Mucosal B cell System
B cells are antibody producing lymphocytes and mucosal B cells provide an active
defence by terminally differentiating into plasma cells that secrete only IgA antibody.
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Once secreted this IgA enters the intestinal lumen and can bind to invading pathogens
reducing their motility and adhesive properties (Kallies et al, 2004; Kaetzel et al, 1991;
Schenk & Mueller, 2008).

2.5 Lung Defences
The lung serves as a massive surface area between the external environment and the
host and as such requires a multilayered defence system to protect from invading
pathogens that are constantly inhaled. There are two types of defence mechanism found
in the lung, the initial mechanical response mechanism and the innate immune response.
The first line of defence involves non-specific receptors that line the lung involved in
mucociliary clearance, cough reflex and the ciliary beat removing invading pathogens.
While this initial line of defence is important it has now been discovered that a more
sophisticated innate immune defence is present providing a key role in removal of
potentially harmful pathogens. Pulmonary epithelial cells produce a variety of small
molecules that are involved in innate immunity. Two of these secreted components SPA and SP-D have been shown to play an important role in host defence (Zaas &
Schwartz, 2005; LeVine & Whitsett, 2001).

2.5.1 Surfactant protein A (SP-A)
SP-A is a surfactant associated protein that is expressed by alveolar type II cells and
binds dipalmitoylphosphatidylcholine (DPPC). Its key role in host defence is enhancing
microbial phagocytosis by macrophages. It acts an opsonin that stimulates uptake of a
variety of pathogens by alveolar macrophages. As wells as enhanced macrophage
uptake, SP-A can also induce calcium dependant neutrophil uptake of certain pathogens
including E. coli (LeVine & Whitsett, 2001).

2.5.2 Surfactant protein D (SP-D)
SP-D is expressed in pulmonary tissue but is also found in other tissues in the body.
Like SP-A, it is expressed by alveolar type II cells and binds phosphatidylinositol in
pulmonary surfactant. SP-D has been shown to bind and aggregate bacteria enhancing
their phagocytosis by alveolar macrophages. In addition to bacteria, SP-D can also bind
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and aggregate certain viral and fungal surfaces including influenza A and Aspergillus
(LeVine & Whitsett, 2001).

2.6 Role of Biofluids
A biofluid is any fluid originating from within the body that can be excreted, secreted,
obtained by a needle or can develop due to a pathological process and ranges from
blood to bile and breast milk to cyst fluid (Medicinenet). There are numerous biofluids
in the body including saliva, blood, urine, stomach acid and bile to name a few. Each
biological fluid has its own important individual role within the body. Some of those
functions include:


Blood: oxygen transport



Saliva: breakdown of starch by amylase and aids in chewing



Urine: excretion of waste metabolites and excess water



Stomach Acid: aids in further digestion and breakdown of food via enzymes



Bile: hydrolyses fat

In addition to the vital physiological role biofluids perform within the body, they have
also been shown to aid in nanoparticle processing including isolating particles from
larger agglomerates, particle coating and modification of surface chemistry (Herzog et
al, 2009). In this study components of two major biofluids found in the body will be
investigated, ursodeoxycholic acid (UDCA), cholic acid (CA) and deoxycholic acid
(DCA) that form part of total bile and dipalmitoylphosphatidylcholine (DPPC) a
component of lung surfactant.

2.6.1 Dipalmitoylphosphatydilcholine (DPPC)
Pulmonary surfactant is composed of a variety of complex phospholipids, lipids and
surfactant specific proteins. DPPC is the most abundant phospholipid, comprising 7080% of total surfactant. Pulmonary surfactant is synthesized by type II pneumocytes and
any deficiency of this fluid can result in serious respiratory disorders such as Acute
Respiratory Distress Syndrome (ARDS). The overall function is to reduce surface
tension at the liquid-air interface at the bronchoalveolar surface (Kumar & Bohidar,
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2010; Serrano & Perez-Gil, 2006). During inspiration, surfactant lowers surface tension
to near equilibrium, minimizing the work of breathing. During exhalation, surface
tension values are reduced, stabilizing the lungs at low air volume and preventing
pulmonary oedema (Bakshi et al, 2008). In order to perform these functions all of the
components of lung surfactant are required to work in synergy.

2.6.2 Bile Acids
Bile acids are steroidal detergents synthesized from cholesterol by hepatocytes which
drain into the bile duct, hepatic duct and finally into the gall bladder for storage. During
digestion and in response to several enzymes, bile is released into the duodenum where
its principle function is lipid digestion. On average 0.4-0.8L of bile is produced each
day with over 95% reabsorbed in the intestine and returned to the gall bladder. Bile
acids themselves are amphiphatic molecules with an unusual structure in that they do
not have a well-defined head and tail group and exist as flat rigid molecules. They can
be divided into two groups (1) primary bile acids, synthesized in the liver from
cholesterol and (2) secondary bile acids, formed following bacterial hydrolysis of the
amide backbone of conjugated bile acids in the large intestine. Bile acids provide a
crucial function in digestion by solubilising and transporting fat soluble nutrients across
the intestinal mucosa. Bile acids adsorb onto the surface of digested lipids and remove
any bound proteins from the surface allowing easy lipid lipolysis by lipid enzymes
(Kumar & Bohidar, 2010; Maldonado-Valderrama et al, 2011; Holm et al, 2013). For
this study three bile acids were investigated;
1. Ursodeoxycholic Acid (UDCA)
2. Cholic Acid (CA)
3. Deoxycholic Acid (DCA)

1. Ursodeoxycholic Acid (UDCA)
UDCA is a secondary bile acid produced from primary bile acids metabolized by gut
bacteria, comprising 3% of total bile acids (Perez & Briz, 2009). Despite its low
abundance it is an extremely interesting bile acid as it has been shown to have direct
antioxidant properties against hydroxyl radicals and can also prevent the retention of
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certain toxic hydrophobic bile acids. UDCA also has a number of therapeutic
applications including dissolving gall stones and as an alternative therapy for hepatitis C
patients in place of interferon therapy (Arisawa et al, 2009; Lapeena et al, 2002).

2. Cholic Acid (CA)
Cholic acid, along with chenodeoxycholic acid (CDCA), is one of the major primary
bile acids in the liver and is synthesized from cholesterol. Cholic acid constitutes about
30-40% of bile acids and together with CDCA makes up almost 80% of the bile acid
component of total bile (Debruyne et al, 2001). Formation of these bile acids is
important in cholesterol homeostasis. The specific enzyme for cholic acid synthesis is
12α-hydoxylase which is important in determining the ratio of cholic acid to CDCA.
Tight regulation of this synthesis is required as it is believed that a change in the ratio of
these two bile acids may result in gallstone formation due to a reduction in the
conversion of cholesterol to bile acids (Del Castillo-Olivares & Gil, 2000).

3. Deoxycholic Acid (DCA)
Deoxycholic acid (DCA) is a secondary bile acid resulting from the anaerobic
dehydroxylation of unabsorbed cholic acid by bacteria residing in the gut. This process
occurs in the colon on any cholic acid that has not been absorbed in the ileum. DCA
constitutes roughly 10-40% of bile acids in total bile (Marcus & Heaton, 1988). DCA
has been noted to promote colonic epithelium proliferation and this proliferation is
related to serum DCA levels (Deschner et al, 1981; Ochsenkuhn et al, 1999). This bile
acid along with others including cholic acid has been implicated in colorectal
malignancies. It has been observed that bile acids can stimulate the growth of malignant
cells and promote their invasion. Certain conjugated bile acids have also been
implicated in breast cysts as elevated levels of these bile acids were observed in cyst
fluid. This may indicate a potential role of glycine conjugated bile acids including
cholic acid, CDCA and DCA in breast malignancies. However other bile acids are also
being exploited as therapies for cancer treatment. UDCA is the most promising with
investigations into a targeted therapy for colorectal cancer (Debruyne et al, 2001).
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2.7 The Immune System
An intact and functioning immune system is vital in the protection against harmful
external stimuli. Inflammation is the process by which cells of both the innate and
adaptive immune system are activated in order to remove an invading agent and repair
any damage caused. The controlled and rapid initiation and effective resolution of
inflammation is vital to maintain normal homeostasis.
The innate immune response is the first line of active defence and comprises a number
of phagocytic cells, including macrophages, neutrophils, and the complement system.
Monocytes in particular are the primary cell type involve in the initial immune response
to external stimuli, recognising distinct patterns (PAMPs) on the surface of pathogens
such as lipopolysaccharide (LPS) via receptors on the cell surface, toll-like receptors
(TLRs) (Palm & Medzhitov, 2009; Beutler, 2009; Oberbarnscheidt et al, 2011) .
Recognition of these patterns is vital in the detection of an infection but also in
determining the type of infection. The response to these PAMPs involves the release of
a variety of pro-inflammatory cytokines including interleukin-1 (IL-1), interleukin-6
(IL-6) and tumour necrosis factor alpha (TNF-α). Monocytes are one of the main
mediators of the initial inflammatory response with an important role in phagocytosis of
foreign material at entry sites (Beutler, 2009; Oberbarnscheidt et al, 2011). Their
production of inflammatory mediators including IL-1, IL-6 and TNF-α, are vital to the
initial immune response. These cytokines have profound effects on associated cells and
the local microenvironment such as leukocyte migration, endothelial adhesion increased
neutrophil activation and antibody secretion all contributing to the inflammatory
response (Rehman et al, 2012; Medzhitov & Janeway Jr, 2000; Kawai & Akira, 2007).
IL-1β is of particular interest due to its central role in the inflammatory process. IL-1β
exerts a number of effects including influencing immune cells such as macrophages and
endothelial cells and also producing systemic effects. Cleavage to its mature form is
essential for directing the host response to injury or infection.

2.7.1 Interleukin-1 (IL-1)
The IL-1 family comprises eleven members of which most are pro-inflammatory but
some can have anti-inflammatory functions. IL-18 and IL-1β are the most fully
characterised and have an unusual property in that they are initially expressed as
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inactive pre-cursors that require additional processing to become biologically active
(Monteleone et al, 2015; Chen & Schroder, 2013). IL-1β in particular is the focus of
many studies due to its highly active state and its secretion from immune cells. Its
functions range from recruitment of immune cells to induction of fever (Dinarello,
1996). It has been shown that IL-1β is involved in certain pathologies, is not required
for normal homeostasis and that a deficiency in this cytokine can have a protective
effect (Joosten et al, 2013; Dinarello, 2011).
Monocytes are the main source of IL-1 which is pivotal in co-ordinating the early
immune response. This cytokine is the most potent fever inducing molecule and as such
is tightly regulated. Over-expression or dysregulation of IL-1 can cause auto
inflammatory disorders and contributes to the progression of septic shock (GoldbackMansky & Kastner, 2009; Dinarello, 2009; Dinarello, 1996). IL-1 has been implicated
in a number of acute and chronic inflammatory disorders and as a result IL-1β has been
isolated as a therapeutic target for the treatment of certain disorders including
rheumatoid arthritis and autoinflammatory syndromes that are characterized by local
and systemic inflammation, recurrent fevers and fatigue (Dinarello, 2011; Dinarello,
2013).

2.7.2 Interleukin-6 (IL-6)
IL-6 is a well-defined multi-functional cytokine involved in the proliferation and
differentiation of cells involved in inflammation. IL-6 activation occurs through binding
to its receptor which can be either membrane bound or soluble (Scheller et al, 2014).
IL-6 has demonstrated a variety of functions in addition to its contribution to the
inflammatory process, including liver regeneration, bone remodelling and metabolism
(Spooren et al, 2011). It has also been shown to have anti-inflammatory properties with
an important role in regulating the levels of other pro-inflammatory cytokines
suggesting a role in the prevention of dysregulation of certain cytokines (Xing et al,
1998; Spooren et al, 2011). The opposing effects exhibited by IL-6 are attributed to the
two receptor types with the soluble receptor responsible for the pro-inflammatory
effects and binding to the membrane bound form accounts for the anti-inflammatory
effects (Wolf et al, 2014).
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IL-6 along with other cytokines including TNF-α, can stimulate the release of
chemokines to attract neutrophils to the site of inflammation and can contribute to the
overall systemic reaction in response to inflammation (Scheller et al, 2011; Gruys et al,
2005). IL-6 induction forms part of the normal initial inflammatory response resulting
from a disruption to the body’s normal homeostasis but its overexpression has been
implicated in a number of pathologies. These can range from autoimmune diseases
including thyroiditis, rheumatoid arthritis to cancer (Feghali & Wright, 1997).
Expression of this cytokine has been shown to be a contributing factor in the
progression of cancers such as colitis associated colon cancer and Kaposi sarcoma. An
increase in levels of circulating IL-6 has also been implicated in the development of
Hodgkin’s lymphoma (Lin & Karin, 2007; Scheller et al, 2011).

2.7.3 Tumour Necrosis Factor Alpha (TNF-α)
TNF-α is a multi-functional molecule which plays a vital role in acute inflammation and
has been described as a very potent cytokine. Along with other pro-inflammatory
cytokines it is important not only in the initiation, but also in the maintenance of
inflammation (Nathan, 2002). Released by a number of cells upon stimulation, mainly
macrophages, TNF-α can mediate a number of responses directly such as fever and
tissue damage, release of acute phase proteins from the liver in addition to cell
proliferation, differentiation and apoptosis (Nathan, 2002; Hehlgans & Pfeffer, 2005).
This cytokine can also exert its effects indirectly by downstream signalling leading to
the activation of other inflammatory factors, such as IL-6, augmenting the inflammatory
response by activation of the cytokine cascade as well as acting as a key factor in
monocyte adhesion to the endothelium by up-regulation of several adhesion molecules
including ICAM-1 (Feghali & Wright, 1997; Warren, 1990; Ende et al, 2014).
In addition to the beneficial role of TNF-α in the inflammatory process and
homeostasis, this cytokine can produce damaging effects to the host. TNF-α has
systemic endotoxic activity that when produced in large quantities, contributes to fever
and shock (Feghali & Wright, 1997; Beutler & Caerami, 1988). Dysregulation can lead
to a chronic inflammatory state and can result in a number of pathological conditions.
Some of the conditions TNF-α has been implicated in include rheumatoid arthritis and
inflammatory bowel conditions (Hehlgans & Pfeffer, 2005). As a result, blocking of
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TNF-α has been and continues to be investigated as a potential therapy for certain
inflammatory disorders (Wong et al, 2008).

2.7.4 The Inflammasome
Induction of IL-1β is particularly interesting as maturation to its fully functioning form
is tightly regulated by the inflammasome. The inflammasome is a complex of multiple
proteins found in the cytoplasm and requires a number of danger signals such as tissue
stress in order to trigger inflammatory caspases. Initial signalling in the innate immune
response via TLRs leads to the transcription of pro-IL-1β but for complete activation a
second signal detected by intracellular sensor molecules is required to activate the
inflammasome, resulting in caspase-1 mediated cleavage to the mature form. The
“sensing” of both signals in a two-step activation process is essential in controlling the
cleavage of cytokines like IL-1β and IL-18 to produce an effective and controlled
inflammatory response against infective agents (Martinon et al, 2002; Latz et al, 2013;
Terlizzi et al, 2014; Schroder & Tschopp, 2010; Gross et al, 2011).
It is now widely accepted that in order to produce the mature active form of IL-1β, gene
expression of this cytokine alone is not sufficient and requires involvement of the
inflammasome. The inflammasome is an important platform allowing for caspase-1
mediated maturation of IL-1β. While a variety of stimuli can induce gene expression of
IL-1β, in order to exert its immunological effects the pro-form must be cleaved by
caspase-1 in order to produce the mature molecule. The most prominently investigated
inflammasome is NLRP3 as it is the most fully characterised, diverse and clinically
significant of all inflammasomes and can be activated by exposure to pathogens and
other environmental irritants (Schroder & Tschopp, 2010). Caspase-1 activity which is
vital for pro-IL-1β cleavage to the bioactive form is tightly regulated by the NLRP3
inflammasome (Latz et al, 2013; Schroder & Tschopp, 2010). In addition to proteolytic
processing of pro-IL-1β, caspase-1 is also required for a form of cell death known as
pyroptosis. This results in rapid pore formation in the plasma membrane of cells leading
to osmotic cell lysis (Satoh et al, 2013). Cleavage to the bioactive form is essential in
order for IL-1β to perform its immunological effects which range from co-ordinating
early immune response through cell activation to systemic responses such as regulation
of appetite, temperature and sleep (Dinarello, 2009; Chen et al, 2011; Kasza, 2013;
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Yang et al, 2012). Inflammasome activation can also play a role in adaptive immunity
as cytokines resulting from its activation are involved in further signalling including
differentiation of T cells into the various subtypes (Chen et al, 2011).

2.8 Nanotoxicity
Toxicity can be defined as the degree to which a substance can harm living organisms.
The area of toxicology studies the interaction and effects of such substances on living
organisms (Timbrell, 1998). As the interaction between living organisms, the
environment and various nanoparticles becomes more common it is now important to
focus not only on the benefits provided by these nanoparticles but to also establish any
risk associated with exposure. Based on the basic definitions of toxicity, nanotoxicology
can be described as the study of the toxic effects of nanoparticles on living organisms
and the environment (Donaldson et al, 2004; Paur et al, 2011; Arora et al, 2012). The
area of nanotoxicology aims to provide answers to some of the concerns raised about
the safety of nanoparticle exposure and to provide clear, conclusive data regarding the
relationship

between

nanoparticles

including

their

concentrationmetrics

and

physicochemical characteristics, and biological systems. The mechanism by which
nanoparticles mediate their toxicity is also an important factor to be considered (Paur et
al, 2011; Suh et al, 2009; Lewinski et al, 2008; Donaldson et al, 2004). AgNP are
becoming of particular interest in nanotoxicology as although they provide a number of
benefits including antibacterial properties it is now apparent that on an ultra-small scale,
they can induce toxicity following internalisation and migrate to various organs around
the body (Sung et al, 2008; DeVasConCellos et al, 2012; Antony et al, 2015).

2.8.1 Nanoparticle Toxicity in the G. I Tract
In this report the focus is on entry and resulting toxicity following oral exposure to
AgNP with a focus on the GI tract, including the lungs, and subsequent entry into the
blood stream. Next to inhalation ingestion of nanoparticles is probably one of the most
common routes of exposure. While toxicity in the lungs following inhalation of AgNP
has been well documented, toxicity brought about by ingestion and the subsequent
effects induced are still not fully understood (Gaillet & Rouanet, 2015). It has been well
documented that prolonged exposure via ingestion to silver results in systemic argyria
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but a full cytotoxic profile of AgNP effects on the GI tract is still required (Gulbranson
et al, 2000; White et al, 2003).
With a total surface area in the range of 200m2 (although this size has recently been
diputed indicating a smaller surface area in the range of roughly 32m2), required for
optimum nutrient exchange and absorption, the GI tract provides one of the largest
surfaces within the body that any internalised nanoparticle will come into contact with
(Powell et al, 2010; Helander & Fändriks, 2014). As discussed previously the GI tract
has been exposed to naturally occurring nanoparticles throughout evolution and has the
capacity to absorb and internalize materials on the nanoscale via a number of uptake
mechanisms (Powell et al, 2010; Acosta, 2009; Des Rieux et al, 2006). This theory can
also be applied to manmade or engineered nanoparticles. Following absorption it is
possible for AgNP to be transported to various organs in the body including the liver
and eventually enter the circulation (Shahare et al, 2013; Bergin & Witzmann, 2013).
The liver in particular operates closely with the GI tract during digestion and is
important in the detoxification of various harmful substances. A number of studies have
reported liver toxicity in response to AgNP exposure and also highlighted it as a major
site of particle accumulation (Hussain et al, 2005; Takenaka et al, 2001; Hadrup &
Lam, 2014; Kim et al, 2008; Sardari et al, 2012). When evaluating the toxicity of
AgNP on the GI tract it must be taken into account the variety of substances the
particles will have contact with. These substances range from the commensal gut
microflora that reside in the intestine to the various biological fluids involved in the
digestive process such as bile and stomach acid, to partially digested food, all which
may influence the particles physicochemical profile and resulting biological response
(Walczyk et al, 2010; Mahmoudi et al, 2011).

2.8.2 Nanoparticle Toxicity and the Immune System
The immune system is a vital component of the body’s defence against foreign elements
such as pathogens and particulates (Chaplin, 2010). Understanding this complex and
sophisticated system is important when investigating nanoparticle toxicity in order to
develop a complete profile of the interaction of nanoparticles with immune cells and the
resulting response induced (Zolnik et al, 2010; Farerra & Fadeel, 2015). Several studies
have focused on investigating the immune-modulatory effects of nanoparticles both in
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pristine form and following their interaction with biological proteins leading to
alterations in the responses induced. These studies have looked at two aspects of
nanoparticle interaction with the immune system: beneficial and harmful (Paino &
Zucolotto, 2015; Barkhordari et al, 2014; Tian et al, 2007; Xu et al, 2013).
Nanoparticles have been shown to initiate inflammation and a subsequent immune
response. For instance carbon nanotubes (CNTs) can affect the phagocytic function of
macrophages leading to an impaired ability to clear an invading pathogen. CNTs may
also impair dendritic cell function, which are vital in stimulating T and B cell responses
thus linking the innate and adaptive responses. This impairment results in
immunosuppression reducing the body’s defence against infection (Dumortier, 2013;
Laverney et al, 2013). AgNP have been noted as potent triggers of an inflammatory
response resulting from interaction with immune cells including macrophages
producing cytokine release and immune cell recruitment with ROS generation often
acting as a contributing factor (Kim & Choi, 2012; Park et al, 2011; Lim et al, 2012;
Martinez-Gutierrez et al, 2012). One of these AgNP mediated responses involves IL-1β
release, a potent cytokine involved in innate immunity which is involved in widespread
systemic effects through activation of the inflammasome (Simard et al, 2015; Yang et
al, 2012). The involvement of AgNP in its release highlights the immunological
significance of these nanoparticles and may have pathological consequences or
contribute to already existing diseases (Birrell & Eltom, 2011; Yang et al, 2012).
As previously mentioned nanoparticle immune system interactions can be manipulated
to provide desirable immune-modulatory effects. An investigation into engineered
nanoparticles has highlighted their potential use as antigen-presenting cells and carriers
of immunostimulatory molecules for vaccination purposes (Zolnik et al, 2010; Farrera
& Fadeel, 2015). Nanomaterials are also being investigated as potential adjuvants.
Adjuvants are important components of vaccines enhancing immunogenicity of a
particular antigen thus increasing a protective immune response. AgNP have been
targeted as a potential adjuvant with a study demonstrating significant adjuvant effects
when tested with bovine serum albumin (BSA) and ovalbumin (OVA) in mice.
Increased levels of specific antibodies along with leukocyte recruitment highlighted the
potential biomedical application of AgNP as an adjuvant (Xu et al, 2013). While these
initial findings look promising AgNP use as an adjuvant is a long way off considering
their toxicity.
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The two sided argument for nanoparticle interaction with the immune system leaves a
lot of questions still unanswered as to the variety of responses induced by exposure, the
role of physicochemical transformation upon entry has on responses induced and also
where to find a balance between the desirable and harmful effects of nanoparticles both
natural and engineered on the immune system.

2.9 Summary
Nanotechnology has a wide variety of applications in consumer products and as a result
the potential contact with living systems cannot be avoided. This has resulted in
concerns being raised about the potential risk nanoparticle exposure has on the health of
humans and also its environmental impact. AgNP in particular have been highly
regarded for their benefits but it is only now coming to light the health risks they pose.
As such a more in depth analysis of their toxic potential is required including looking at
their interaction with various components of biological systems and the resulting
responses produced following oral exposure. This includes assessing interactions with
components of biofluids such as bile and lung surfactant to establish if this can
influence the biological response provoked by AgNP as well as the consequences of
AgNP entry into the circulation. From the literature reviewed and the evidence provided
on the toxicity of AgNP exposure, this study aims to investigate the modification of
AgNP physicochemical characteristics and toxicity by biofluid components. In addition
an investigation into the induction of an innate immune response following particle
absorption into the blood will be undertaken. Hopefully this study can provide a more
realistic and detailed investigation into the toxicological effects of AgNP and contribute
to the on-going development of a complete risk assessment detailing the potential risk
posed by exposure to AgNP.
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Chapter 3

General Experimental
3.1 Introduction
This chapter will introduce and outline the various techniques used in characterising and
determining the cytotoxic effect of AgNP. Full characterisation of nanoparticles is
crucial in assessing the size, shape, stability and other properties of particles prior to
cytotoxicity testing. It is these properties which will ultimately affect how AgNP will
interact with cells and other biological entities upon entering the body and determine
their cytotoxic profile. The AgNP in question are PVP coated particles purchased from
Sigma-Aldrich, Dublin (Catalogue No: 758329). Together with the physicochemical
characterisation, the methods used for cytotoxic, inflammatory and immunological
evaluation will also be discussed in this chapter.

3.2 Test materials and reagents
Polyvinylpyrrolidone (PVP) coated silver (Ag) nanopowder of < 100nm Catalogue No:
758329, was purchased from Sigma-Aldrich Ltd (Dublin, Ireland). 3-(4, 5Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) Catalogue No: M5655
and 2’, 7’- dichlorofluorescin diacetate (DCFH-DA) Catalogue No: D6883 as well as
cell culture media, supplements, trypsin solution, lipopolysaccharide (catalogue No:
L4391), polymyxin B (catalogue No: P0972), Tri-reagent (catalogue No: T9424), 1Bromo-3chloropropane (catalogue No: B9673), 2-propanol (Catalogue No: I9516),
ethanol (Catalogue No: E7023), PCR primers, adenosine 5’-triphosphate disodium salt
hydrate (ATP) (Catalogue No: A6419) and Ac-YVAD-CMK an inhibitor of the
inflammasome were all purchased from Sigma-Aldrich Ltd (Ireland). Alamar blue (AB)
was purchased from Biosciences (Dublin, Ireland). UDCA (Catalogue No: U5127), CA
(Catalogue No: C1129), DCA (Catalogue No: D2510) and DPPC were purchased from
Sigma-Aldrich (Dublin, Ireland). Reverse transcription qScript™ kit (Catalogue No:
95047) was purchased from Quanta Bioscience (Maryland, USA). Two step reverse
transcription of DNA was performed using LightCycler® 480 SYBR Green I Master kit
(Catalogue No: 04 887 352 001) purchased from Roche (Sussex, UK).
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3.3 Characterisation of nanoparticles
Prior to the cytotoxicity testing, pristine AgNP and AgNP in various dispersions were
characterised. The suspensions of AgNP were prepared in deionised water (dH2O),
DMEM and RPMI media using a bath-sonicator for 20 minutes (Degussa-Ney
ULTRAsonik 57X 50/60 Hz, California, USA) prior to size and zeta potential analysis.

3.3.1 Scanning Electron Microscopy (SEM)
Scanning electron microscopy (SEM) generates a number of signals at the surface of
specimens using a focused beam of high-energy electrons. Signals received from the
electron-sample interaction reveal information regarding the external morphology,
chemical composition, crystalline structure and orientation of the sample. A 2dimentional image of the sample is generated by data collected over a selected area of
the sample surface. Using conventional SEM techniques an area of 1cm to 5 microns
can be imaged.
Scanning electron microscopy was employed to estimate nanoparticle size from the
images produced by this technique. A Hitachi SU 6600 FESEM instrument was used to
obtain images of the AgNP. First the SEM was calibrated with Au on Carbon standard
provided by Agar Scientific (Essex, UK). Samples were prepared by dispersing particles
in ethanol by sonication 750 watts Ultrasonic Processor tip (Branson Ultrasonics, Ultra
sonic processor VCX-750W) at 40% amplitude for a total of 45 seconds. Samples were
spin coated onto pure silicon wafers which had been thoroughly cleaned by sonication
in acetone for 30 minutes followed by boiling in propanol for 30 minutes. Silicon
wafers were then left to air dry in a dust free environment and the nanoparticle sample
was then spin coated onto wafers 24 hours prior to measurement.

3.3.2 Dynamic Light Scattering (DLS)
Dynamic light scattering (DLS) is a technique employed for measuring the
hydrodynamic radius of particles. Particles are illuminated by a laser which scatters
light due to Brownian motion. Smaller particles are moved further and more rapidly
producing greater fluctuations of light.The intensity of this light scatter is fluctuated at a
rate dependant on the size of a particle. Analysis of these fluctuations or scatter pattern
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yields information on the hydrodynamic radius of the particle using the Stokes-Einstein
equation (equation 3.1):

Equation 3.1 Stokes-Einstein equation

D is the diffusion constant
kB is Boltzmanns constant
T is absolute temperature
η is the viscosity of the medium
r is the radius of a spherical particle

DLS and zeta potential measurements were performed with the aid of a Malvern
ZetaSizer Nano ZS (Malvern Instruments, Worcestershire, UK) operating with version
5.10 of the systems Dispersion Technology Software (DTS Nano). For size
measurement DTS0012 disposable sizing cuvettes were used. The samples were
equilibrated at 25°C for 2 minutes before each measurement.

3.3.3 Zeta Potential Analysis
Zeta potential is a measure of particle stability. The liquid layer surrounding a particle
consists of two parts an inner region where ions are tightly bound and an outer region
where they are less firmly bound. Within the outer layer is a boundary known as the
slipping plane where ions and particles form a stable entity and the potential at this
boundary is the zeta potential.
Zeta potential measurements were performed with the aid of a Malvern ZetaSizer Nano
ZS (Malvern Instruments, Worcestershire, UK) operating with version 5.10 of the
systems Dispersion Technology Software (DTS Nano). For zeta potential analysis,
DTS1060T clear disposable zeta cells were used and measurements were performed
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with the automatic model setting, using a voltage of five to minimize artefacts and
charring of media proteins during analysis.

3.3.4 BET Analysis
The specific surface area of AgNP was established with a Micrometrics GEMINI BET.
BET sample holders were filled with a known mass of powdered nanoparticles and
measured. The sample was degassed for two hours at room temperature with nitrogen
gas prior to analysis. Nitrogen gas was used as the absorptive gas and a multipoint
method was used in the estimation of specific surface area.

3.4 Cell culture
HepG-2 cells (ATCC: HB-8065) an immortalized hepatocellular carcinoma cell line,
Hep2 (ATCC: CCL-23) a cell line of laryngeal origin, A549 (ATCC: CCL-185) an
immortalized carcinogenic alveolar cell line and the human monocyte cell line THP-1
(ATCC: TIB202) were employed this study. HepG-2 cells were cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM) with 2mM L-glutamine, sodium pyruvate and
supplemented with 10% foetal bovine serum (FBS) at 37°C in humidified 5% CO2.
Hep2 cells were cultured in RPMI-1640 medium supplemented with 10% FBS, 45
IU/ml penicillin and 45 IU/ml streptomycin at 37°C in humidified 5% CO2. A549 cells
were cultured in RPMI-1640 medium supplemented with 10% foetal bovine serum
(FBS), 2mM L-glutamine and 45 IU/ml penicillin and 45 IU/ml streptomycin at 37°C in
humidified 5% CO2. The THP-1 cell line was cultured in RPMI 1640 (Sigma-Aldrich,
Ireland) supplemented with 12.5% foetal bovine serum and 2mM L-glutamine. Cells
were incubated at 37°C in humidified 5% CO2. All cell culture media including FBS
other reagents and supplements are from Gibco purchased through Biosciences (Dublin,
Ireland).

3.5 Cytotoxic evaluation
The AB and MTT assays were performed for assessment of cytotoxicity of AgNP to the
cell lines. The test used a range of eight concentrations of AgNP (3.91-500µg/ml) in
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which effects were likely to occur, this in turn allowed inhibitory concentration (IC50) to
be calculated. In all cases results were compared to an unexposed control (cells in
culture media only), eliminating any dependence of the cell line exposures on well type,
seeding efficiency and numbers, exposure times and volumes. A stock suspension of
AgNP was prepared aseptically from which different concentrations of nanoparticles
were prepared in the respective HepG-2, Hep2, A549 and THP-1 cell media followed
by sonication (Branson Ultrasonics, Ultra sonic processor VCX-750W, maximum
amplification 40%). As a positive control 10% DMSO was prepared in the respective
media. For cytotoxic analysis of nanoparticles in the presence of biofluid components, a
range finding experiment was performed to determine concentration of interest for the
definitive experiment. A stock solution of this test concentration was prepared for each
biofluid component, UDCA, CA and DCA, and the surfactant DPPC in the appropriate
cell media. A concentrationfinding experiment for each bile acid was performed in the
respective cell lines to determine a working concentration for cytotoxic studies. The
working concentration was noted to have no cytotoxic effect when exposed to cells
alone. Based on the concentrationfinding experiments and previous studies,
concentrations of 50µM, 1mM and 0.125mM were prepared for UDCA, CA and DCA
respectively and a concentration of 2.2 x 10-7M UDCA was prepared for Hep2 cell line
(Arisawa et al, 2009). Using this solution of each biofluid component and DPPC, a
stock dispersion of AgNP was prepared aseptically from which a range of nanoparticle
concentrations was prepared. For cytotoxic analysis of nanoparticles in the presence of
DPPC a concentration of 0.25µg/ml was chosen based on previous studies (Herzog et
al, 2009). A stock solution of this test concentration (0.25µg/ml) was prepared for
DPPC in RPMI-1640. For all assays and exposure scenarios fresh nanoparticle
suspensions were prepared for each experiment.

3.5.1 Alamar Blue assay
The alamar blue assay is a cell viability assay that measures the proliferation of cells.
Growing cells maintain a reducing environment in their cytosol that causes the REDOX
indicator contained in the AB dye to be converted from the non-fluorescent resazurin, to
the fluorescent resorufin dye. The fluorescence is measured and relates to the quantity
of proliferating cells present.
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For the AB assay, cells were seeded in 96 well microtitre plates (Nunc, Denmark) at a
density of 1 x 10⁵, 5 x 104, 4 x 104 and 3 x 104 cells per ml for 24, 48, 72 and 96 hour
exposures respectively in 100µl of cell culture media containing 10% FBS. At least
three independent experiments were conducted with six replicate wells employed per
concentration per plate in each independent experiment. After 24 hours of cell
attachment, plates were washed with 100µl per well PBS and treated with increasing
concentrations of AgNP prepared in media for 24, 48, 72 and 96 hours. All incubations
were performed at 37°C in a 5% CO2 humidified incubator. The assay was performed
according to manufacturer’s instructions. Briefly, control media and test exposures were
removed, cells were rinsed with 100µl PBS and 100µl of AB solution (5% [v/v]
solution of AB) prepared in fresh media with no added supplements were added to each
well. After 3 hour incubation AB fluorescence was measured at excitation and emission
wavelength of 531nm and 595nm respectively in TECAN GENios (Grodig, Austria).
Wells containing AB solution and media only were used as blanks. For this assay the
mean fluorescence units for six replicate cultures were calculated for each exposure
treatment. Acellular studies were performed with test particles and the AB dye to
confirm no interference of the particle with dye conversion (Gupta Mukherjee et al,
2012).

3.5.2 MTT assay
The MTT assay is used to measure the mitochondrial integrity of cells. Viable cells
depend on an intact mitochondrial respiratory chain. When cells are alive the yellow
tetrazolium salt (MTT) is cleaved to a purple formazan dye by succinate dehydrogenase
a component if the mitochondrial respiratory chain. Cells are then solubilised with an
organic solvent and the absorbance is measured.
As with the AB assay a parallel set of three plates were set up for the MTT assay,
seeded and exposed as previously described. After the same exposure times as AB
assay, 24, 48, 72 and 96 hours, test medium was removed. Cells were washed with
100µl PBS and 100µl of freshly prepared MTT solution (5mg/ml MTT in media
{without supplements}) was added to each well. After 3 hour incubation the solution
was removed, cells were rinsed 100µl PBS and 100µl MTT fixative (DMSO) was added
to each well. Plates were shaken at 240rpm for 10 minutes. Following this step the
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supernatant was removed and transferred to a new 96 well plate for analysis as it has
been observed that sedimentation of AgNP on the bottom of wells interferes with
absorbance readings, producing higher values. Absorbance was read at 595nm in
TECAN GENios (Grodig, Austria). Acellular studies were performed with test particles
and the MTT dye to confirm no interference of the particle with dye reduction (Gupta
Mukherjee et al, 2012).

3.5.3 Reactive Oxygen Species (ROS) studies
The ROS assay uses a cell permeable fluorogenic probe, dichlorodihydrofluorescin
diacetate (DCFH-DA) to detect intracellular reactive oxygen species. DCFH-DA is
diffused into cells and deacetylated by cellular esterases to the non-fluorescent DCFH.
DCFH is then rapidly oxidised to the fluorescent DCF by ROS. The fluorescence is
measured and is directly proportional to the levels of ROS in cells.
Intracellular oxidative stress was quantified using a 2’, 7’-dichlorofluorescin diacetate
(DCFH-DA) plate assay to detect intracellular hydroperoxides and probe for a wide
range of ROS. Confluent cells were trypsinized and seeded at a density of 1 x10⁵ cells
per ml prepared in media, onto 96 well black bottomed plates (Nunc, Denmark) and
allowed to attach for 24 hours. Six independent experiments were performed with six
replicate wells for negative control, positive control and test concentrations on each
plate. A working stock of 20µM DCFH-DA in PBS was prepared and all test
concentrations, positive and unexposed negative controls were prepared in this working
stock and exposed to cells. The negative control consisted of 20µM DCFH-DA in PBS
only, the positive control was 5µM hydrogen peroxide (H2O2) prepared in DCFHDA/PBS working stock and the AgNP test concentrations (3.91-500µg/ml) together
with the AgNP-biofluid component test concentrations were prepared in the DCFHDA/PBS working stock. Prior to cellular testing, acellular studies were performed with
the test particles and the DCF dye at all test scenarios to confirm no reduction of the dye
due to AgNP interference. No reduction of DCFH-DA by AgNP was noted (Gupta
Mukherjee et al, 2012).
After 24 hours of attachment, the media was removed and wells were washed with PBS,
100µl per well. Cells were then treated with 100µl of positive control, negative control
and test concentrations and plates were incubated for 15min, 30 min, 1hr, 2hr, 3hr, 4hr,
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5hr and 6hr. The rate of intracellular ROS production was monitored at each time point
by the emission of DCFH-DA at 529nm by excitation at 504nm at the various time
points (plates were re-incubated after each time point reading). Readings were
performed on a TECAN GENios plate reader (Grodig, Austria).

3.5.4 Confocal Microscopy
The confocal microscope enables visualisation deep within living tissues and cells. It
uses point illumination and a spatial pinhole to eliminate out of focus light allowing
only light within the focal plane to be detected. This allows for increased contrast and
the ability to produce 3-dimensional structures from the images obtained.
Confluent cells were trypsinized and at a concentration of 1 x 105 cells per ml, 100µl of
cell suspension were seeded onto 35mm glass bottom dishes (MatTek Corporation,
Ashland, MA, USA). Glass dishes were incubated for 1 hour. Following incubation 1ml
of cell culture media was added to cell suspensions. Dishes were re-incubated and
allowed to attach for 24 hours. A working stock of 10µM CM-H2DCFDA (Molecular
Probes- Invitrogen, California, USA) was prepared in DMSO. A stock suspension of
AgNP was prepared aseptically, from which different concentrations of nanoparticles
could be prepared, was prepared in cell media followed by bath-sonication (DegussaNey ULTRAsonik 57X, California, USA). As a positive control, 10% DMSO was
prepared in the respective cell culture media. The negative control consisted of cell
culture media only.
After 24 hours of attachment, media was removed and glass dishes were washed with
PBS 1ml per dish. Cells were treated with 100µl of CM-H2DCFDA and incubated for
30 minutes. After incubation, dishes were washed in PBS 1ml per dish. 1ml test
concentrations, negative and positive controls were added to dishes and incubated for 1
hour. After incubation dishes were washed in PBS 1ml per dish and imaged
immediately. Images were taken on a Zeiss 510 LSM confocal microscope with an
external argon ion laser source of 488nm excitation and using a bandpass filter of 505530nm to detect the fluorescent DCF dye.
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3.5.5 Clonogenic assay
The clonogenic assay, standardised by Franken et al (2006), was initially developed in
1956 by Puck and Marcus. The assay was performed in six well plates (Nunc, Denmark)
each seeded with 1ml of cell suspension in media, 400 cells per ml, and 1ml of media
alone. Cells were allowed to attach for 12 hours to ensure there were single cells at the
bottom of each well at the time of exposure. After the attachment period, wells were
washed with PBS 2ml per well and then treated with increasing concentrations of AgNP
(3.91-500µg/ml) prepared in RPMI or AgNP prepared in RPMI with DPPC, 2ml per
well. Plates were then incubated for 10 days, 37°C 5% CO2 in a humidified incubator
(Herzog et al, 2007; Casey et al, 2008). Two replicate wells on each plate were used for
controls. This was performed for each test concentration. Following incubation, test
exposures and controls were removed and wells washed with 2ml per well PBS. Finally
cells were fixed and stained with 20% carbol fuschin in dH2O (BDH, Poole, UK) and
colonies were manually counted. For all assays 10% DMSO prepared in supplemented
media was used for positive control.

3.6 Inflammatory Studies
3.6.1 IL-8 & TNF-α
Release of inflammatory markers Interleukin 8 (IL-8) and tumour necrosis factor alpha
(TNF-α) were studied using Human ELISA Max™ deluxe sets for IL-8 and TNF-α of
BioLegend Inc. (San Diego, California). Supernatant samples were collected prior to
inflammatory studies. Sample collection was performed in six well plates (Nunc,
Denmark) each seeded with 1ml of cell suspension in RPMI, 5 x 10 4 cells per ml. Plates
were incubated at 37°C for 24 hours. After incubation cells were treated with 1ml of
increasing concentrations of AgNP (3.91-500µg/ml). Plates were incubated and cell
supernatant collected at designated time intervals, 1 through 6 hours. After sample
collection inflammatory studies were performed as per manufactures instructions. All
reagents and standards were prepared as per instructions and all reagents were brought
to room temperature prior to use. In brief, one day prior to running ELISA 100µl of
capture antibody (IL-8/TNF-α) was added to each well of a Nunc Maxisorp™ 96
microwell plate. Plates were sealed and incubated for 16-18 hours at 4°C. Following
capture antibody attachment, plates were washed 4 times with at least 300µl wash
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buffer per well with residual buffer removed by firmly tapping plate on absorbent paper.
To block non-specific binding 200µl assay diluent A was added to each well. Plates
were sealed and incubated at room temperature for 1 hour with shaking at 200rpm.
Following incubation, plates were washed as per instructions and 50µl of samples and
standards were added to wells. Plates were sealed and incubated at room temperature for
2 hours with shaking. Following incubation plates were washed in wash buffer and
100µl detection antibody solution was added to each well, plates were then sealed and
incubated at room temperature for 1 hour with shaking. Plates were washed in wash
buffer and 100µl of Avidin-HRP solution was added to each well. Plates were sealed
and incubated for 30 minutes at room temperature with shaking. Following incubation,
plates were washed in wash buffer and 100µl TMB substrate solution C was added to
each well with incubation in the dark for 15 minutes. After incubation, 100µl stop
solution was added to each well and absorbance was read at 450nm and 570nm within
30 minutes using a SpectraMax® M3 Microplate reader (Molecular Devices, California,
USA).

3.7 Pro-inflammatory Cytokine Gene Expression Analysis
3.7.1 Cell Line Treatment with AgNP
The human monocyte cell line THP-1 was cultured in RPMI 1640 (Sigma-Aldrich,
Ireland) supplemented with 12.5% foetal bovine serum and 2mM L-glutamine. Cells
were incubated at 37°C in humidified 5% CO2. For exposures, cells at density of 1 x 105
cells per ml in 10mls cell culture media were seeded in T25 flasks (Corning Life
Sciences) and incubated overnight at 37°C in humidified 5% CO2. Designated flasks
were then exposed to either two concentrations of AgNP (50 and 100µg/ml), LPS
(1µg/ml) or a combination of AgNP and LPS. AgNP and LPS and a combination of
AgNP and LPS in cell culture media were added to assigned flasks making a final
volume of 20mls per flask. Flasks were incubated for 1, 6, 8 or 24 hours. Following
exposures cell suspensions were centrifuged at 1200rpm for 10 minutes at 4°C.
Supernatants were removed and stored for further analysis and cells were re-suspended
in 1ml PBS ready for RNA extraction.
AgNP exposure doses for later gene expression studies were chosen based on Inhibitory
Concentration (IC50) of THP-1 cells exposed to increasing concentrations of AgNP (1.963

250µg/ml) as determined by the alamar blue (AB) cytotoxicity assay. Cells were seeded
in 96 well microtitre plates (Nunc, Denmark) at a density of 1 x 10⁵ cells/ml for 24 hour
exposure in 50µl cell culture media, after which designated flasks were exposed to 50µl
of increasing concentrations of AgNP. At least three independent experiments were
conducted with six replicate wells employed per concentration per plate in each
independent experiment. Plates were treated with increasing concentrations of AgNP
prepared in media for 24 hours. This time point was chosen as gene studies require
shorter exposure times in order to detect gene expression. Following incubation the
assay was performed according to manufacturer’s instructions. Briefly, 50µl AB
solution was added to wells (total volume 150µl) and incubated for 3 hour. Following
incubation AB fluorescence was measured at excitation and emission wavelength of
531nm and 595nm respectively using a SpectraMax® M3 Microplate reader (Molecular
Devices, California, USA). Wells containing AB solution and media only were used as
blanks with 10% DMSO used as a positive control. For this assay the mean fluorescence
units for six replicate cultures were calculated for each exposure treatment. IC50 values
were calculated from the average response of three independent experiments fitted to a
sigmoidal curve and a four parameter logistic model used to calculate IC50 with a
(p<0.05).
In an experiment to establish possible endotoxin contamination of AgNP, THP-1 cells
were incubated with polymyxin B (20µg/ml) for 1 hour prior to AgNP exposure. Cells
at density of 1 x 105 cells per ml in 10mls cell culture media were seeded in two sets of
four (eight total) T25 flasks (Corning Life Sciences) and incubated overnight at 37°C in
humidified 5% CO2. One set of flasks were incubated with 20µg/ml polymyxin B for 1
hour prior to exposure. Designated flasks were then exposed to either AgNP (50 µg/ml),
LPS (1µg/ml) or a combination of AgNP and LPS. AgNP and LPS and a combination
of AgNP and LPS in cell culture media were added to assigned flasks making a final
volume of 20mls per flask. Flasks were incubated for 8 hours. Following exposures, cell
suspensions were centrifuged at 1200rpm for 10 minutes at 4°C. Supernatants were
removed and cells were re-suspended in 1ml PBS ready for RNA extraction and
subsequent gene expression analysis. The presence of polymyxin B prevented LPS
induced gene expression but did not inhibit AgNP induced gene expression. Endotoxin
was not detected in AgNP used in this study.
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For IL-1β ELISA studies, THP-1 cells (n=5) were plated alone or stimulated with LPS
(10ng/ml) for 4 hours and exposed to ATP (5mM) for 1 hour or AgNP (50 and
100µg/ml) for 6 hours at 37°C. In some cases cells were pre-treated with Ac-YVADCMK (20µM) for 1 hour prior to ATP and AgNP exposures.

3.7.2 Primary Monocyte Isolation and Treatment with AgNP
20mls of whole blood were taken from 20 normal healthy donors after acquiring
internal ethical approval via a review board and individual donor consent in heparinized
vacutainers and all samples were processed immediately. Monocytes were extracted by
positive selection process using CD14 Dynabeads® from Invitrogen by Life
Technologies (Dublin, Ireland). Prior to use beads were washed and re-suspended as per
manufacturer instructions. For the isolation process 500µl beads per 20mls whole blood
were utilized and the procedure was performed as per instructions. Briefly, whole blood
samples were diluted 1:2 in monocyte isolation buffer and centrifuged at 600g for 10
minutes at room temperature. Following centrifugation the upper layer was discarded
and the blood re-suspended to the original volume in monocyte isolation buffer. Blood
was transferred to 15ml tubes and 500µl Dynabeads® were added to each sample.
Tubes were incubated for 20 minutes at 2-8°C with gentle tilting. Following incubation,
tubes were placed in the DynaMag™ 15 magnet (Invitrogen by Life Technologies,
Dublin, Ireland) for 2 minutes. For positive monocyte selection, the supernatant was
carefully removed and discarded from the tubes which remained in the magnet and had
attached monocytes in the tube. 15ml isolation buffer was added to tubes with gentle
mixing to wash monocytes from the tubes. This wash step was repeated twice more to
obtain a high purity of extracted monocyte cells. The pellet was then re-suspended in
RPMI-1640 cell culture medium.
Cells were counted on a Beckman Z™ Series COULTER COUNTER® (Brea,
California, USA) and were seeded at a concentration of 4 x 104 cells per ml (500µl total
volume) in a 24 well plate (Nunc, Roskilde, Denmark), and incubated at 37°C with 5%
CO2 overnight. Cells were then exposed to AgNP concentration of 50µg/ml (IC 50
concentration). Plates were incubated for 8 hours at 37°C with 5% CO2.
Experimentation was limited on the extracted monocytes as only as small number of
monocytes was harvested per donor blood sample. Therefore all optimisation
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experiments incorporating concentration, time and the effects of LPS stimulation were
carried out on THP-1 cells prior to these experiments.
Following incubation cells were removed from the base of the 24 well plates using a
cell scraper (Sarstedt, Numbrecht, Germany), suspended in cell culture media, and spun
in a pre-cooled microfuge at 3000g for 5 minutes at 4°C. Cell pellets were re-suspended
in 1ml PBS for subsequent RNA extraction.

3.7.3 Gene Expression Analysis
The ability of AgNP exposure to induce pro-inflammatory cytokine gene expression
was evaluated using RT-PCR. THP-1 cells and monocytes from a human cohort (n=20)
were cultured in vitro and exposed to AgNP as described in the previous section. Once
cells were centrifuged and the pellet re-suspended, total RNA was isolated using the
Tri-reagent protocol developed by Chomczynski & Sacchi (1987). Briefly, the pellet
was re-suspended in a pre-cooled microfuge at 3000g for 5 minutes at 4°C. The
supernatant was removed and 1ml of Tri-reagent added. Samples were allowed to stand
at room temperature for 5 minutes then 0.2ml of 1-Bromo-3chloropropane per ml of
Tri-reagent was added. Samples were mixed for 15 seconds and allowed to stand for 2
minutes at room temperature before centrifugation at 12000g for 15 minutes at 4°C. The
aqueous phase (colourless upper liquid) was transferred to a fresh tube. 0.5ml of
isopropanol per ml of Tri-reagent was added to each tube, and incubated at room
temperature for 5 minutes. Tubes were centrifuged at 12000g for 10 minutes at 4°C, the
supernatant was removed and the pellet was washed with 1ml ethanol. The RNA pellet
was re-suspended in 30µl of DEPC H2O. First strand cDNA was synthesized using
qScript™ kit Quanta Bioscience (Maryland, USA), according to manufactures
instructions. Briefly, reverse-transcription master mix was prepared; 15µl of master mix
was pipetted into individual tubes followed by 5µl each RNA sample. Tubes were
mixed gently and contents were collected by brief centrifugation. Tubes were placed in
a Thermocycler following the protocol and the run was initiated.
The resulting cDNA was amplified using quantitative real time PCR using
LightCycler® 480 SYBR Green I Master from Roche Life Science (Sussex, UK).
Samples were analysed on LightCycler® 480 white 96 well plates from Roche Life
Science (Sussex, UK).
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Table 1 Table of forward and reverse primer sequences for housekeeping gene actin,
and for target genes IL-1, IL-6 and TNF-α
Gene

Forward Sequence

Reverse Sequence

Actin

5’-ACTCTTCCAGCCTTCCTTCC

5’-GTTGGCGTACAGGTCTTTGC

IL-1

5’-GGGCCACACATCTACTAGGC

5’-TGGGTATCTCAGGCATCTCC

IL-6

5’-

5’-

GATGCAATAACCACCCCTGACCC

CAATCTGAGGTGCCCATGCTAC

5’-AAGAGAATTGGGGGCTTAGG

5’-CAGGGATCAAAGCTGTAGGC

TNFα

Cycling conditions were the same for all primers and as follows: 95°C for 5 minutes,
followed by 45 cycles of 95°C for 10 seconds, 60°C for 10 seconds and 72°C for 10
seconds, followed by 1 cycle of melting curve of 95°C for 5 seconds, 65°C for 1 minute
then cooling at 4°C. PCR was performed on a Roche LightCycler®480 system (Sussex,
UK). CT data results were obtained directly from the LC480 program (using SYBR
green fluorescence) and used to determine the pro-inflammatory gene expression levels
following AgNP exposure. The delta delta (ΔΔ) CT method of relative quantification
was applied in the analysis of RT-PCR gene expression data (Livak & Schmittegen,
2001).

3.7.4 Human IL-1β ELISA
Release of Human IL-1β was studied using a Human IL-1β ELISA Max™ Deluxe set
from BioLegend Inc. (San Diego, CA, USA). THP-1 cells were plated in 24 well plates
(Nunc, Roskilde, Denmark) 2 x 105 cells per well in 200µl of 10% FBS 1640 RPMI
medium. AgNP in cell culture media were added to each well making a final volume of
400µl per well. Cell culture supernatant was collected after 6 hours and stored at -80°C.
ELISA carried out as per manufacturer instructions. Briefly, one day prior to
investigation 96 well plates were coated with diluted Capture Antibody solution, 100µl
per well. Plates were sealed and incubated overnight between 2 and 8°C. The following
day plates were washed 4 times with wash solution as per instructions and 200µl 1X
Assay Diluent A was added to each well in order to block plates. Plates were sealed and
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incubated at room temperature for 1 hour with shaking. After incubation plates were
washed 4 times and 50µl of Assay Buffer D was added to wells that would contain
sample or standard. 50µl of sample or standard was added to the appropriate wells and
plates were sealed and incubated at room temperature for 2 hours with shaking.
Following incubation, plates were washed 4 times and 100µl of diluted Detection
Antibody solution was added to each well. Plates were sealed and incubated at room
temperature for 1 hour with shaking. After incubation plates were washed 4 times and
100µl of diluted Avidin-HRP solution was added to each well. Plates were sealed and
incubated at room temperature for 30 minutes with shaking. Following incubation plates
were washed 5 times with soaking for 30 to 60 seconds per wash. 100µl of Substrate
Solution was added to each well and plates were incubated in the dark for 20 minutes.
After incubation 100µl of Stop Solution was added to each well to stop the reaction.
Absorbance was measured immediately at 450nm and 570nm using a SpectraMax® M3
Microplate reader (Molecular Devices, California, USA).

3.8 Statistical analysis
At least three independent experiments were performed for each cytotoxicity endpoint.
Results for each assay were expressed as a percentage of unexposed control ± standard
deviation with control values set as 100%. Statistically significant differences between
samples and their respective controls were calculated using the statistical analysis
package InStat (GraphPad Software Inc, San Diego, California). Statistically significant
differences were set at p<0.05. Normality of data was confirmed with Q-Q percentile
plots and Kolmogorov-Smirnov tests. Equality of variances was evaluated using Levène
tests. One-way analysis of variances (ANOVA) followed by Dunnett’s multiple
comparison tests were carried out for normally distributed samples with homogeneous
variances. Non-parametric tests, namely Kruskal-Wallis followed by Mann-Whitney-utests were applied to samples without normal distribution and/or inhomogeneous
variances. Cytotoxicity data (where appropriate) was fitted to a sigmoidal curve and a
four parameter logistic model used to calculate the Inhibitory Concentration (IC 50)
values. The IC50 value refers to a concentration of a compound where a 50% effect is
observed, in this case a reduction in cell viability. IC50 values were reported as ±95%
confidence intervals. IC50 values were estimated using XLfit3™, a curve fitting add on
for Microsoft® Excel (ID Business Solutions, UK).
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For real-time PCR experiments, relative quantification analysis directly from the LC480
program (from the real-time PCR experiments using SYBR green fluorescence) was
used to determine the pro-inflammatory gene expression levels following AgNP
exposure. The reference gene (Actin) normalises sample to sample differences and was
important to determine the changes in expression of different genes, according to
concentrationand time.
The quantitative endpoint for real-time PCR is the threshold cycle (CT). It is defined as
“The PCR cycle at which the fluorescent signal of the reporter dye crosses an arbitrarily
placed threshold” (Schmittegen & Livak, 2008). A mathematical model widely used in
the analysis of RT-PCR data is the delta delta (ΔΔ) CT method (Livak & Schmittegen,
2001). This was applied to the raw CT data to give a ratio of target gene to the control
gene to demonstrate gene expression changes. Mean-fold changes are calculated from
mean normalised values of raw CT data between samples. The ΔΔCT mathematical
model normalises sample to sample differences. The aim was to determine the effect of
AgNP on the pro-inflammatory cytokine gene expression. This method enabled the
measurement of gene expression changes of target genes normalised to Actin
(housekeeper gene) monitored at AgNP exposure (50 and 100µg/ml) at 1, 6, 8 and 24
hours relative to the expression without AgNP exposure (control). The value of the
mean-fold change of gene expression without AgNP (control) was 1. The mean-fold
changes in gene expression of each target gene were plotted by Microsoft Excel, and the
graphs present either up-regulation or down-regulation of samples determined by
whether they reach above or below the control sample value of 1.
Statistically significant differences between samples and their respective controls were
calculated using the statistical analysis package InStat. Statistically significant
differences were set at p<0.05. Normality of data was confirmed with Q-Q percentile
plots and Kolmogorov-Smirnov tests. Equality of variances was evaluated using Levène
tests. One-way analysis of variances (ANOVA) followed by Dunnett’s multiple
comparison tests were carried out for normally distributed samples with homogeneous
variances. Non-parametric tests, namely Kruskal-Wallis followed by Mann-Whitney-utests were applied to samples without normal distribution and/or inhomogeneous
variances.
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3.9 Chapter Summary
This chapter has highlighted the various techniques employed to characterise the
physical and chemical properties of AgNP and also the various assays used to determine
the toxic effect (if any) of these particles on the chosen cell lines. The following
chapters will discuss the results obtained using the techniques described here.
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Chapter 4

Physicochemical Characterisation of Silver Nanoparticles

Adapted from “Potential of biofluid components to modify silver nanoparticle
toxicity” and “The surfactant dipalmitoylphophatidylcholine modifies acute
responses in alveolar carcinoma cells in response to low concentrationsilver
nanoparticle exposure”

4.1 Introduction
Nano-metals, in particular silver nanoparticles (AgNP) have shown remarkable
antimicrobial properties and as a result have been applied to various consumer products
(Sozer & Kokini, 2009; Sotiriou & Pratsinis, 2011; Chen & Schluesener, 2008). The
widespread contact with AgNP has raised concerns over their possible toxicity upon
entering the body. Paramount to their proposed toxicity is their physicochemical
characteristics including, size, shape and also their interaction with cell culture media
and its various protein components. This chapter will explore the interaction of AgNP
with biofluid components, ursodeoxycholic acid (UDCA), cholic acid (CA), and
deoxycholic acid (DCA), three components of bile and dipalmitoylphosphatidylcholine
(DPPC) a major component of human lung surfactant. These biofluid components were
selected to correspond to the exposure route investigated in this report. Bile plays a
central role in lipid digestion and absorption of nutrients while lung surfactant is
essential for the normal breathing process (Maldonado-Valderrama et al, 2011; Seranno
& Peres-Gil, 2006). The various biofluids play important roles within the body and it is
essential that we establish how AgNP will interact with them, as inevitably they will
come into contact with one another upon exposure. Before toxicity testing was
performed the AgNP were fully characterised using Scanning Electron Microscopy
(SEM), Dynamic Light Scattering (DLS) particle size analysis and zeta potential
analysis. Where possible, measurements were performed on AgNP as purchased and on
test suspensions of the same. The ability of the aforementioned biofluid components to
alter particle size, aggregation and particle stability was monitored and discussed. The
importance of establishing physicochemical characteristics of nanoparticles has been
highlighted as a critical component when performing toxicity testing. As nanoparticle
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characteristics will most likely change in cell culture media and biological systems from
the pristine powder, performing a full physicochemical profile will provide insight into
the toxic mechanisms of nanoparticles. Failure to adequately characterise nanoparticles
will make any toxicological data insignificant, of limited value and will not be
comparable to other studies with a similar nanomaterial (Warheit, 2008). In light of this
observation a full physicochemical profile of AgNP will follow, first focusing on
particle size and any alterations from the pristine powder when in suspensions of cell
culture media and in the presence of biofluid components.

4.2 Particle Size
The methods of particle characterisation employed to determine the relative size of
AgNP as purchased and in various suspensions were SEM and DLS. Figure 4.1 (a) and
(b) shows SEM analysis of a dilute sample of AgNP. This sizing method was performed
on pristine particles as purchased from Sigma-Aldrich (Catalogue No: 758329). SEM
revealed spherical particles with a size of 50-70nm. This method reflects the physical
particle diameter of the pristine particles as purchased. In a study published by Gupta
Mukherjee et al (2012), SEM analysis determined a diameter of <50nm for the same
Sigma-Aldrich AgNP employing the same preparation method for SEM analysis as this
study. While this method of particle sizing provides useful information on the pristine
AgNP, it does not represent how particles will be presented to biological systems upon
entering the body and how the various biofluids they come into contact with may affect
them. While SEM analysis provides a fast analysis of nanoparticles with a simple
sample preparation, analysis of biological samples by this method requires fixation and
any change in nanoparticle size due to interaction with biological material cannot be
monitored by this method. DLS analysis will allow monitoring of the system AgNP are
suspended in and provide data on particle hydrodynamic radius and any change that
occurs due to the presence of certain biological material, in this case protein
components of cell culture media, biofluid components and the surfactant DPPC.
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(a)

(b)

Figure 4.1 (a) and (b) SEM micrograph at scale bar of 500nm image pristine AgNP (a)
at a magnification of x80,000 and (b) at a magnification of x70,000 dispersed in ethanol
to a concentration of 1.56µg/ml by sonication using Ultrasonic Processor tip

4.3 DLS Analysis of AgNP with Biofluid Components UDCA, CA and DCA
DLS size measurements were performed on pristine AgNP suspended in dH2O and cell
culture media with and without the addition of the tested biofluid components to the
media. A concentration of AgNP was chosen for DLS analysis of 15.6µg/ml
representing a concentrationat which a toxic effect was observed, as will be discussed in
chapters 5 and 6. DLS data from this study is illustrated in figure 4.2 (a)-(d). When
suspended in a biological media the various proteins within that media can associate
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with any nanoparticles present and it is postulated that this protein coating can
determine the response of biological systems rather than the particles themselves
(Lynch et al, 2007). It can be assumed that any protein association that occurs in the
nanoparticle dispersions presented here may impact the hydrodynamic radius of
particles and cause possible agglomeration.
From DLS analysis, AgNP size in dH2O was determined to be 34nm ±SD 3.5nm. A
shift in hydrodynamic radius was observed in preparations of AgNP in RPMI.
Dispersed in RPMI alone there are two clear peaks observed one representing RPMI
itself and the other at approximately 40nm representing AgNP. Upon addition of UDCA
to the dispersion no effect on the hydrodynamic radius was noted. The two peaks were
still observed with only a slight increase in size distribution. This variation may be
explained by a shift in the plane of shear upon addition of UDCA as UV-Vis
spectroscopic analysis demonstrated no significant interaction of AgNP with the cell
culture media components. In the presence of DMEM there was a shift in the
distribution of AgNP compared to their dispersion in dH2O. The first peak remained
relatively unchanged apart from a reduced number of particles falling within this size
range. The second wider peak demonstrated the greatest change with the majority of
particles falling within this size range which has shifted to below 100nm. However
upon addition of UDCA, CA and DCA (figure 4.2 (b) – (d)) significant changes were
noted with only one peak between 1-10nm observed which was attributed to DMEM.
UDCA, CA and DCA have a large size distribution (greater than 200nm) and may result
in the formation of large agglomerates with nanoparticles, causing them to precipitate
out at an elevated rate preventing their detection by DLS analysis resulting in the
detection of DMEM only. A possible reason may be due to masking of particles in
larger agglomerates caused by the presence of CA and DCA or potentially the particles
may have fallen out of solution at a faster rate following addition of these biofluid
components preventing their detection. Further investigation is required into why these
particular dispersions of AgNP and biofluid components cannot be detected by DLS
analysis and how this will ultimately affect their toxicological testing. This may result
in altered toxic responses due to association of biofluid components with particles. This
will be discussed in more detail in chapters 5 and 6.
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Figure 4.2 (a) – (d) Dynamic Light Scattering size (nm) particle number (count)
distribution plot of AgNP (15.6µg/ml) dispersed in media, dH2O and in the presence of
(a) UDCA (RPMI), (b) UDCA (DMEM), (c) CA and (d) DCA. Data presented is the
average of three individual experiments

4.4 DLS Analysis of AgNP with DPPC
Figure 4.3 demonstrates DLS measurements on AgNP suspended in dH2O, in RPMI cell
culture media and in the presence of DPPC. A representative concentration of AgNP
(15.6µg/ml) that produces a biological effect was chosen. Two peaks were demonstrated
in analysis of AgNP alone with the greatest number of particles falling in the range of
34nm ±3.5. The broader peak can be attributed to particle agglomeration. A slight shift
in hydrodynamic radius was observed in preparations of AgNP in RPMI. Dispersed in
RPMI alone two clear peaks were observed one representing RPMI itself and the other
at approximately 40nm representing AgNP. The addition of DPPC caused little change
in hydrodynamic radius but produced a larger peak at the 20-40nm range suggesting
possible isolation of particles from larger agglomerates with its addition to the system.
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Figure 4.3 Dynamic Light Scattering size (nm) particle number distribution plot of
AgNP (15.6µg/ml) dispersed in media, dH2O and in the presence of DPPC. Data
presented is the average of three individual experiments

4.5 UV-Vis Spectroscopy
UV-Vis absorption spectroscopy was performed to identify the features of the cell
culture media RPMI and DMEM and of AgNP dispersed in the culture media. This
method was employed to explore if AgNP interact with cell growth medium and its
various constituents. The UV-Vis spectrum of cell culture media consists of a number
of features at 360, 410 and 560nm. There is also a feature at 270nm that is not
illustrated. The feature at 410nm is the 10% foetal bovine serum (FBS) that is added to
culture media which also displays another feature at 270nm, the feature at 360nm is
riboflavin, a vitamin present in the medium and finally the feature at 560nm can be
attributed to the phenol red indicator.
The UV-Vis absorption analysis of the different preparations of AgNP in cell culture
media and with the addition of biofluid components demonstrated no changes to the
spectra. The lack of alteration suggests that secondary toxicity caused by nutrient
depletion would be unlikely. Data are presented in Appendix A4.4.1 (a) and (b).
While DPPC appeared to have no influence on particle size the data indicate an
influence on particle agglomeration. As such UV-vis absorption was performed to
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determine any interaction between the various components of the different suspensions.
No interaction between components was demonstrated indicating that a secondary
toxicity due to depletion of nutrients would be unlikely. Data are presented in Appendix
A4.4.2.

4.6 Stability and Surface area
Zeta potential analysis, illustrated in Tables 4.1 and 4.2, was performed using the same
sample preparations as for sizing analysis. Typically values above 30mV or below 30mV indicate stability of the overall system. Zeta potential analysis of AgNP dispersed
in dH2O (Table 4.1) showed instability of particles at all test concentrations which is
unexpected as the particles purchased are PVP coated. When the particles were
dispersed in the test media differences were noted and the AgNP in RPMI demonstrated
stable results, whereas interestingly dispersion of AgNP in DMEM was revealed to be
unstable. Upon the addition of the bile components CA, DCA and UDCA however, the
system was also found to be unstable. The large values noted when particles were
dispersed in RPMI and RPMI with UDCA would suggest a tendency to repel each other
and as such reduce the likelihood of agglomeration. The lower values for AgNP in
DMEM and DMEM with UDCA, CA and DCA suggest reduced repulsive forces
between particles increasing the potential to agglomerate (Xia et al, 2006). This may
result in particle precipitation out of solution as observed in DLS analysis. However it
can be assumed from the data that the addition of biofluid components does not modify
the overall stability of the system compared to the values noted for dispersions of AgNP
in cell culture media alone.
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Table 4.1 Table of Zeta Potential results for three concentrations of AgNP 3.91, 15.6
and 62.5µg/ml dispersed in different cell culture media and in the presence of different
biofluid components. Data expressed as average value ±SD of three individual
experiments.
62.5µg/ml

15.6µg/ml

3.9µg/ml

AgNP Only

-15.5 ±1.2mV

-31.2 ± 0.9mV

-22.1 ± 6.6mV

AgNP RPMI
AgNP DMEM

-473.7
±50.8mV
-7.9 ± 5.1mV

-380 ±
121.1mV
1.9 ± 3.4mV

-221 ±
117.2mV
-11.2 ± 7.2mV

AgNP 1mM CA-DMEM

-7.1 ± 6.9mV

-2.6 ± 3.4mV

-27.6 ± 5mV

AgNP 0.125mM DCADMEM
AgNP 50µM UDCA-DMEM

-4.9 ± 9.8mV

-12.1 ± 5mV

-5.5 ± 8.9mV

-6.6 ± 2.3mV

-8.1 ± 6.4mV

-6 ± 5mV

Zeta potential analysis was also performed on AgNP suspensions with DPPC as
illustrated in Table 4.2. When suspended in cell culture media and in the presence of
DPPC the system was stable. The addition of DPPC was noted to have no impact on the
overall stability.

Table 4.2 Table of Zeta Potential results for three concentrations of AgNP 3.91, 15.6
and 62.5µg/ml dispersed in RPMI and in the presence of DPPC. Data expressed as
average value ±SD of three individual experiments.
62.5 µg/ml

15.6 µg/ml

3.9µg/ml

AgNP Only

-15.5 ± 1.2mV

-31.2 ± 0.9mV

-22.1 ± 6.6mV

AgNP RPMI

-473.7 ± 50.8mV

-380 ± 121.1mV

-221 ± 117.2mV

AgNP 0.25 µg/ml DPPC-RPMI

-454 ± 175.6mV

-485 ± 106.5mV

-440.3 ± 434.5mV
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BET analysis was also employed to determine surface area of AgNP powder as
purchased and yielded a surface area of 2.3 ± 0.1 m2/g.

4.7 Discussion
The physicochemical characteristics of AgNP play an important role in how they will
interact with biological systems. The size, associated surface area, shape and chemical
composition have all been shown to be of great importance to nanoparticle toxicity. Size
influences surface area which leads to greater cell contact, while shape can also
influence interactions for example, truncated triangular nanoparticles show increased
toxicity compared to spherical nanoparticles and it is believed that cylindrical particles
can cross the cell membrane easier than other shapes due to their ability to harness the
clatherin machinery (Renwick et al, 2004; Rai et al, 2009; Kam et al, 2004).
It is now well established that upon entry into the body nanoparticles almost
immediately become coated in protein and that this adsorbed layer or “corona” is
important in biological responses to nanoparticle exposure (Gray, 2004; Lynch &
Dawson, 2008). While there will be adsorption of the proteins of biofluid components,
DPPC and cell culture media onto the nanoparticle surface, it can be assumed that these
proteins will associate and dissociate from AgNP at different rates depending on a
factors such as concentration and affinity (Lynch et al, 2007).
Proteins tend to agglomerate upon dispersion in an aqueous solution and may coat
AgNP trapping them within agglomerates increasing the rate at which they fall out of
solution. A number of studies have investigated this dispersion to determine how this
affects overall toxicity. It is known that nanoparticles once suspended in cell culture
media can precipitate out of solution and agglomerate at different rates. As such this
raises a number of questions relating to dosimetry and the effect of agglomerate
formation on the end result of nanoparticle exposure. As well as influencing the results
of toxicity it can also influence exposure times as agglomerate formation and
precipitation may increase the time taken for delivery of the full concentrationto cells.
Further investigation is required to develop a method of including dosimetric
parameters into toxicological testing so that accurate results for in vitro assays can be
obtained that are comparable to animal models (Cohen et al, 2014; Cohen et al, 2013;
Kroll et al, 2009; Teeguarden et al, 2007).
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Zeta potential analysis was also performed and a change in values would indicate
interaction of nanoparticles with biofluid components, the surfactant DPPC and cell
culture media, suggesting indirect toxicity caused by their interaction (Casey et al,
2007; Casey et al, 2008). No change on overall stability was noted following biofluid
component or DPPC addition. The overall particle stability also influences size and
agglomerative state. Larger unstable zeta potential values were noted for AgNP
dispersions in RPMI with UDCA addition. These large values suggest particles will
repel each other reducing the potential to agglomerate. The lower values noted for
AgNP dispersions in DMEM with UDCA, CA, DCA suggest low repulsive forces and
thus a tendency to agglomerate. This may explain the lack of particle size data due to
particle precipitation out of solution potentially caused by agglomeration. The
dispersant is an important factor in particle stability thus effecting size and possible
agglomeration (Xia et al, 2006).
A recent study demonstrated that AgNP exposed to synthetic stomach fluid led to
transformations in particles including particle aggregation, changes in particle
morphology and the release of silver ions (Mwilu et al, 2013). It was suggested that
alterations to AgNP size and surface properties due to exposure to synthetic stomach
acid may impact their transformation through the gastrointestinal tract and may in turn
influence AgNP interaction with the cells they encounter. The binding of proteins be it
from cell culture media, biofluid components or other surfactants can aid in the binding
of particles to cell surfaces, their trafficking through biological systems and the
resulting effects. Very recently in a study by Wang et al (2013), the protein surface
coating or “corona” was identified as providing a Trojan horse effect to nanoparticles.
Initial entry of nanoparticles into the cell did not cause immediate toxicity it was only
when the nanoparticles were transported to the lysosome and the surface coating was
degraded in the acidic environment, that toxicity was observed. At this point, much later
after initial exposure, loss of lysosomal integrity and release of its contents was noted
followed by cell death via apoptosis (Wang et al, 2013). These findings can be related
to the work undertaken in this study as biofluid components and the surfactant DPPC
are protein entities and will ultimately form part of the protein corona and may
contribute to particle interactions with living systems and any related toxicity which
will be further discussed in chapters 5 and 6.
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This reiterates the importance of performing realistic exposure scenarios in
toxicological testing to determine nanoparticle interactions in biological systems. These
results highlight the importance of establishing the physicochemical characteristics of
AgNP in a variety of biological suspensions, as their interaction with these biofluids
influence their interactions with cellular components and biological systems and will
ultimately determine their distribution throughout the body and the signalling pathways
and end responses they induce.

4.8 Chapter Summary
This chapter has illustrated the physicochemical characteristics of AgNP both as
purchased and with the addition of biofluid components and the surfactant DPPC. The
ability of the tested biofluid components and DPPC to influence AgNP size, aggregative
state and stability were discussed. By gaining an understanding of these characteristics
and how AgNP interact with biofluid systems within the body, may help in our
understanding of how this contact may modify interaction with biological systems and
any associated toxicity. The presence of biofluid components and surfactants may
change how AgNP interact with biological systems, their distribution within the body,
how a cell “sees” the particle and ultimately the response that results from particle-cell
interaction.

82

References
Casey A, Davoren M, Herzog E, Lyng F.M, Byrne H.J, Chambers G. (2007) Probing
the interaction of single walled carbon nanotubes within cell culture medium as a
precursor to toxicity testing. Carbon. 45, 34-40
Casey A, Herzog E, Lyng F.M, Byrne H.J, Chambers G, Davoren M. (2008) Single
walled carbon nanotubes induce indirect cytotoxicity by medium depletion in A549
lung cells. Toxicol Lett. 179, 78-84
Chen X, Schluesener H. J. (2008) Nanosilver: A nanoproduct in medical application.
Toxicol. Lett. 176 (1), 1-12
Cohen J, Deloid G, Pyrgiotakis G, Demokritou P. (2013) Interactions of engineered
nanomaterials in physiological media and implications for in vitro dosimetry.
Nanotoxicology. 7, 417-431
Cohen J. M, Teeguarden J. G, Demokritou P. (2014) An integrated approach for the in
vitro dosimetry of engineered nanomaterials. Part Fibre Toxicol. 11, 20
Gray J.J. (2004) The interaction of proteins with solid surfaces. Curr Opin Struct Biol.
14, 110-115
Gupta Mukherjee S, O’Claonadh N, Casey A, Chambers G. (2012) Comparative in vitro
cytotoxicity study of silver nanoparticle on two mammalian cell lines. Toxicol In Vitro.
26, 238-251
Kam N. S. W, Jessop T. C, Wender P. A, Dai H. J. (2004) Nanotube molecular
transporters: Internalization of carbon nanotube-protein conjugates into mammalian
cells. J Am Chem Soc. 126, 6850-6851
Kroll A, Pillukat M. H, Hahn D, Schnekenburger J. (2009) Current in vitro methods in
nanoparticle risk assessment: limitations and challenges. Eur J Pharm Biopharm. 72,
370-377
Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S, Dawson K.A. (2007)
The nanoparticle-protein complex as a biological entity; a complex fluids and surface
science challenge for the 21st century. Adv Colloid Interfac. 134-135, 167-174
Lynch I, Dawson K.A. (2008) Protein-nanoparticle interactions. Nano Today. 3, 40-47
83

Maldonado-Valderrama J, Wilde P, Macierzanka A, Mackie A. (2011) The role of bile
salts in digestion. Adv Colloid Interfac. 165, 36-46
Mwilu S.K, El Badawy A.M, Bradham K, Nelson C, Thomas D, Scheckel K. G,
Tolaymat T, Ma L, Rogers K. R. (2013) Changes in silver nanoparticles exposed to
human synthetic stomach fluid: Effects of particle size and surface chemistry. Sci Total
Environ. 447, 90-98
Rai M, Yadav A, Gade A. (2009) Silver nanoparticles as a new generation of
antimicrobials. Biotecnol Adv. 27, 76-83
Renwick L.C, Brown D, Clouter A, Donaldson K. (2004) Increased inflammation and
altered macrophage chemotactic responses caused by two ultrafine particle types. Occup
Environ Med. 61, 442-446
Serrano A. G, Perez-Gil J. (2006) Protein-lipid interactions and surface activity in the
pulmonary surfactant system. Chem Phys Lipids. 114, 105-118
Sotiriou G. A, Pratsinis S. E. (2011) Engineering nanosilver as an antibacterial,
biosensor and bioimaging material. Curr Opin Chem Eng. 1 (1), 3-10
Sozar N, Kokini J.L. (2009) Nanotechnology and its applications in the food sector.
Trends Biotechnol. 27, 82-9
Teeguarden J. G, Hinderliter P. M, Orr G, Thrall B. D, Pounds J. G. (2007)
Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity
assessments. Toxicol Sci. 95, 300-312
Wang F, Yu L, Monopoli M.P, Sandin P, Mahon E, Salvati A, Dawson K. A. (2013)
The biomolecular corona is retained during nanoparticle uptake and protects the cells
form the damage induced by cationic nanoparticles until degraded in lysosomes.
Nanomed-Nanotechnol. 9, 1159-1168
Warheit D. B. (2008) How meaningful are the results of nanotoxicity studies in the
absence of adequate material characterization? Toxicol Sci. 101, 183-185
Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh J. I,
Wiesner M. R, Nel A. E. (2006) Comparison of the abilities of ambient and

84

manufactured nanoparticles to induce cellular toxicity according to an oxidative stress
paradigm. Nano Lett. 6, 1794-1807

85

Chapter 5

Adapted from “Potential of biofluid components to modify silver nanoparticle
toxicity”

5.1 Introduction
Nanotechnology has been described as a new frontier in science and technology with
many different applications in fields including textiles, electronics, medicine, cosmetics
and food (Sozar & Kokini, 2009; Bouwmeester et al, 2009). Silver nanoparticles
(AgNP) in particular are becoming the material of choice for incorporation into
consumer goods mainly due to their antimicrobial properties (Choi et al, 2008).
When considering nanoparticle exposure it is important to take into account not only the
route of entry to the body but also the various biological systems, biofluids and
surfactants they will encounter. Indeed as a result of the potential interaction with
various components of biofluids, nanoparticles may be affected, ultimately changing
how they interact with cells and the responses they evoke.
With the ever increasing use of nanoparticles in food products and with pending EU
legislation enforcing that all forms of engineered nanoparticles present in food must be
stated on food packaging ie. “nano-labelling” it is now more crucial than ever that the
interaction between nanoparticles and living systems is thoroughly investigated (Nano
and other Emerging Technologies Blog, 2013). In particular, the potential toxic effect of
nanoparticles to the gastrointestinal (GI) tract and their interactions with various
biofluids associated with this system must be determined.
The GI tract has been noted as a major area of AgNP deposition coupled with
pathological responses. A number of studies have demonstrated damaged microvilli and
intestinal glands, abnormal pigmentation and an increase in intestinal goblet cells
following oral administration of AgNP in rats (Hadrup & Lam, 2014; Shahare &
Yashpal, 2013; Jeong et al, 2010; Kim et al, 2010). The liver in particular is an
important site of nanoparticle deposition following ingestion with reports of high
concentrations of AgNP reported in mice 24 hours after exposure. Inhalation also
provides a route to the liver. Mucocilliary clearance of nanoparticles can result in entry
to the GI tract and deposition in the liver. Accumulation of AgNP can lead to liver
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toxicity including bile duct hyperplasia and inflammation (Kim et al, 2008; Nemmar et
al, 2002). The liver has also been identified as a one of the main pathways involved in
nanoparticle excretion. Hepato-biliary secretion is believed to be a main route of
intestinal secretion of nanoparticles with evidence of gold and polystyrene nanoparticle
excretion by this route. Accumulation of nanoparticles within bile canaliculi is
suggestive of the important role of bile in the intestinal secretion and elimination of
nanoparticles in faeces (Zhao et al, 2014; Johnston et al, 2010; Semmler-Behnke et al,
2008).
A biofluid is any fluid originating from within the body that can be excreted, secreted,
obtained by a needle or can develop due to a pathological process and ranges from
blood to bile and breast milk to cyst fluid (Medicinenet). It has been shown that certain
biofluids and surfactants can aid the processing of nanoparticles and can isolate
nanoparticles from larger agglomerates by coating the particle or modifying its surface
chemistry (Herzog et al, 2009). Interactions with various surfactants can result in
adsorption of a variety of different molecules and proteins onto the surface of
nanoparticles. As a result, many studies have shown that this “coating” can affect how a
nanoparticle interacts with the biological environment. These affects range from
changes in the particle itself such as ion release and changes in morphology to the
responses it induces and where it is trafficked within the body (Herzog et al, 2009;
Mwilu et al, 2013; Ehrenberg et al, 2009; Wang et al, 2013; Misra et al, 2012;
Aggarwal et al, 2009). It is this ability of biofluids to interact and process foreign bodies
that make them integral to the defence systems of the body. In this study three
components of bile were chosen and are referred to as biofluid components throughout
as they were studied individually. The biofluid components employed were cholic acid
(CA), deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA).
Bile salts are organic solutes synthesized from cholesterol by hepatocytes (Kumar &
Bohidar, 2010; Perez & Briz, 2009). Cholic acid is one of the major primary bile acids
in the liver and is synthesized from cholesterol and constitutes about 30-40% of bile
acids (Debruyne et al, 2001). Formation of these bile acids is important in cholesterol
homeostasis. Deoxycholic acid is a secondary bile acid and constitutes roughly 10-40%
of total bile (Marcus & Heaton, 1988). DCA has also been demonstrated to promote
colonic epithelium proliferation (Deschner et al, 1981; Ochsenkuhn et al, 1999). UDCA
is a secondary bile acid comprising 3% of total bile acids (Perez & Briz, 2009). Despite
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its low abundance it has been shown to have direct antioxidant properties and can
prevent the retention of certain toxic hydrophobic bile acids. UDCA has also a number
of therapeutic applications including dissolving gall stones and has shown promise as a
targeted cancer therapy (Arisawa et al, 2009; Lapenna et al, 2002; Debruyne et al,
2001).
This study aims to demonstrate if biofluid components can modify nanoparticle toxicity.
Their incorporation may enhance or reduce cytological effects and has often been
overlooked in cytotoxicity screening, which will be addressed here. The European
Union define a nanomaterial as “A natural, incidental or manufactured material
containing particles in an unbound state or as an aggregate or as an agglomerate, and
where for 50% or more of the particles in the number size distribution, one or more
external dimensions is in the range 1-100nm” (European Commission, 2011). In
keeping with this definition it is important to investigate the interaction of biofluid
components with nanoparticles to determine if the chemistry is affected resulting in a
change in size distribution or agglomerative state potentially causing the nanoparticles
to fall outside the criteria of a nanomaterial as per the EU definition.

This was

investigated and previously discussed in chapter 4. The cell lines chosen were HepG-2 a
hepatocellular carcinoma (liver) and Hep2 an epithelial cell line employed as a control.
A cytotoxic profile of AgNP was carried out using the standard cytotoxic assays 3-(4, 5Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) and Alamar Blue (AB)
viability assays. A 2’, 7’-dichlorofluorescin diacetate (DCFH-DA) plate assay was used
to detect any intracellular ROS generation in response to AgNP exposure.

5.2 Cytotoxicity Testing
Viability assays were performed to determine the effect of AgNP exposure to HepG-2
and Hep2 cell lines. The ability of the biofluid components UDCA, CA and DCA to
modify the toxic response of AgNP was also evaluated. Cytotoxicity data for AgNP
exposure in the HepG-2 and Hep2 cell lines are presented in table 5.1. The results of the
MTT assay are presented for each cell line in the presence and absence of the respective
biofluid component. Both MTT and AB assays were performed for each cell line.
Results for AB assay are presented in Appendix A5.2.
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5.2.1 Cytotoxic evaluation HepG-2 cell line to AgNP exposure alone and in the
presence of UDCA, CA and DCA
Figure 5.1 represents the cytotoxic response of HepG-2 cells to AgNP exposure
determined by the MTT assay. In the presence of AgNP cell viability decreases in a
concentrationand time dependent manner, with a substantial decline in mitochondrial
integrity detected at concentrations of 15.6µg/ml and above. A significant decrease in
cell survival occurs at concentrations of 15.6µg/ml after 48 hour exposure while a
significant reduction in cell viability at all exposure time points occurs at AgNP
concentrations of 31.25µg/ml and upwards.

Figure 5.1 Cytotoxicity of AgNP in HepG-2 cells after 24, 48, 72 and 96hr exposures
as determined by the MTT assay. Data expressed as percentage of control mean ± SD of
three individual experiments. * denotes a statistically significant (p<0.01) difference
from the unexposed control

A DCF-DA plate assay was employed to detect any ROS production in response to
AgNP exposure over a 24 hour period. Readings were taken every hour for 6 hours.
Following this, readings were then taken at 12 and 24 hours to detect any delayed
intracellular ROS production in response to increasing concentrations of AgNP. Figure
5.2 illustrates ROS generation in response to AgNP exposure. The study showed that
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the amount of ROS produced increased with increasing length of nanoparticle exposure
and also with increasing concentration. ROS production was noted at concentrations of
7.8µg/ml and above after 15 minutes exposure and was shown to increase with
concentrationand exposure time. The greatest level of ROS production was observed at
a concentration of 500µg/ml after 12 hours of exposure. A reading at 24 hours showed a
decline in ROS production compared to the 12 hour time point which can be associated
with cell death. Confocal microscopy was employed to confirm ROS induction due to
AgNP exposure at a concentration of 31.25µg/ml in figure 5.3.

Figure 5.2 ROS generation in HepG-2 cells after different time points of AgNP
exposure. Data expressed as percentage of control mean ± SD of six independent
experiments.
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(b)

(a)

Figure 5.3 Confocal image (x40) of cells exposed to 31.25µg/ml AgNP suspended in
cell culture media. Image taken on a Zeiss 510 LSM confocal microscope with an argon
ion laser, excitation 488nm using a band pass filter 505-530nm to detect DCF. (a) LSM
image demonstrating intracellular ROS, (b) overlay of LSM and bright field image.

Figures 5.4 and 5.5 show the toxic response of AgNP to HepG-2 cells, but in the
presence of UDCA. The same concentrationdependent response was noted as with the
previous assays, following exposure to AgNP alone with this response increasing over
time. The MTT assay (figure 5.4) showed a significant decline in cell viability after 96
hours at a concentration of 7.81µg/ml. At a 15.6µg/ml concentration of AgNP a
significant decrease in viability was observed following 48, 72 and 96 hour exposures.
It was only at concentrations of 31.25µg/ml and above that a significant reduction in
cell survival was noted at all exposure time points. Interestingly the presence of UDCA
appeared to have had no effect on cellular response to AgNP exposure, with almost
identical patterns of toxicity observed both with and without the addition of UDCA.
This suggests that the presence of UDCA does not modify AgNP toxicity.
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Figure 5.4 Cytotoxicity of AgNP in HepG-2 cells with added UDCA after 24, 48, 72
and 96hr exposures as determined by the MTT assay. Data expressed as percentage of
control mean ± SD of three independent experiments. * denotes a statistically
significant (p<0.01) difference from the unexposed control

In the presence of UDCA (figure 5.5) a similar pattern of ROS production was observed
as with the AgNP exposure alone although it appeares more erratic with larger error
bars. The same concentrationand time dependent response was observed with ROS
induction detected following 15 minute exposure at concentrations as low as 3.91µg/ml.
A similar trend was observed with ROS induction in the presence of AgNP alone and a
maximum ROS production was observed at a concentration of 500µg/ml after 12 hour
exposure. Following 24 hour exposure ROS production was shown to decline, again this
can be attributed to cell death. ROS induction by a concentration of 31.25µg/ml AgNP
was confirmed by confocal microscopy illustrated in figure 5.6. It is apparent from the
data that UDCA does not alter oxidative stress induced by AgNP exposure and can be
concluded that UDCA does not modify AgNP ability to induce intracellular ROS
production.
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Figure 5.5 ROS generation in HepG-2 cells after different time points of AgNP
exposure in the presence of UDCA. Data expressed as percentage of control mean ± SD
of six independent experiments.

(a)

(b)

Figure 5.6 Confocal image (x40) of cells exposed to 31.25µg/ml AgNP suspended in
cell culture media in the presence of UDCA. Image taken on a Zeiss 510 LSM confocal
microscope with an argon ion laser, excitation 488nm using a band pass filter 505530nm to detect DCF. (a) LSM image demonstrating intracellular ROS, (b) overlay of
LSM and bright field image.
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Figure 5.7 represents the exposure of HepG-2 cells to AgNP in the presence of CA.
Again a concentrationand time dependent response to AgNP exposure was observed
with this assay. A noted decline in cell viability can be seen after 24 hours of exposure
at an AgNP concentration of 3.91µg/ml and then an apparent increase in viability
compared to the unexposed control after longer exposure periods at the same
concentration, indicative of possible cell recovery. At an AgNP concentration of
3.91µg/ml after a 24 hour exposure a significant decline in cell viability was apparent.
At exposure times of 48 and 72 hours a significant decline in viability was also
observed when compared to the unexposed control. At 15.6µg/ml and above, significant
reduction in cell survival could be seen at all exposure concentrations when compared
to the unexposed negative control. As observed with UDCA, the addition of CA does
not appear to modify the toxicity of AgNP and the response in the presence of CA is
seemingly identical, with no significant difference or change between the two.

Figure 5.7 Cytotoxicity of AgNP in HepG-2 cells with added CA after 24, 48, 72 and
96hr exposures as determined by the MTT assay. Data expressed as percentage of
control mean ± SD of three independent experiments. * denotes a statistically
significant (p<0.01) difference from the unexposed control
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Further studies were performed with the DCF-DA plate assay to determine the ability of
AgNP with addition of CA to induce oxidative stress. Figure 5.8 demonstrates ROS
production in a concentrationand time dependent manner. Generation of ROS was noted
at the higher concentrations of 125, 250 and 500µg/ml. Induction of intracellular ROS
was noted after 15 minutes of exposure compared to the unexposed control, with the
highest generation detected after this time and at the highest AgNP concentration,
500µg/ml. After 15 minutes of exposure ROS production begins to decline in a stepwise pattern as exposure time progresses with no ROS detected after the 4 hour
exposure point. In comparison to HepG-2 exposure to AgNP alone, the addition of CA
alters the pattern of ROS production. In the presence of CA, ROS induction occurs
almost immediately after exposure to AgNP and then declines rapidly compared to
earlier time points with no ROS detected after 4 hours. Induction of ROS only occurs at
the higher exposure concentrations 125, 250 and 500µg/ml. Exposure to AgNP alone
results in a much lower percentage of ROS induction compared to the unexposed
control that increases over time and only begins to decline after 12 hours of exposure. In
the presence of CA induction of ROS occurs much quicker but declines at a similar rate
whereas in the presence of AgNP only, ROS production is more sustained over time.
Confirmation of ROS induction by AgNP at a concentration of 3.91µg/ml in the
presence of 1mM CA was verified by confocal microscopy as illustrated in figure 5.9.
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Figure 5.8 ROS generation in HepG-2 cells after different time points of AgNP
exposure in the presence of CA. Data expressed as percentage of control mean ± SD of
six independent experiments.

(a)

(b)

Figure 5.9 Confocal image (x40) of cells exposed to 31.25µg/ml AgNP suspended in
cell culture media in the presence of CA. Image taken on a Zeiss 510 LSM confocal
microscope with an argon ion laser, excitation 488nm using a band pass filter 505530nm to detect DCF. (a) LSM image demonstrating intracellular ROS, (b) overlay of
LSM and bright field image.
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Figure 5.10 illustrates the toxic response of HepG-2 cells to AgNP exposure in the
presence of DCA. As can be seen in figure 5.10 a loss in mitochondrial integrity is
demonstrated at the lowest AgNP concentration of 3.91µg/ml at all exposure time
points. Significant loss was noted at a concentration 3.91µg/ml after 24 hour exposure.
There was a significant reduction at this concentration after 72 and 96 hour incubations
but not after 48 hour incubation again this may be due to cell recovery. As the AgNP
are in low doses it is possible they have fallen out of solution at this time and any effect
was induced within the first 6-12 hours following exposure. After this point any
surviving cells may be starting to recover and replicate. The same pattern is observed at
a concentration of 7.81µg/ml. A significant reduction was observed at all exposure time
points from a concentration of 15.6µg/ml and above.

Figure 5.10 Cytotoxicity of AgNP in HepG-2 cells with added DCA after 24, 48, 72
and 96hr exposures as determined by the MTT assay. Data expressed as percentage of
control mean ± SD of three independent experiments. * denotes a statistically
significant (p<0.01) difference from the unexposed control

The induction of ROS upon exposure to AgNP with the addition of DCA (figure 5.11)
follows a similar pattern to that observed with the addition of CA. However it can be
seen that ROS are induced at much lower concentrations of AgNP when compared to
the CA and in the presence of AgNP alone. ROS were detected after 15 minutes at a
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concentration of 31.25µg/ml and higher with maximum ROS production occurring at
500µg/ml after a 15 minute exposure. After 15 minutes ROS levels began to decline
with increasing exposure time. When compared to exposure of HepG-2 cell to AgNP
alone, the observed ROS induction occurs at lower concentrations of AgNP and does
not increase with time but begins to decline after 15 minutes. Indeed to the case of CA,
where ROS induction occurs much earlier but is short lived. It appears that AgNP
exposure in the presence of DCA results in the greatest ROS induction compared to the
unexposed control and at lower doses when compared to the AgNP exposure with CA
and AgNP exposure alone. Confirmation of ROS induction by AgNP at a concentration
of 3.91µg/ml in the presence of 0.125mM DCA is confirmed by confocal microscopy as
illustrated in figure 5.12.

Figure 5.11 ROS generation in HepG-2 cells after different time points of AgNP
exposure in the presence of DCA. Data expressed as percentage of control mean ± SD
of six independent experiments.
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(a)

(b)

Figure 5.12 Confocal image (x40) of cells exposed to 31.25µg/ml AgNP suspended in
cell culture media in the presence of DCA. Image taken on a Zeiss 510 LSM confocal
microscope with an argon ion laser, excitation 488nm using a band pass filter 505530nm to detect DCF. (a) LSM image demonstrating intracellular ROS, (b) overlay of
LSM and bright field image.

The AB assay was also performed for the HepG-2 cell line in the presence and absence
of UDCA, CA and DCA where a concentrationand time dependent response was also
observed resulting from AgNP exposure. AB gives a more general picture of the loss in
cell viability by targeting the cytosol of the cell and detecting a change in the cytosolic
environment. A similar pattern of toxicity was observed with the addition of DCA
having a substantial effect on cell viability occurring after 24 hours of exposure (see
Appendix A5.2.1 (a)-(d)).
Statistical analysis (p<0.05) comparing the differences in toxicity induced by AgNP
alone and in the presence of the tested biofluid components highlighted statistically
significant differences between the toxicological data. The presence of CA and DCA
significantly altered the cytotoxic effect induced by AgNP on HepG-2 cells, at a
concentration of 15.6µg/ml and above the response curves were found to be statistically
(p<0.05) different. This change was noted at 48, 72 and 96 hour time points. UDCA was
noted not to significantly alter the toxicity of AgNP in HepG-2 cells.
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5.2.2 Cytotoxic evaluation of Hep2 cell line to AgNP exposure alone and in the
presence of UDCA
As a control, another cell line was tested to establish if biofluid components could
modify the effects of AgNP exposure in areas other than their target organs. To
investigate this, the Hep2 cell line was selected. The same exposure concentrations were
employed and the effects of AgNP toxicity in the presence of biofluid components were
investigated. UDCA was selected as the test bile acid. A concentrationfinding
experiment was performed to determine the highest concentration of UDCA that the
Hep2 cell line could withstand without causing toxicity. This concentration was found
to be 2.2 x 10-7 M and this was the working concentration employed for the following
experiments.
Figure 5.13 displays the cytotoxic response of Hep2 cells to AgNP exposure determined
by the MTT assay. This assay demonstrates a typical concentrationand time dependent
pattern with significant reduction in cell survival noted at all concentrations following
72 hour exposure. A significant reduction in viability after 72 and 96 hours was
observed at doses of 7.81µg/ml and above and after 48 hours at a concentration of
31.25µg/ml and above. Furthermore a significant decrease in cell survival compared to
the unexposed control was observed for all exposure time points at a concentration of
62.5µg/ml and upwards.
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Figure 5.13 Cytotoxicity of AgNP to Hep2 cells after 24, 48, 72 and 96hr exposure as
determined by the MTT assay. Data expressed as percentage of control mean ± SD of
three independent experiments. * denotes a statistically significant (p<0.01) difference
from the unexposed control

Figure 5.14 illustrates the toxic response of AgNP to Hep2 cells in the presence of
UDCA. The data demonstrate that in the presence of UDCA there is a dramatic
reduction in cell viability compared to when cells are exposed to AgNP alone. No
significant change in cell viability occured after 24 hour exposure but a significant
reduction following 48, 72 and 96 hour exposures was noted at all tested concentrations
of AgNP. The data presented illustrates that compared to AgNP exposure alone the
presence of UDCA does modify toxicity.
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Figure 5.14 Cytotoxicity of AgNP to Hep2 cells with added UDCA after 24, 48, 72 and
96hr exposures as determined by the MTT assay. Data expressed as percentage of
control mean ± SD of three independent experiments. * denotes a statistically
significant (p<0.01) difference from the unexposed control

A DCF-DA plate assay was also employed to investigate intracellular oxidative stress,
to see if the presence of UDCA could influence the generation of ROS in response to
AgNP exposure. Exposure to increasing concentrations of AgNP induced ROS
production in a concentrationand time dependent manner (figure 5.15). ROS production
was detected at exposure concentrations of 7.81µg/ml and above with maximum
production noted at 500µg/ml. Induction of ROS was observed after 15 minutes of
exposure with maximum production observed after 1 hour after which levels of
detectable ROS began to decline. In the presence of UDCA (figure 5.16) a substantial
reduction in ROS generation was observed when compared to exposure to AgNP alone
and ROS were only detected at higher concentrations of AgNP, above 250µg/ml. A
maximum level ROS production with added UDCA was observed at a concentration of
500µg/ml after 1 hour and as illustrated by the data the percentage of ROS induction
when compared to the negative control is substantially reduced compared to the amount
generated in the absence of UDCA.
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Figure 5.15 ROS generation in Hep2 cells after different time points of AgNP
exposure. Data expressed as percentage of control mean ± SD of six independent
experiments

Figure 5.16 ROS generation in Hep2 cells after different time points of AgNP exposure
in the presence of UDCA. Data expressed as percentage of control mean ± SD of six
independent experiments

The AB assay was performed for the Hep2 cell line in the presence and absence of
UDCA where a concentrationand time dependant response was also observed resulting
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from AgNP exposure. A similar pattern of toxicity was observed with the addition of
UDCA having a substantial effect on cell viability occurring after 24 hours of exposure
(see appendix A5.2.2 (a)-(b)).
Statistical analysis (p<0.05) comparing the differences in toxicity induced by AgNP
alone and in the presence of UDCA in Hep2 cells highlighted statistically significant
differences between the toxicological data. A significant effect on toxicity was noted in
the presence of UDCA from the lowest test concentration up to 250µg/ml after 48 and
96 hour time points compared with exposure to AgNP alone.

5.3 Discussion
It is clear from the literature that exposure to nanoparticles is becoming more
widespread mainly due to their continued incorporation into various consumer products.
Upon exposure, nanoparticle contact with surfactants and biofluids is inevitable and it is
important to take these events into account when examining toxicity. This study aimed
to investigate this interaction to identify a possible modification of toxicity by
individual components of one of the major biofluids within the body.
As discussed in chapter 4, the physicochemical characteristics of AgNP play an
important role in how they will interact with biological systems. The size, associated
surface area, shape and chemical composition have been shown to be of great
importance to nanoparticle toxicity (Renwick et al, 2004; Rai et al, 2009; Kam et al,
2004). Together with the ion release associated with nanoparticle biofluid interaction, as
previously discussed, a number of contributing factors relating to the physicochemical
characteristics must be considered when interpreting overall nanoparticle toxicity
(Warheit, 2007; Beer et al, 2012).
The cytotoxicity studies undertaken illustrate that mitochondrial integrity (MTT) and
the general health of the cell (AB) is affected by exposure to AgNP and that the chosen
biofluid components have different modifying effects. Table 5.1 concisely illustrates
IC50 values for both assays providing an overall synopsis of toxicity. From the data
presented it can be suggested CA and DCA do have some modifying effects. While not
altering the pattern of toxicity in the viability assays, the pattern of ROS induction is
altered upon their addition. The addition of CA and DCA induces greater levels of ROS
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induction with DCA producing the greatest response following a 15 minute exposure at
the highest concentration of AgNP compared to the unexposed control. AgNP exposure
alone produces much lower levels of ROS with maximum values only slight higher
compared to the unexposed control. This increase in ROS production and at earlier
points of exposure may suggest a more rapid or alternative pathway of cell death in the
presence of CA and DCA. Previous studies have shown that lipid peroxidation by
nanomaterials is a contributing factor to the generation of ROS and the overwhelming
of natural antioxidant systems. ZnO is noted as enhancing lipid peroxidation
contributing to increased ROS generation while AgNP exposure in rats can cause
increased lipid peroxidation and quench naturally occurring antioxidants. It is postulated
that the increased levels of ROS following AgNP-CA and AgNP-DCA exposure
enhances lipid peroxidation within cells resulting in the greater levels of ROS noted
compared to AgNP exposure alone (Premanathan et al, 2011; Adeyemi & Faniyan,
2014). This upsurge in generation may be the result of a reactive product formed by the
interaction of AgNP and biofluid components. Further investigation into the mechanism
of cell death and the potential role of lipid peroxidation within cells must be
investigated.

Table 5.1 Calculated IC50 values (µg/ml) resulting from exposure to AgNP for the AB
and MTT assays in the HepG-2 and Hep2 cell lines. * Denotes lethal concentrationless
than the lowest exposure concentration. IC50 values were calculated from the average
response of three independent experiments fitted to a sigmoidal curve and a four
parameter logistic model used to calculate Inhibitory Concentration (IC50) with a
(p<0.05)
Cell Line

AB assay IC50 (µg/ml)

24hr
HepG-2
5.50
HepG-2 + UDCA 6.30
HepG-2 + CA
4.03
HepG-2 + DCA
4.28
Hep2
45.06
Hep2 + UDCA
439.16

48hr
7.80
9.10
6.24
6.49
31.58
4.25

72hr
5.50
5.30
4.78
2.99
8.80
0.27

MTT assay IC50 (µg/ml)
96hr
4.20
5.70
7.94
6.24
91.90
0.94
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24hr
119.51
135.06
0.0004
1389.30
388.39
0.0007

48hr
45.34
66.52
0.0003
746.29
157
<3.91*

72hr
44.59
31.81
0.001
0.002
2.19
<3.91*

96hr
49.20
10.97
215.48
0.003
43.41
<3.91*

While no modification in toxicity by UDCA was noted in the HepG-2 cell line,
modification was noted in Hep2 cells. A delay in toxicity in the first 24 hours after
exposure together with a reduction in ROS production strongly suggests that UDCA can
modify Hep2 toxic response to AgNP exposure. While it appears to increase AgNP
toxicity, ROS induction is significantly reduced suggestive of an antioxidant effect. This
may indicate an alternative mechanism of cell death. These data indicate that UDCA
can modify AgNP toxicity in a cell type different from that of its normal target.
While it is clear AgNP cause toxicity, it must be considered how much of this toxicity is
attributed to the release of silver ions. A study by Beer et al (2012) addressed this
phenomenon, identifying to what level the fraction of silver ions in various AgNP
suspensions (commercially available and laboratory synthesized) influence toxicity
(Beer et al, 2012). The study concluded that free silver ions in AgNP preparations do
indeed play a considerable role in the overall toxicity of AgNP suspensions. However
other studies are in agreement that at lower concentrations of metal ions, the uptake of
nanoparticles leads to additional toxicity compared to higher concentrations where it
appears the particles do not contribute to further toxicity (Navarro et al, 2008; Kim et
al, 2009). Beer et al (2012) postulate that the mechanism of toxicity for AgNP is
dissolution of particles in lysosomes, previously observed for copper oxide (CuONP)
nanoparticles, possibly due to a protective barrier effect of the plasma membrane but
this barrier can be evaded by a Trojan horse mechanism when nanoparticles are taken
up by cells (Studer et al, 2010; Limbach et al, 2007). It must also be considered that
sonication of AgNP suspensions and other preparation methods may have contributed to
silver ion release and therefore toxicity. For example during sonication the energy
released in order to break up large AgNP aggregates is converted to thermal energy
which may promote dissolution of silver ions from particles (Liu & Hurt, 2010). From
this information it is clear that when investigating AgNP toxicity, the role of both silver
ions and the particles themselves must be considered.
In order to monitor the potential modification of the chosen biofluid components on
AgNP toxicity in cells found outside of their normal target area, an epithelial laryngeal
cell line was chosen. The biofluid components under study have been employed as
pharmaceutical agents and medications. UDCA is widely used as a method of gallstone
dissolution (Arisawa et al, 2009; Lapenna et al, 2002). This treatment has numerous
trade names, including Actigall™ and BILIVER™, and is an oral treatment presented
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as an alternative to surgery. CA and DCA also have medical applications. CA is used as
treatment for children and adults with inborn errors in bile acid synthesis. Orphacol™ as
it is known is taken orally and is vital in preventing the development of cholestatic liver
disease (European Medicines Agency, 2013). DCA also has uses as a therapeutic drug
used to treat localized fat deposits via subcutaneous injection. Studies have also
reported the conjugation of heparin to deoxycholic acid in order to develop an oral
delivery system for anticoagulant treatment preferable to the standard intravenous and
subcutaneous injection (Lee et al, 2001; Kim & Vaishali, 2006). The fact that these bile
acids are or may be utilized in a medicinal capacity highlights that they will be present
in areas of the body other than the liver. As such the data presented here on a laryngeal
cell line is a relevant line of investigation given that in most cases these bile acid
derived treatments are given orally. As the data demonstrate, the effect on toxicity in
cell lines of different origins must be seriously considered and a more complete
cytotoxic profile of AgNP to include exposure site contributions be established.

5.4 Chapter Summary
This chapter has demonstrated the modifying effect of some of the common biofluid
components on AgNP toxicity. The data presented demonstrate that biofluid
components can significantly influence the toxic profile of AgNP. As such future
studies must consider the effects various biofluids and their components have on the
processing of nanoparticles upon entry to the body, their presentation to cells,
distribution and the biological processes they induce. Finally researchers must not just
consider the toxicity of the isolated nanoparticles but that of a combined effect
including, the local environment and the ions they release which have been shown to
contribute considerably to toxicity.
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Chapter 6

Adapted from “The surfactant dipalmitoylphophatidylcholine modifies acute
responses in alveolar carcinoma cells in response to low concentrationsilver
nanoparticle exposure”

6.1 Introduction
Nanoparticle exposure via inhalation is probably the most common entry point for
nanoparticles and during recent decades the generation of engineered nanoparticles for
applications in medicine, food, cosmetics and electronics to name a few has increased
the likelihood of exposure exponentially (Sozar & Kokini, 2009; Bouwmeester et al,
2009).
Inhalation provides an easy entry route for engineered nanoparticles in nano-carrier
systems for drug delivery allowing an easy route for targeted, controlled and noninvasive delivery. Liposomes in particular have been the nano-carrier of choice in the
development of improved and intelligent drug delivery systems (Varez-Lorenzo et al,
2009; Shum et al, 2001). While inhalation provides an alternative method of
pharmaceutical delivery, improving both the treatment and comfort of patients, it also
provides easy entry for undesirable nanoparticles. A number of studies have been
undertaken to explore lung entry of various nanoparticles and their subsequent
distribution around the body. Cerium oxide (CeO2) nanoparticles have been shown to
cause acute toxicity in the lungs following exposure. It was postulated that this could
lead to chronic inflammation days after the exposure period with particles deposited in
the lungs as they penetrate through the alveolar wall into the systemic circulation
(Srinivas et al, 2010). Silver nanoparticle (AgNP) exposure in the lung has also been
shown to induce cytotoxicity along with zinc oxide (ZnO) and titanium dioxide (TiO2).
Although all nanometals induced toxicity they did so at differing levels with ZnO
inducing greater levels of toxicity in alveolar macrophages compared with the other two
nanometals. The induced toxicity may also lead to excessive secretion of certain
biological agents causing dysfunction in the cytokine network, reducing the efficiency
of the respiratory immune system (Liu et al, 2013).
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Due mainly to their antibacterial qualities AgNP are currently one of the most utilized
nanomaterials on the market providing a diverse range of applications including medical
devices, antibacterial textiles and toys and food packaging (Sozar & Kokini, 2009;
Bouwmeester et al, 2009). While AgNP have been highly regarded for their benefits,
their increased incorporation into everyday consumer products has generated
considerable interest in establishing the risk exposure has on human health and the
environment. A more in depth toxicological assessment of nanoparticle-biological
interaction is required and a focus must now be shifted onto the influence of biofluids
and surfactants on toxicological outcome (Mwilu et al, 2013; Ehrenberg et al, 2009;
Wang et al, 2013; Misra et al, 2012; Aggarwal et al, 2009). In light of this and the easy
entry of nanoparticles both beneficial and otherwise, this study investigates the
interaction and toxicological influence of a component of lung surfactant on AgNP
toxicity on the lung.
Pulmonary surfactant is composed of a variety of complex phospholipids, lipids and
surfactant specific proteins. Dipalmitoylphosphatidylcholine (DPPC) is the most
abundant phospholipid, comprising 70-80% of total surfactant. The overall function is
to reduce surface tension at the liquid-air interface at the bronchoalveolar surface with a
dysfunction in surfactant associated with certain respiratory disorders (Kumar &
Bohidar, 2010; Serrano & Perez-Gil, 2006; Bakshi et al, 2008). In recent studies DPPC
has been used to improve the properties of liposomes to produce more successful in vivo
methods of delivery. For example its inclusion in liposome encapsulation of cancer
drugs can improve delivery of the complete drug concentration to tumour cells
improving killing of cancer cells (Yavlovich et al, 2011).
The aim of this investigation is to assess the toxic response of a carcinogenic lung cell
line, A549, to in vitro exposure to AgNP. The ability of DPPC to affect or modify any
observed toxicity was also established. The physicochemical characteristics of
nanoparticles play a vital role in toxicological investigation and were previously
discussed in chapter 4 together with the effect of DPPC on their characteristics. A
cytotoxic profile was carried out using a number of viability assays including 3-(4, 5Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), alamar blue and a 2’,
7’-dichlorofluorescin diacetate (DCFH-DA) plate assay to detect intracellular oxidative
stress induced by exposure. The influence of DPPC on the outcome of toxicity was also
assessed using the same assays. A subsequent study was performed to monitor the effect
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on the release of inflammatory markers interleukin-8 (IL-8) and tumour necrosis factor
alpha (TNF-α) upon exposure to AgNP in the presence of DPPC.

6.2 Cytotoxicity Testing
The cytotoxicity of AgNP on A549 cells was assessed using the viability assays MTT,
Alamar blue (AB) and a DCF-DA plate assay to detect intracellular oxidative stress.
The influence of DPPC on the observed toxicity was investigated using the same array
of toxicological assays. A positive control of 10% DMSO was employed for all viability
assays and 5µM H2O2 was employed for ROS studies. The ability of AgNP to induce an
inflammatory response and the impact of DPPC on this response was also investigated
using ELISA based assays for the detection of IL-8 and TNF-α release. Cytotoxicity
data for AgNP exposure is presented in table 6.1. The results of the MTT assay are
presented for toxicity testing in the presence and absence of DPPC. Both MTT and AB
assays were performed. Results for AB assay are presented in Appendix A6.2.

6.2.1 Cytotoxic evaluation A549 cell line to AgNP exposure alone and in the
presence of DPPC
Figure 6.1 represents the cytotoxic response of A549 cells to AgNP exposure as
determined by the MTT assay. Reduction in cell viability due to exposure occurred in a
concentrationand time dependent manner. A significant reduction in mitochondrial
integrity was observed after 48 hours at all AgNP concentrations. Significant reduction
after 72 and 96 hour exposures was noted at concentrations of 15.6μg/ml and above
compared to the unexposed control, while a significant reduction in cell survival at all
exposure times occurred at 31.25μg/ml and above.
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Figure 6.1 Cytotoxicity of AgNP in A549 cells after 24, 48, 72 and 96hr exposure as
determined by the MTT assay. Data expressed as percentage of control mean ± SD of
three individual experiments. * denotes a statistically significant (p< 0.05) difference
from the unexposed control

A DCF-DA plate assay was employed to detect any ROS production in response to
AgNP exposure over a 6 hour period with readings taken every hour. This study
indicated no intracellular ROS production in response to AgNP exposure. The
generation of intracellular hydro peroxides was noted at the highest concentration,
500μg/ml, with production increasing in a time dependant manner. Induction of ROS
was first detected at this concentration after 15 minutes, with the highest induction
observed after 1 hour. Results are presented in Appendix A 6.2.
The ability of DPPC to influence toxicity was investigated using the same array of cytotoxicological tests.
Figure 6.2 displays the toxic response of A549 cells to AgNP in the presence of
0.25μg/ml DPPC. A concentrationdependant response to AgNP exposure was observed.
A change in toxicity was not noted, however the pattern appeared altered in the
presence of DPPC. A short delay in toxicity between 48 and 72 hours was observed
after which a significant reduction in cell viability occurred. Significant reduction in cell
survival to all exposure concentrations was noted after 72 hours. After 24 hours,
significant loss in cell viability was observed at a concentration of 15.6μg/ml with a
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significant decline at 7.8μg/ml and above following 96 hour exposure. Significant cell
death compared to the unexposed control at all exposure intervals was observed at
62.5μg/ml and above. The addition of DPPC may alter the pattern of toxicity by causing
a delay in the first 48 hours, after which a significant reduction in viability is observed
at 72 hours.

Figure 6.2 Cytotoxicity of AgNP in A549 cells with added DPPC after 24, 48, 72 and
96 hour exposures as determined by the MTT assay. Data expressed as percentage of
control mean ± SD of three independent experiments. * denotes a statistically
significant (p < 0.05) difference from the unexposed control

The delay and increase in viability at lower nanoparticle concentrations at 48 hours may
result from surviving cells beginning to replicate. DPPC is a surfactant and as such will
associate with the nanoparticles surface. This association may result in a “Trojan horse”
effect or delayed toxicity as observed at lower concentrations in the first 48 hours. After
this time it is possible the DPPC coating has been removed following nanoparticle entry
to the cell and trafficking to various cellular compartments allowing the naked
nanoparticle to exert its toxic effects (Wang et al, 2013).
In addition to cytotoxic evaluation, the clonogenic assay was performed to analyse the
effect of longer exposures to AgNP. This assay was performed over a 10 day exposure
period and monitored the ability of cells to form colonies in the presence of AgNP. The
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ability of cells to proliferate following AgNP exposure with the addition of DPPC was
significantly reduced compared to the unexposed control. This was observed at all
exposure concentrations. It was found that the ability of A549 cells to proliferate was
inhibited at the lowest concentration of 3.91μg/ml and above with no colony formation
and therefore no cell survival at concentrations of 62.5μg/ml and above, as shown in
figure 6.3. Interestingly, it appeared that the addition of DPPC increased the toxicity of
AgNP towards cells with significant reductions in colony formation compared with
exposure to AgNP alone.

Figure 6.3 Cytotoxicity of AgNP alone and with added DPPC after 10 day exposure as
determined by the clonogenic assay. Data are expressed as percentage of control mean ±
SD of four independent experiments. * denotes a statistically significant (p<0.05)
difference from the unexposed control

A DCF-DA plate assay was employed to investigate the effect of DPPC on ROS
generation in A549 cells following AgNP exposure. From the data it appeared that in
the presence of DPPC there was increased generation of intracellular ROS from a
concentrationof 31.25µg/ml and above. Figure 6.4 illustrates ROS production in a
concentrationand time dependant manner. Induction was detected at concentrations as
low as 31.25μg/ml after 15 minutes exposure, with maximum production noted at
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500μg/ml after 30 minutes. ROS production was detected up to 6 hours after initial
exposure at a concentration of 500μg/ml and up to 4 hours after initial exposure at
250μg/ml. Significant increases were noted at doses of 62.5µg/ml after 30 minutes,
125µg/ml after 15 and 30 minute exposures and at higher doses significant generation
was observed from 15 to 30 minutes and 2 to 3 hours at 250µg/ml and at 15 minutes to
5 hours at 500µg/ml. From the data it is clear that the presence of DPPC modifies
oxidative stress in A549 cells by increasing intracellular ROS formation following
AgNP exposure.

Figure 6.4 ROS generation in A549 cells after different time points of AgNP exposure
in the presence of DPPC. Data expressed as percentage of control mean ± SD of six
independent experiments. * denotes a statistically significant (p<0.05) difference from
the unexposed control

6.3 Inflammatory Studies
The ability of AgNP to induce IL-8 and TNF-α production and the effect of the addition
of DPPC was investigated using ELISA based assays.
Figure 6.5 demonstrates IL-8 release following exposure to AgNP. At the highest
concentration, 50µg/ml, production of IL-8 was observed after 2 hours. Levels were
shown to decline after 3 hours with a second peak in levels demonstrated after 4 hours.
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The lower concentrationof AgNP caused IL-8 release initially after exposure with
increasing generation up to 2 hours after exposure. A similar reduction in levels was
detected at 3 hours after which an increase in IL-8 was detected at 4 and 6 hours. A
significant increase in IL-8 compared to the unexposed control was noted at 2, 3, 4 and
6 hours at a concentration of 50µ/ml and at all intervals at 25µg/ml. The data suggest
that at sub-lethal levels of AgNP, 25µg/ml, a more immediate and long lived
inflammatory response is initiated compared to higher toxic doses.

Figure 6.5 Induction of IL-8 in A549 cells at 1-4 and 6 hours following exposure to
AgNP. Data expressed as percentage of control mean ±SD of three individual
experiments. * denotes a statistically significant (p<0.05) difference from the unexposed
control
Figure 6.6 represents IL-8 release in A549 cells following AgNP exposure with the
addition of DPPC. The data show that the presence of DPPC alters the pattern of IL-8
release in cells. The levels of IL-8 detected were substantially higher than exposure to
AgNP alone and production occurs at a faster rate with greater levels detected after 1
hour exposure. Similar to figure 6.5 a second spike in release was detected at 6 hours.
The presence of DPPC generated an immediate and prolonged inflammatory response
compared to exposure to AgNP alone as illustrated by IL-8 levels detected at 1 and 6
hours. Significant release was noted at 1, 2, 3 and 6 hours for all doses compared to the
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unexposed control. While DPPC leads to an enhanced production of IL-8, the pattern
appears not to be dependent on concentration suggesting that regardless of AgNP
concentrationthe same biological response is initiated.

Figure 6.6 Induction of IL-8 in A549 cells at 1-4 and 6 hours following exposure to
AgNP in the presence of DPPC. Data expressed as percentage of control mean ±SD of
three individual experiments. * denotes a statistically significant (p<0.05) difference
from the unexposed control
Figure 6.7 illustrates TNF-α release following AgNP exposure. Generation of TNF-α at
a concentrationof 25µg/ml was immediate and short lived with peak levels detected
after 1 hour and a rapid reduction observed at 2 hours and above. A similar pattern was
detected at the highest concentrationwith high levels released after 1 hour followed by a
swift decline. However as demonstrated with IL-8, a second spike in TNF-α levels
occurs at 6 hours. Significant TNF-α release was detected after 1 hour following
25µg/ml exposure and after 1, 2, 3 and 6 hours after 50µg/ml exposure.
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Figure 6.7 Induction of TNF-α in A549 cells at 1-4 and 6 hours following exposure to
AgNP. Data expressed as percentage of control mean ±SD of three individual
experiments. * denotes a statistically significant (p<0.05) difference from the unexposed
control
In the presence of DPPC (figure 6.8) substantially lower levels of TNF-α were released
compared to AgNP alone. TNF-α was generated after 1 hour exposure with a decline in
levels detected after at 2 hours. Unlike exposure to AgNP alone, the second increase in
levels was detected at 3 hours and gradually increased with time. Significant increases
in TNF-α release were noted at 1, 3, 4 and 6 hours at a concentrationof 50µg/ml and at
1, 4 and 6 hours at 25µg/ml. It appears the presence of DPPC produces a prolonged
inflammatory response similar to that observed with IL-8 release. The addition of DPPC
also modifies the pattern of TNF-α release, which similar to IL-8, is not dependent on
AgNP concentration.
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Figure 6.8 Induction of TNF-α in A549 cells at 1-4 and 6 hours following exposure to
AgNP in the presence of DPPC. Data expressed as percentage of control mean ±SD of
three individual experiments. * denotes a statistically significant (p<0.05) difference
from the unexposed control

6.4 Discussion
It is apparent from the literature that exposure to nanoparticles is becoming more
widespread mainly through their continued incorporation into consumer products. As a
result there is an increasing incidence of direct contact between nanoparticles and
biological systems. This growing concern of nanoparticle exposure highlights the need
for a complete and thorough toxicological investigation to determine what effects are
induced and what factors within biological systems play a role in the resulting effects.
The physicochemical characteristics of AgNP play an important role in how they will
interact with biological systems. In this instance a thorough characterisation of
nanoparticles was undertaken and previously discussed in chapter 4, with no interaction
between components evident. Despite the lack of interaction, the effect individual
components play on resulting toxicity must always be considered as physicochemical
characterisation can never truly represent interactions occurring in vitro or in vivo.
Table 6.1 displays cytotoxic data for both viability assays. The AB assay demonstrates
an increase in IC50 values at 72 and 96 hours. This assay has multiple sites of conversion
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within the cell and thus gives an indication into both viability and general cell function.
As such the increase in cell viability observed may be attributed to cell recovery. The
A549 cell line has a doubling time of 22 hours and it is possible that after the first 48
hours of exposure where toxicity is observed any surviving cells begin to replicate again
slowly resulting in an increase in IC50 values. This was also observed at 96 hours with
the addition of DPPC. In the MTT assay which is indicative of mitochondrial integrity
only, a time dependant reduction in values was observed. Exposure to AgNP was also
noted to induce an inflammatory response with release of IL-8 and TNF-α. The
presence of DPPC significantly altered the levels of release induced by exposure on
A549 cells. The difference in levels released when DPPC was present compared to
AgNP exposure alone was found to be statistically (p<0.05) significant at all exposure
concentrations and time points.

Table 6.1 Calculated IC50 values (µg/ml) resulting from exposure to AgNP for the AB
and MTT assays in the A549 cell line. ** Denotes where a 50% effect was not
observed. IC50 values were calculated from the average response of three independent
experiments fitted to a sigmoidal curve and a four parameter logistic model used to
calculate Inhibitory Concentration (IC50) with a (p<0.05)
Cell Line

AB Assay IC50 (µg/ml)

MTT Assay IC50 (µg/ml)

24hr

48hr

72hr

96hr

24hr

48hr

72hr

96hr

A549

116.23

11.68

39.86

118.40

340

115

116

91

A549 + DPPC

46.06

45.30

41.78

96.84

**

**

49

80

(b)

The mechanism of cell death caused by AgNP can be related to oxidative stress.
Mitochondrial cell death by ROS generation has been described in a number of studies
as the primary mechanism of nanoparticle related cell death with its generation forming
a critical step in initiation of apoptotic pathways (Martindale & Holbrook, 2002; Sastre
et al, 2000; Piao et al, 2011). ROS are generated under normal physiological conditions
and are continually eliminated by naturally occurring antioxidants. Under certain
“stressful” conditions cells are unable to maintain homeostasis as increased quantities of
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ROS are produced which overwhelm the antioxidant systems (Arora et al, 2008; Piao et
al, 2011). Previous studies have shown that AgNP not only induce ROS but can also
inhibit antioxidants such as glutathione (Arora et al, 2008; Hussain et al, 2005;
Chairuangkitti et al, 2013; Piao et al, 2011). This process may be in part due to lipid
peroxidation caused by nanoparticle exposure. AgNP and ZnO have been identified as a
cause of lipid peroxidation enhancing ROS production while also quenching naturally
occurring antioxidants (Premanathan et al, 2011; Adeyemi & Faniyan, 2014). This
response induces downstream dysfunction such as inflammation and DNA damage
within the cell, culminating in cell death (Nel et al, 2006). While mitochondrial
involvement appears to be the mechanism of cell death, other pathways have been
hypothesised. Death via a ROS-independent pathway has also been observed in A549
cells following exposure to AgNP. This results in cell cycle arrest rather than cell death
by interfering with a regulatory protein critical in progression of the cell cycle
(Chairuangkitti et al, 2013). This may partially explain the lack of ROS induction
observed following AgNP exposure but with a reduction in viability still evident. Cells
may be arrested at various stages of the cell cycle without the involvement of ROS
following AgNP exposure as demonstrated in the data.
The induction of oxidative stress is a critical step in the biological response to
nanoparticle exposure and causes a number of cellular implications including an
enhanced inflammatory response. Excessive ROS production leads to activation of a
number of pro-inflammatory cytokines including IL-8 and TNF-α within the lung,
which have been implicated in certain respiratory disorders (Henricks & Nijkamp,
2001; Zuo et al, 2013). IL-8 is involved in the activation and migration of cells such as
neutrophils, during acute inflammation. It can also up-regulate adhesion molecules
involved in adherence and migration of cells through the endothelium (Feghali &
Wright, 1997; Lim et al, 2012). The lung epithelium in particular is an important source
of IL-8 and as such is a key player in the mediation of lung inflammation (Donaldson et
al, 1998). IL-8 has been the focus of a number of studies related to nanoparticle
toxicity, with its release implicated in the recruitment of inflammatory cells to the lung
(Singh et al, 2007). Specifically, following AgNP exposure, significant release of IL-8
from macrophages has been demonstrated, with both particle size and the generation of
ROS playing a crucial role in its release (Lim et al, 2012; Park et al, 2011).
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TNF-α is a potent cytokine involved in the initiation and maintenance of inflammation
(Nathan, 2002). TNF-α can mediate a number of responses directly such as fever and,
tissue damage, as well as causing indirect effects by downstream signalling leading to
the activation of other inflammatory factors including IL-6 (Feghali & Wright, 1997;
Warren, 1990). This cytokine has been implicated in the development of pulmonary
fibrosis following silica micro-particle exposure causing increased endothelial
permeability to macromolecules as well as its up-regulation following exposure to
various nanoparticles (Napierska et al, 2012; Henning et al, 1987; Pryhuber et al, 2003;
Piguet et al, 1990). The detection of increased levels of both IL-8 and TNF-α following
exposure implicates AgNP in the inflammatory process with an augmented response
observed following the addition of DPPC. The increased levels of IL-8 in particular
correlates to the ROS generation observed following its addition. In the case of IL-8, an
immediate release is observed in the presence of DPPC and its early release has been
proposed as a potential bio-marker for acute inflammation in relation to AgNP exposure
which the data presented here supports (Lim et al, 2012; Park et al, 2011).
The ability of the DPPC to increase and prolong the activation of both cytokines
compared to AgNP alone suggests progression from acute to chronic inflammation. It
has been proposed that high levels coupled with sustained release of these cytokines
may prevent resolution resulting in the development of chronic inflammation. It was
observed that in certain cases it was not the highest AgNP concentration that generated
the greatest cytokine release. This is not surprising as high concentrations can cause
cells to enter a death process whereas lower concentrations can induce an inflammatory
reaction. Lim et al demonstrated cytokine gene expression at sub lethal concentrations
of AgNP, in particular IL-8 release at 2.5µg/ml (Lim et al, 2012).
DPPC is a major component of lung surfactant produced by type II alveolar cells,
similar to A549 cells, and as such has been used as a surfactant model in numerous
toxicity studies (Kumar & Bohidar, 2010; Dobbs et al, 1987; Foucaud et al, 2007;
Porter et al, 2008; Sager et al, 2007). Employed as a particle coating, DPPC has been
shown to exert a protective effect preventing degradation and allowing controlled
release of encapsulated drug compounds; however there is increasing evidence of its
contribution to toxicity and induction of oxidative stress (Kaviratna & Banerjee, 2009;
Herzog et al, 2009; Foucaud et al, 2007; Hamilton Jr et al, 2008). The data highlight the
importance of ROS in cell toxicity particularly in the presence of DPPC. DPPC appears
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to increase oxidative stress within the cell in agreement with other studies where it was
also found that its addition significantly increased ROS production in A549 cells
(Herzog et al, 2009; Foucaud et al, 2007). An investigation into different variations of
silica nanoparticles including iron- and titania- containing particles, noted increased
levels of intracellular ROS generation. This was believed to occur through nanoparticle
entry by a Trojan-horse type mechanism dependant on surface chemistry of particles
(Limbach et al, 2007). A similar theory can be applied to this study and the increased
oxidative stress observed following the addition of DPPC. It is possible that interaction
with DPPC causes particles to have a higher level of dispersion, increasing the surface
area available for interaction and therefore increasing the likelihood of cellular uptake resulting in generation of ROS. It must also be considered that the surface chemistry
and activity of particles is altered by DPPC, changing its toxicity, making the particles
more reactive and thus more toxic (Herzog et al, 2009; Hamilton Jr et al, 2008; Buford
et al, 2007).
The observation that cell death can occur via a number of pathways in A549 cells
indicates a two tiered mechanism of cell death, cell cycle arrest and ROS mediated
mitochondrial dependant cell death (Piao et al, 2011). The data in this study suggest that
while not changing nanoparticle toxicity DPPC may influence death pathways as
demonstrated by the induction of oxidative stress. The observation that DPPC leads to
ROS generation in A549 cells suggests a possible switching from a ROS independent
pathway as described by Chairuangkitti et al, 2013 causing cell cycle arrest to a ROS
dependent pathway culminating in apoptotic cell death (Chairuangkitti et al, 2013).
Further mechanistic studies are required to conclusively determine if pathway switching
due to DPPC interaction is occurring.

6.5 Chapter Summary
This chapter has demonstrated the role of DPPC in modifying toxicity, namely inducing
intracellular ROS production. Its interaction with AgNP highlights the importance of
particle-surfactant interactions and the altered effects produced when in contact with
mammalian cells. The data presented are in agreement with previous studies illustrating
the impact on toxicity caused by nanoparticle contact with DPPC and the resulting
alteration in ROS generation and inflammatory response. These findings may contribute
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to developing a realistic risk assessment of nanoparticle exposure and the potential
biological outcomes following entry and interaction with various fluids and surfactants
present in the body.
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Chapter 7

Silver nanoparticle induce pro-inflammatory gene expression and inflammasome
activation in human monocytes

7.1 Introduction
Silver nanoparticles (AgNP) are one of the most commonly utilized nanoparticles due to
their antimicrobial properties (Duncan, 2011). As a result, the likelihood of exposure is
becoming more frequent thus posing potential health risks that must be addressed.
Cytotoxicity induced by AgNP exposure has been demonstrated in a number of studies
with a variety of factors influencing observed cyto- and geno-toxic effects (Choi et al,
2010; Kim et al, 2009; Lankoff et al, 2012). Upon exposure AgNP have been shown to
induce immune reactions at sub-lethal concentrations, including IL-8 induction and are
involved in the generation of reactive oxygen species (ROS) (Lim et al, 2012).
Following inhalation, nanoparticles have been shown to infiltrate the alveolar cell wall
causing toxicity in alveolar macrophages which leads to dysfunction in the cytokine
network by potentially penetrating the alveolar wall and infiltrating the bloodstream.
This results in the translocation and distribution of nanoparticles to various organs and
potential detection by circulating blood monocytes (Liu et al, 2013; Johnson et al, 2010;
Kim & Choi, 2012).
An intact and functioning immune system is vital in the protection against harmful
external stimuli. The controlled and rapid initiation and effective resolution of
inflammation is vital to maintain normal homeostasis. Dysregulation of the immune
response has been implicated in many human disease processes including
autoimmunity, allergy and cancer (Lin & Karin, 2007; Scheller et al, 2011). The innate
immune response is the first line of active defence and comprises a number of
phagocytic cells with monocytes particularly, the primary cell type which are involved
in the initial immune response by recognising distinct pathogen associated molecular
patterns (PAMPs) such as lipopolysaccharide (LPS) via toll-like receptors (TLRs) on
the cell surface (Matzinger, 1994; Beutler, 2009; Oberbarnscheidt et al, 2011). The
subsequent release of cytokines from immune cells co-ordinate the immune response
and are vital in determining the type of response required and can synchronize the
various immunological elements required.
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The production of cytokines must be tightly regulated in order to prevent an
overstimulation of the immune response which may lead to the initiation of a
pathological process. IL-1β is one cytokine that is tightly regulated at the transcriptional
and post-translational level by inflammasomes. Due to its vast influence both on innate
immunity and the systemic response its production requires a two-step signalling
process; an initial priming step resulting in gene expression followed by inflammasome
activation which results in the cleavage of the inactive form essential for IL-1β
maturation and subsequent secretion (Dinarello, 2009; Schroder & Tschopp, 2010;
Gross et al, 2011; Latz et al, 2013). Nanoparticles including titanium dioxide (TiO2),
silica and also AgNP have been shown to cause inflammasome activation resulting in
IL-1β release (Winter et al, 2011; Yang et al, 2012).
As the initial release of cytokines following exposure to an external threat is pivotal in
mounting an effective immune response, the aims of this study were to investigate the
ability of AgNP to induce such a response in a monocyte cell line and to compare the
response to that which occurs from LPS stimulation alone. Following this investigation
the immunological response of AgNP on primary human monocytes was investigated to
determine if a similar response was induced following exposure. The AgNP induced
transcription of pro-inflammatory cytokines- IL-1, IL-6 and TNF-α as well as well as
release of IL-1β as an indirect marker of inflammasome activation was investigated.
This study aims to provide an insight into the activation of innate immune responses
following AgNP exposure in human whole blood monocytes and provide an indication
of the role of the inflammasome in this response by secretion of mature IL-1β, which
drives inflammation.

7.2 Results
7.2.1 Cytotoxicity Testing
The AB assay was performed to determine the active and cytotoxic concentrations of
THP-1 cells to AgNP exposure so that IC50 concentration values could be used to elicit
a gene response for the follow up studies. A concentrationdependent reduction in cell
viability was observed (figure 7.1) following AgNP exposure for 24 hours. IC50
concentration was calculated as described previously. From this data it was determined
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that the most active and cytotoxic concentrations of AgNP for the remaining gene THP1 monocyte studies were 50 and 100µg/ml (IC50).

Figure 7.1 Cytotoxicity of AgNP in THP-1 cells after 24hr exposure as determined by
the AB assay. Data expressed as percentage of control mean ± SD of three independent
experiments. * denotes a statistically significant (p<0.01) difference from the unexposed
control

7.2.2 THP-1 pro-inflammatory cytokine gene expression in response to AgNP
exposure
The induction of pro-inflammatory gene expression by THP-1 monocyte cell line as a
result of AgNP exposure was investigated. The response to AgNP at concentrations of
100 and 50µg/ml, based on IC50 values, were tested. To determine immune response
following exposure, transcript levels of pro-inflammatory cytokines IL-1, IL-6 and
TNF-α in THP-1 monocytes were quantified by RT-PCR. Actin was used as the internal
control. Results revealed a significant increase in transcript levels of all cytokines. In an
experiment to establish possible endotoxin contamination of AgNP, THP-1 cells were
incubated with polymyxin B (20µg/ml) for 1 hour prior to AgNP exposure. Endotoxin
was not detected in AgNP used in this study (Appendix A7.2).

136

Induction of IL-1 transcript levels demonstrate a significant increase at both
concentrations after 1, 6 and 8 hour exposures at 50µg/ml and after 6 and 8 hour
exposures at 100µg/ml (figure 7.2) compared to the unexposed control. At all exposure
concentrations a time dependent increase was noted peaking at 8 hours. At both
concentrations, levels of IL-1 begin to decrease after 24 hour exposure. Levels of IL-1
at this time point were not significant compared to the unexposed control.
A statistically significant up-regulation in IL-6 induction (figure 7.3) was noted
following all exposure time points at all exposure doses compared to the unexposed
control. The increase in transcript levels occurs in a time dependent manner at AgNP
concentration of 100µg/ml. IL-6 induction peaks 1 hour after exposure at a 50µg/ml
concentrationwith a step-wise reduction observed with time. At 24 hours a significant
increase in transcript levels compared to the unexposed control was noted at this
concentration.
Induction of TNF-α (figure 7.4) was detected after 1, 8 and 24 hours at 50µg/ml with a
significant increase in induction compared to the unexposed control. At the highest
exposure concentration, 100µg/ml, up-regulation of TNF-α was detected after 1 and 6
hour exposures with a significant increase in transcript levels observed after 24 hours
compared to the unexposed control.
The increase in transcript levels for TNF-α and IL-6 after 24 hours suggests prolonged
induction and longer time points need to be investigated to determine if levels continue
to rise.
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Figure 7.2 Fold increase in IL-1 induction in THP-1 cells exposed to 50µg/ml and
100µg/ml AgNP and compared to the unexposed control ± SD of three independent
experiments. * denotes a statistically significant (p<0.05) difference from the unexposed
control. Actin was used as the internal control

Figure 7.3 Fold increase in IL-6 induction in THP-1 cells exposed to 50µg/ml and
100µg/ml AgNP and compared to the unexposed control ± SD of three independent
experiments. * denotes a statistically significant (p<0.05) difference from the unexposed
control. Actin was used as the internal control
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Figure 7.4 Fold increase in TNF-α induction in THP-1 cells exposed to 50µg/ml and
100µg/ml AgNP and compared to the unexposed control ± SD of three independent
experiments. * denotes a statistically significant (p<0.05) difference from the unexposed
control. Actin was used as the internal control

7.2.3 Synergistic effect of LPS and AgNP on pro-inflammatory gene expression
AgNP were investigated for any potential synergism with LPS with respect to proinflammatory gene expression. Following exposure to a combination of LPS and AgNP,
THP-1 cells demonstrated enhanced levels of gene expression compared to both the
unexposed control and exposure to LPS or AgNP alone. Significant increases in IL-1
gene expression were observed at 6, 8 and 24 hours following LPS and combined
50µg/ml AgNP and LPS exposures (Figure 7.5). For exposure to combined 100µg/ml
AgNP and LPS, significant increases compared to the unexposed control were noted at
6 and 8 hours. IL-6 induction (Figure 7.6) demonstrated significant increases in all
exposure scenarios at 6, 8 and 24 hours compared to the unexposed control with
significant increases in expression of TNF-α (Figure 7.7) observed at all time points and
in all exposures compared to the unexposed control. For all of the cytokines, greater
levels of induction were noted in the combined AgNP-LPS exposures compared to LPS
exposure alone.
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In addition to significant differences compared to the unexposed control studentnewman-keuls multiple comparison tests were performed to determine if the difference
in levels of expression between LPS exposed, AgNP exposed and AgNP-LPS exposed
samples was significant. For IL-1 expression significant differences were noted for 6
(p<0.001), 8 (p<0.05) and 24 hours (p<0.01) between all exposure scenarios with the
exception of 100µg/ml AgNP compared to 100µg/ml AgNP-LPS and compared to
50µg/ml AgNP-LPS which showed no significant difference in IL-1 induction after 24
hour exposure. Following 1 hour exposure no significant differences in IL-1 gene
expression were observed. IL-6 expression demonstrated statistically significant
differences between all exposure scenarios with p values of p<0.001 at all exposure
time points. Levels of TNF-α up-regulation demonstrated a significant difference
between all exposure scenarios at all time points, with p values of p<0.01 after 1 hour
and p<0.001after 6, 8 and 24 hours.

Figure 7.5 Fold increase in IL-1 induction in THP-1 cells following exposure to 1µg/ml
LPS and a combination of AgNP and LPS compared to the unexposed control ± SD of
three independent experiments. * denotes a statistically significant (p<0.05) difference
from the unexposed control. Actin was used as the internal control

140

Figure 7.6 Fold increase in IL-6 induction in THP-1 cells following exposure to 1µg/ml
LPS and a combination of AgNP and LPS compared to the unexposed control ± SD of
three independent experiments. * denotes a statistically significant (p<0.05) difference
from the unexposed control. Actin was used as the internal control

Figure 7.7 Fold increase in TNF-α induction in THP-1 cells following exposure to
1µg/ml LPS and a combination of AgNP and LPS compared to the unexposed control ±
SD of three independent experiments. * denotes a statistically significant (p<0.05)
difference from the unexposed control. Actin was used as the internal control
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7.2.4 Primary monocyte cytokine gene expression in response to AgNP exposure
Human blood monocytes were extracted from a cohort of 20 healthy donors and
examined to determine whether a similar innate immune response was induced to the
THP-1 monocytes. These monocytes were exposed only to a concentration of 50µg/ml
AgNP for 8 hours due to the limited supply of monocytes extracted per donor sample.
This exposure concentration and time point was chosen from the previous THP-1
studies as they appeared to be the most active test points.
The following results are presented for the average response to AgNP exposure in 20
healthy donors. As expected all donors displayed individual variation in response to
AgNP for each cytokine. Therefore, the coefficient of variation (CV) was calculated for
each cytokine between donors to determine the levels of variation between all blood
donor samples. IL-1 demonstrated a CV of 63.7%, IL-6 54.5% and TNF-α 51.2%.
The results (figure 7.8) demonstrate general up-regulation of all cytokines in all donors
responding to AgNP exposure compared to an unexposed control. Non-parametric
statistical analysis was performed due to the donor samples being one-off samples.
Combined levels (n=20) of IL-1 and TNF-α showed statistically significant upregulation compared to the unexposed control as determined by the Mann-Whitney test.
Figure 7.9 demonstrate the individual responses of 10 donors to AgNP exposure. As the
data illustrate variation in individual gene expression was observed between donors as
well as variation in the expression of each cytokine per donor. Kruskal-Wallis nonparametric analysis comparing the difference in expression levels of each individual
cytokine between each of the 10 donors was found to be non-significant for all three
cytokines. Spearman non-parametric assessment of differences between the levels of
expression of the three cytokines per donor sample was shown to be non-significant.
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Figure 7.8 Fold increase in IL-1, IL-6 and TNF-α gene expression in primary
monocytes following 8 hour AgNP exposure compared to an unexposed control ± SD of
twenty independent experiments. * denotes a statistically significant (p<0.05) difference
from the unexposed control. Actin was used as the internal control

Figure 7.9 Fold increase in pro-inflammatory cytokine gene expression, IL-1, IL-6 and
TNF-α in primary monocytes of 10 donors following 8 hour AgNP exposure compared
to an unexposed control ± SD of three independent experiments. Actin was used as the
internal control
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7.2.5 AgNP-induced inflammasome activation and cytokine secretion
Following the investigation into pro-inflammatory cytokine up-regulation by AgNP
exposure, it was hypothesized that the induction of cytokine secretion could be due to
inflammasome activation. The ability of AgNP to induce cytokine release following
pre-treatment of cells with LPS was investigated to determine the potential
inflammasome activation by AgNP themselves. An ELISA assay for IL-1β secretion
(Figure 7.10) was performed on the supernatant of THP-1 cells following 6 hour
exposure to AgNP to detect inflammasome induced cleavage of pro-IL-1β. The assay
was also employed to confirm pro-inflammatory gene expression through detection of
protein product, IL-1β, in cell supernatant. Production of the protein confirmed
inflammasome activation driven by AgNP exposure.

Figure 7.10 Release of IL-1β (pg/ml) from THP-1 cells following 6 hour exposure to
AgNP. LPS (10ng/ml) was pre-treated 4 hours before exposure and Ac-YVAD-CMK
(20µM) inhibitor was treated 1 hour before exposure. ATP (5mM) was employed as a
positive control. Data expressed as percentage of control mean ± SD of five independent
experiments. *denotes a statistically significant difference (p<0.05) from the unexposed
control.
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An increase in IL-1β levels compared to the unexposed control was noted for both
exposure concentrations. While IL-1β release was significantly increased compared to
the unexposed control, levels were still low coming in under 20pg/ml. Following pretreatment with LPS for 4 hours levels of IL-1β release significantly increased to levels
of 20pg/ml and above. The highest increase was noted at the 50µg/ml dose. Pretreatment of cells with LPS only, resulted in a significant increase in IL-1β release
compared to the unexposed control similar to the levels observed for treatment of cells
with AgNP only. The combined pre-treatment with LPS and exposure to AgNP caused
significant IL-β release compared to the unexposed control and significantly higher
levels when compared to AgNP and LPS exposure alone. This suggests a synergistic
effect between AgNP and LPS in inflammasome activation.
Inclusion of the inhibitor prevented IL-1β release in all exposure scenarios. The
inhibitor is specific to caspase-1which prevents the proteolytic cleavage of pro-IL-1β
into the mature active form. These results indicate a possible role of caspase-1 in AgNP
mediated inflammasome activation.

7.3 Discussion
The prevalence of AgNP in consumer products as well as their use for the improvement
of medical devices and in biomedical applications increases in the incidence of human
exposure (Sotiriou & Pratsinis, 2011; Chen & Schluesner, 2008). Translocation and
systemic distribution of nanoparticles has been documented and as such the influence of
exposure in the circulatory system and the associated risk must be assessed (Johnson et
al, 2010; Van der Zande et al, 2012; Loeschner et al, 2011).
In this study it was established that exposure to AgNP resulted in significant
transcription of inflammatory cytokines IL-1, IL-6 and TNF-α. AgNP exposure can
generate intracellular reactive oxygen species (ROS) in mammalian cells, with
excessive production linked to cell damage and initiation of an inflammatory response
(Lim et al, 2012; Asharani et al, 2009). Oxidative stress in monocytes coupled with the
release of inflammatory cytokines is a natural protective response; however, this process
can become pathogenic when normal cell control systems are overwhelmed. Evidence
has indicated a correlation between ROS production and inflammation resulting in an
amplified response. Oxidative stress causes expression of cytokines including IL-1, IL-6
145

and TNF-α which in turn contribute to ROS generation. This produces an amplification
loop between oxidative stress and inflammation initiated by AgNP exposure (Kim &
Ryu, 2013). This loop while potentially contributing to resolution may also cause
continued pro-inflammatory cytokine induction past the threshold of resolution thus
inducing a continued inflammatory response and toxicity (Lander, 1997; Acker, 2005;
Franco et al, 2012). The pro-inflammatory cytokine expression detected following
AgNP exposure and the amplified expression noted following exposure to AgNP and
LPS combined may result from ROS production. These AgNP have previously been
shown to be potent inducers of ROS (Murphy et al, 2015; Gupta Mukherjee et al,
2012). Further investigation is required to determine if a similar ROS driven mechanism
occurs following exposure to these specific AgNP.
The increased gene expression observed by the combination of AgNP and LPS
exposures indicated a synergystic effect and may further indicate a potential interaction
which exacerbates the inflammatory response, potentially contributing to a greater
immune reaction. As previously discussed, significant increases in levels of all
cytokines compared to the unexposed control were noted. Significant differences in the
expression of all cytokines after 6, 8 and 24 hours, were determined when comparing
the differences in cytokine levels of cells exposed to either a combination of AgNP and
LPS compared to AgNP, or LPS alone. An interaction between AgNP with LPS would
explain the increased gene expression compared with exposure to AgNP or LPS alone.
An important part of AgNP toxicity is attributed to nanoparticle-biomolecule
interactions. Upon entry, nanoparticles associate with various biomolecules producing a
surface coating. The variety of biomolecules within the body leads to any number of
combinations coating the particle surface, making it an important contributory factor of
cellular response to nanoparticles and the extent of toxicity (Murphy et al, 2015; Lynch
et al, 2006; Monopoli et al, 2012; Dubey et al, 2015). A nanoparticles biomolecule
surface coating can induce a Trojan horse effect whereby toxicity appears delayed only
to occur days later, resulting from dissolution of the biomolecule coating within the
lysosome following cellular internalisation (Wang et al, 2013). An interaction between
AgNP and LPS must be considered, and it is clear that numerous factors contribute to
the responses induced. Further investigation is required to determine this interaction
with particular attention paid to the biomolecule surface coating in order to understand
the complete effect of AgNP exposure.
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Following investigation into gene expression by AgNP exposure in THP-1 cells, human
blood monocytes extracted from a cohort of 20 healthy donors were exposed to AgNP
to determine if a similar innate immune response was induced. While significant upregulation in IL-1 and TNF-α compared to the unexposed control was observed when
comparing the donors as a whole, variation between individual donors in their
expression of a particular cytokine and variation between the levels of the three
cytokines expressed by each donor was also noted. Even under the same experimental
conditions variation in gene expression was expected. There is evidence of donorspecific gene expression patterns which can be attributed to the data shown here and
also the large error observed when the expression patterns for a particular cytokine were
grouped and averaged. Statistical analysis of the variation, which ranged from 51.263.7%, were performed but indicated the variations between donors were nonsignificant. Several studies involving donor blood samples have demonstrated variation
in gene expression patterns with each donor producing differing levels following
exposure to a particular stimulus. Many factors can contribute to the variation in
expression, from environmental and physiological factors to the time of day of sample
taking (Howe et al, 2005, 2009; Whitney et al, 2003). The inflammatory response in
human circulating blood is a complex systemic process involving numerous factors
which contribute to the large CVs and varied results. A larger cohort of samples to
include other cells per donor such as lymphocytes would be an interesting investigation
to elucidate this response on a more clinical level.
The effect of AgNP on the release of IL-1β and its potential to cause inflammasome
activation yielded some interesting results. Exposure to AgNP alone resulted in a low
but significant level of IL-1β release compared to the unexposed control. Pre-treatment
of cells with LPS followed by AgNP resulted in significantly higher IL-1β release
indicative of a synergistic relationship between the two. This result corresponds to the
increase in gene expression observed following combined AgNP-LPS exposure. This
effect on IL-1β release may potentially have pathological consequences and result in a
greater immune response produced by minimally activated cells when AgNP are
present. Given their commonality in consumer products and the incidence of exposure,
their presence may trigger an exacerbated immune reaction in what would have been a
minimal immune response. Another interesting observation was that the lower
concentrationexposure produced the greatest release indicating that at sub-lethal
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concentrations of AgNP a greater response is induced, and this is an important
dosemetric consideration. This type of reaction has been observed in other studies
examining AgNP exposure which the findings here support (Lim et al, 2012; Yang et
al, 2012). The inclusion of an inhibitor highlights the involvement of caspase-1 in
inflammasome activation and potentially the specific involvement of the NLRP3
inflammasome which has been shown to become activated upon AgNP exposure (Yang
et al, 2012; Simard et al, 2015). The involvement of caspase-1 would explain the low
levels of IL-1β release following cell exposure to AgNP or LPS alone as it has been
shown that monocytes constitutively express activated caspase-1 and as a result only
require one stimulating event in order to cleave pro-IL-1β, which may explain the low
levels detected following exposure to AgNP or LPS alone (Netea et al, 2009).
The first signal in inflammasome activation leading to production of pro-IL-1β is often
NF-κB. AgNP have been shown to stimulate this pathway resulting in downstream
effects ranging from cell cycle arrest to apoptosis (Eom & Choi, 2010). A causative
mechanism of NF-κB expression is ROS, which can lead to several inflammatory
responses including mitochondrial DNA release, causing NLRP3 inflammasome
activation (Gloire et al, 2006; Shimada et al, 2012; Hehner et al, 2000). AgNP entry
into cells is believed to occur via receptor-mediated endocytosis, and evidence suggests
that AgNP can activate toll like receptor pathways, another mechanism of NF-κB
activation (Kim et al, 2007; Kim et al, 2012). It is possible that TLR-2 is involved as it
has been shown that AgNP induced apoptosis can be partially mediated by the TLR-2
signaling pathway (Kim et al, 2012; Dubey et al, 2015). Interaction of AgNP with a
TLR coupled with AgNP induction of NF-κB highlights a possible mechanism for
inflammasome activation. Further investigation into specific TLR-AgNP interactions is
required to determine any involvement. The heightened gene expression to combined
AgNP-LPS exposure may suggest involvement of the TLR-4 signaling pathway, a
receptor that specifically recognizes LPS, as another potential initiation event in
inflammasome activation.
ROS, specifically mitochondrial superoxide, have been implicated in the formation of
the inflammasome complex. Two additional mechanisms have also been identified, one
involves interaction of AgNP with cell membrane affecting integrity and resulting in
alteration to K+ efflux channels, the other involves cathepsin release following particle
entry into the lysosome which in turn affects mitochondrial function resulting in ROS
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release and thus inflammasome formation (Yang et al, 2012). Another contributor to
inflammasome activation by AgNP was recently identified as degradation of a stress
sensor associated with the endoplasmic reticulum brought on by exposure (Simard et al,
2015). Further investigation is required to determine if one or all of these mechanisms
are responsible for inflammasome activation by the specific AgNP utilized in this study.
In addition, AgNP have been investigated for their potential adjuvant properties with
studies indicating a significant adjuvant effect in mice (Xu et al, 2013). This evidence
of the immunostimulatory effect of AgNP highlights the immunological significance of
AgNP and is in agreement with the data presented in this study regarding gene
expression and IL-1β release induced by AgNP exposure alone and the increased levels
released following the combined exposure to AgNP and LPS.

7.4 Chapter Summary
This chapter has highlighted the immunological significance of AgNP exposure and
consideration must be given when assessing the influence of AgNP on the cells of the
immune system. These results indicate that AgNP could potentially have pathological
implications or indeed exacerbate already existing pathological conditions.
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Chapter 8

General Discussion and Future Work

8.1 Discussion
This thesis has clearly demonstrated that AgNP exposure can induce an innate immune
response in monocytes through pro-inflammatory cytokine up-regulation with
inflammasome involvement. In addition this study has illustrated the importance of
components of biological fluids in the modification of AgNP toxicity. In chapter 1 a
number of questions were asked regarding AgNP toxicity and their influence on
biological systems following oral exposure, below the main findings of this thesis are
identified and discussed.
To date the work performed for this project has included:
1. Characterisation of pristine AgNP and AgNP in the presence of biofluid
components UDCA, CA, DCA and DPPC, identifying any modifying effects
2. Cytotoxic evaluation of AgNP on multiple cell lines associated with oral
exposure, liver, larynx and lung (HepG-2, Hep2 and A549 respectively)
3. Investigation into the modifying effects of the aforementioned biofluid
components on the observed toxicity
4. Investigation into the innate immune response induced by AgNP exposure on a
monocyte cell line (THP-1)
5. Investigation into the innate immune response induced by AgNP exposure on
primary human monocytes and how this compares to the response induced in
THP-1 cells
6. Identifying the involvement of the inflammasome complex in AgNP induced
innate immune response
The aim of this work was to fully characterise AgNP and to explore their toxic potential
on a variety of cell lines associated with oral exposure. Following this, the ability of
certain biofluid components associated with oral exposure to modify the cytotoxicity of
AgNP was established. Prior to cytotoxic evaluation, it was determined if the presence
of biofluid components could alter the physicochemical characteristics of AgNP. Most
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cyto-toxicological studies are aimed at the risk associated with dermal exposure and
inhalation, this study aimed to assess the risk of oral exposure to AgNP to include
ingestion but also inhalation, as the two systems operate millimetres apart and the
likelihood of cross exposure between the two is unavoidable. Following initial
investigation, this study went on to focus on the potential innate immune response
induced by AgNP in circulating white blood cells following absorption into the blood
stream. The focus of this work was to mimic more realistic exposure scenarios and
concentrationmetrics associated with real world nanoparticle exposure. The interaction
between humans, the environment and nanoparticles is becoming more widespread and
frequent, highlighting the importance of establishing the real risks associated with
exposure.
The first step in any cyto-toxicological investigation is to establish the physicochemical
characteristics of the nanoparticle of interest. A number of methods including scanning
electron microscopy, dynamic light scattering analysis and UV/VIS absorption
spectroscopy were performed independently to provide a complete picture of the
characteristics of AgNP. BET was also employed to determine the surface area of
particles. All techniques were performed on the particle powder as purchased. Analysis
revealed a particle size between 50-70nm by SEM. DLS analysis which determines the
hydrodynamic radius of particles, revealed an average size of 34nm ± SD 3.5. BET
analysis on the nanoparticle powder revealed a surface area of 2.3 ± 0.1 m2/g. The same
techniques were also performed on the AgNP in the presence of the biofluid
components under investigation, UDCA, CA, DCA and DPPC to determine any
alteration to the size or agglomerative state of the particles. On the addition of biofluid
components to nanoparticle suspensions dispersed in the appropriate cell culture media
(RPMI or DMEM); DLS revealed a shift in particle size in the presence of DPPC and
UDCA but remained within the size range observed for AgNP dispersed in media alone.
Following addition of UDCA, CA and DCA (dispersed in DMEM); particle size was
revealed to fall within the size range for the cell culture media. It has been observed that
upon entry into the body a material becomes almost immediately coated in protein and
this may be the case upon addition of the various biofluid components. These
components may associate with and coat the particle upon contact causing alterations to
particle size. However it has also been demonstrated that proteins contained in cell
culture media can also associate with particles and it can be assumed that this is also
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occurring. With this in mind it would be expected that the association or coating with
various proteins would cause particles to agglomerate and an increase in particle size
observed but, neither scenario occurs. The lack of an increase in particle size in the case
of UDCA and DPPC (dispersed in RPMI) may be attributed to a shift in the plane of
shear. This shift was also noted when particles were dispersed in cell culture media
only. Addition of UDCA, CA or DCA resulted in a large shift in hydrodynamic radius
demonstrating one peak falling within the size range of DMEM. These biofluid
components have a large size distribution (greater than 200nm) and may cause the
formation of large agglomerates with AgNP, resulting in precipitation of particles out of
solution at an elevated rate preventing their detection by DLS analysis. This may
explain why only one peak is observed following analysis of these dispersions which is
attributed to DMEM. Further investigation is required to determine why these particular
AgNP-biofluid dispersions cannot be detected by DLS analysis. Whatever the process
may be interaction between AgNP and biofluid components may potentially influence
their interaction with living systems, their distribution and the biological responses they
induce.
In terms of producing a toxic response in cells, it was important to establish whether
AgNP could interact with the components and various growth factors of cell culture
media thus influencing toxicity. Any interaction with media components could lead to a
secondary toxicity due to depletion of vital growth factors essential for cell survival.
UV/VIS absorption was employed to study this effect. The spectra revealed all of the
features for cell culture media at 360, 410 and 560nm with AgNP and DPPC, UDCA,
CA and DCA revealing no features. The results indicated no interaction of particles
with cell culture media or biofluid components. It was concluded that no secondary
toxicity occurs due to depletion of media components.
Zeta potential analysis was also carried out to assess the overall stability of AgNP in the
various dispersions. Values varied among the suspensions. The overall system is stable
at values above +30mV and below -30mV. Analysis of AgNP dispersed in dH2O was
unstable at all test concentrations. Dispersion in RPMI was shown to stabilize the
system and with the addition of DPPC showed no change. Similar stability data was
obtained for AgNP dispersed in DMEM and addition of UDCA, CA or DCA had no
effect. The lack of change in zeta potential values corresponds to the DLS data where no
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significant change in hydrodynamic radius was observed. A change in hydrodynamic
radius, indicating interaction between particles and biofluid components, would
correspond to a change in zeta potential values suggesting indirect toxicity resulting
from an interaction (Casey et al, 2007; Casey et al, 2008). The large values noted for
AgNP in RPMI with DPPC and UDCA correspond to the DLS data, suggesting that
particle have a tendency to repel each other preventing the likelihood of agglomeration
and a change in size. The low unstable values noted for AgNP dispersion in DMEM
with UDCA, CA and DCA while indicting no change in the overall system may explain
the lack of particle size data. The lower values suggest a reduced repulsion force
increasing the tendency to agglomerate (Xia et al, 2006). The addition of these biofluid
components together with DMEM may result in agglomeration and thus precipitation of
particle out of solution preventing detection by DLS analysis. However no significant
changes were noted indicating biofluid components do not affect the overall stability of
cell media-nanoparticle system.

Following physicochemical characterisation of AgNP and establishing their interactions
with the selected biofluid components, the ability of these components to modify
toxicity was assessed. A number of toxicological tests were performed to determine the
toxic effect induced by AgNP on two cell lines associated with the GI tract, liver
(HepG-2) and laryngeal (Hep2) and if biofluid components associated with these tissues
had modifying effects. In terms of the effect of UDCA on the HepG-2 cell line, no
change in toxicity was noted however, CA and DCA did have modifying effects. The
pattern of toxicity as demonstrated in the AB and MTT viability assays remained
unchanged following addition of CA and DCA to the system but significant changes
were observed in the levels of ROS generated. The levels of ROS were significantly
greater in AgNP-CA and AgNP-DCA dispersions compared to AgNP exposure alone.
The increased production of ROS is potentially due to increased levels of lipid
peroxidation caused by the combination of AgNP and biofluid components. Lipid
peroxidation is a naturally occurring process driven by ROS but in an uncontrolled state
may lead to altered cell structure and function (Mylonas & Kouretas, 1999). It has been
demonstrated that certain nanomaterials such as ZnO nanoparticles can enhance this
process causing increased ROS production with AgNP also implicated in this process
due to the quenching of natural antioxidant systems and increased ROS generation
(Premanathan et al, 2011; Adeyemi & Faniyan, 2014). From the data it is postulated
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that it is this mechanism of cell destruction occurring as the levels of ROS are
substantially increased in the presence of both AgNP-CA and AgNP-DCA compared to
AgNP alone. While exposure to AgNP alone can result in an increase in lipid
peroxidation it is possible that the addition of CA and DCA can result in an escalation
of this process which then has a knock on effect on cell viability. This may be the result
of a reactive product produced from the interaction of AgNP with CA and DCA. Further
investigation is required to determine the mechanism of cell death and the role of lipid
peroxidation in the pathway.

As a continuation of this investigation into biofluid modification of toxicity, a laryngeal
(Hep2) cell line was investigated to establish if the biofluid components could have
modifying effects on areas of the body outside their normal target organs. For this
UDCA was chosen as the biofluid component to be investigated. A significant
modification in AgNP toxicity was observed in this study. A delay in cytotoxicity was
noted at 24 hour exposure with a significant reduction in viability following prolonged
exposure (48, 72 and 96 hours). This delay was coupled to a significant reduction in
ROS generation following UDCA addition suggesting a possible antioxidant effect of
UDCA within the first 24 hours after exposure. It is possible that UDCA causes a
delayed toxicity following association with AgNP in the first 24 hours due to a Trojan
horse type mechanism after which particle trafficking and dissolution within the cell
results in degradation of UDCA leaving the “naked” AgNP free to cause toxicity (Wang
et al, 2013; Mwilu et al, 2013).

The biofluid components investigated in this thesis are employed as pharmaceutical
agents and medications and as such highlights their potential to be present systemically
and not just confined to the liver. As a result the observations in this thesis are a
relevant line of investigation particularly as these bile acid derived treatments are given
orally. The data highlight the need for a complete and detailed cytotoxic profile of
AgNP and not just of the isolated effects but of the combined effect encompassing the
local environment, cellular components and other contributors at the exposure site.

As exposure through inhalation is the most common route of nanoparticle entry a follow
up study was undertaken to investigate the interaction of a component of lung
surfactant, DPPC, with AgNP and its potential to influence toxicity and induce an
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inflammatory response. Toxicity data demonstrated the effect of AgNP on the viability
of a lung cell line, A549. Due to the rapid doubling time of this cell line, 22 hours, the
greatest level of toxicity was at higher doses and shorter exposure times (24-48 hours).
The apparent cell recovery at lower AgNP concentrations at 72 and 96 hours was
attributed to replication of the surviving cells. Long term viability studies demonstrated
a reduced capacity for cell proliferation and colony formation in the presence of DPPC.
The greatest modification in toxicity was noted in the generation of ROS in the presence
of DPPC compared to substantially lower levels generated following exposure to AgNP
alone. The induction of oxidative stress plays a central role in cell death caused by
AgNP exposure. AgNP are potent inducers of oxidative stress and coupled with their
ability to diminish natural antioxidant stocks are critical in initiating apoptosis
(Martindale & Holbrook, 2002; Sastre et al, 2000; Piao et al, 2011; Arora et al, 2008;
Hussain et al, 2005; Chairuangkitti et al, 2013). Lipid peroxidation may also play a role
in this process enhancing ROS generation (Premanathan et al, 2011; Adeyemi &
Faniyan, 2014). This cell death process requires involvement of the mitochondria
however another death pathway has been identified in this particular cell line which
does not require the induction of ROS. This ROS-independent pathway results in cell
cycle arrest halting proliferation rather than inducing apoptosis (Chairuangkitti et al,
2013). It is possible that the results observed in this thesis indicate death pathway
switching following addition of DPPC. Exposure to AgNP alone produced low levels of
ROS at high concentrations only but addition of DPPC resulted in significant ROS
induction at a number of different concentrations suggesting a switch from a ROSindependent mechanism causing cell cycle arrest to a ROS-dependent mechanism
culminating in apoptotic cell death.

The induction of oxidative stress resulting from AgNP exposure has a number of
important knock on effects including cellular and DNA damage and the induction of
inflammatory cytokine release (Nel et al, 2006). In this study the release of IL-8 and
TNF-α were investigated and these particular cytokines have been associated with
AgNP exposure and implicated in certain lung disorders (Singh et al, 2007; Lim et al,
2012; Park et al, 2011; Napierska et al, 2012). While AgNP exposure resulted in their
release from A549 cells, the addition of DPPC caused a significant increase in release.
This implicates AgNP as an initiator of inflammation with its interaction with DPPC
serving to increase its potency. The increased levels and immediate release of IL-8 in
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particular support reports of its potential use as a bio-marker of acute inflammation in
response to AgNP exposure (Lim et al, 2012; Park et al, 2011). The alteration in both
IL-8 and TNF-α release caused by DPPC suggest the potential to induce a chronic
inflammatory state due to high levels released at prolonged exposure times. The data
also suggest that it is at sub-toxic doses of AgNP that produce the greatest inflammatory
response which has previously been reported (Lim et al, 2012). The alterations in ROS
generation and inflammatory cytokine release by DPPC can possibly be explained by
interactions between this surfactant and AgNP. Any potential interaction may increase
particle dispersion or alter the surface chemistry resulting in greater surface area
available for interaction increasing the likelihood of cellular uptake and cellular
trafficking. A similar Trojan horse mechanism has been suggested for other
nanoparticles which result in increased levels of ROS generation (Limbach et al, 2007).
It is possible that DPPC-AgNP interaction results in alteration to particle characteristics
producing a more reactive and thus more toxic particle. The results indicate that not
only are sub-lethal concentrations of AgNP potent inducers of an inflammatory
response but that the favoured protective surface coating DPPC is a major contributor to
oxidative stress induction.

The final part of this thesis involved identifying the ability of AgNP to induce an innate
immune response in circulating blood cells. Due to the possibility of AgNP
translocation into the blood stream it is an important part of any risk assessment to
investigate any potential effects on the circulatory system (Loeschner et al, 2011;
Gaillet & Rouanet, 2015). AgNP exposure to THP-1 cells showed a significant upregulation in gene expression of IL-1, IL-6 and TNF-α. Oxidative stress has been
implicated in the up-regulation of inflammatory cytokines. The induction of proinflammatory cytokines by ROS generation can result in a positive feedback loop
whereby the subsequent cytokine expression further drives the production of ROS (Kim
& Ryu, 2013; Lander, 1997; Acker, 2005; Franco et al, 2012). While this mechanism
may result in resolution, uncontrolled amplification may cause this process to turn
pathogenic, eventually resulting in toxicity. The cytokine up-regulation following AgNP
and combined AgNP-LPS exposure may result from ROS production. As these AgNP
have previously been shown to be potent inducers of ROS in certain mammalian cell
lines, further investigation is required to determine if this mechanism is what drives the
innate immune response caused by exposure (Gupta Mukherjee et al, 2012; Lim et al,
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2012; Asharani et al, 2009). The increased gene expression following combined
exposure to AgNP and LPS indicated a synergistic relashionship between the two. This
combined effect produced pro-inflammatory cytokine gene expression at significantly
higher levels compared with exposure to AgNP or LPS alone. An interaction between
AgNP and LPS would explain the significantly increased levels generated. An
important consideration in nanoparticle toxicity is the interaction with various
biomolecules following exposure. Nanoparticle interaction with biomolecules can result
in particle coating and this coating has the potential to determine the biological
responses induced and also determine particle trafficking through the body (Lynch et al,
2006; Laurent et al, 2012; Monopoli et al, 2012; Dubey et al, 2015). It must be
considered therefore the potential interaction between AgNP and LPS, in particular the
biomolecule surface coating, and how this contributes to the augmented response.
As a continuation of the initial investigation into AgNP induced immune response, an
identical set of experiments was performed on primary human monocytes extracted
from a cohort of twenty healthy donors to determine if a similar response was generated
in primary cells. The results demonstrated significant up-regulation of IL-1 and TNF-α
compared to the unexposed control. The main finding from this study was the large
variation between donors in the levels of expression and also the variation in the
expression of each cytokine by each donor. These results while demonstrating large
errors only highlight the importance of donor variation and agree with existing evidence
of donor specific responses and individual variation. Studies involving blood samples
have noted donor-specific gene expression patterns with different levels of a particular
target generated in response to the same stimulus and under identical conditions. The
reasons for this varied response can range from environmental factors to the time of day
of sample taking (Howe et al, 2005, 2009; Whitney et al, 2003). Although AgNP were
shown to induce pro-inflammatory cytokine gene expression in primary monocytes, the
variation between donors must be considered and further investigations into AgNP
immune responses should be performed using a larger cohort of samples and perhaps
also the inclusion of other donor cells to form a complete account of the response.
Following the determination of pro-inflammatory cytokine up-regulation, an
investigation into the release of IL-1β protein was performed to determine if
inflammasome activation plays a role in AgNP mediated immune response. Low levels
of IL-1β were released following AgNP exposure but pre-treatment with LPS followed
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by AgNP exposure produced the greatest levels of release. As with the gene expression
data this may suggest an interaction between the two. This result may have pathological
consequences potentially producing a greater immune response in minimally active cells
due to the presence of AgNP. The results also demonstrated that at sub-lethal
concentrations of AgNP the greatest IL-1β release was observed which has been
detailed in other investigations into the inflammatory activity of AgNP (Lim et al, 2012;
Yang et al, 2012). The reduction in IL-1β release following the inclusion of an inhibitor
suggests the involvement of caspase-1 and specifically the activation of the NLRP3
inflammasome upon exposure. Its involvment may also explain the low levels of IL-1β
release following exposure to AgNP or LPS alone as monocytes have been shown to
constitutively express caspase-1 allowing cleavage of pro-IL-1β into the bioactive form
and its subsequent release from the cell requiring (Yang et al, 2012; Simard et al, 2015;
Netea et al, 2009).
Inflammasome activation involves a two signal sequence. The first stimulates gene
expression; the second involves cleavage of the inactive cytokine to the mature active
form. The first signal is often NF-κB and AgNP have been shown to stimulate this
pathway resulting in downstream effects ranging from cell cycle arrest to apoptosis.
ROS have been shown to cause NF-κB induction with AgNP contributing to ROS
generation. AgNP have also been shown to interact with TLRs which can then lead to
activation of the NF-κB signalling pathways. TLR-2 in particular has been involved in
AgNP mediated apoptosis and due to the interaction of AgNP with LPS it is also a
possibility that TLR-4 may be involved as it specifically recognises LPS (Kim et al,
2007; Kim et al, 2012; Dubey et al, 2015). The interaction of TLRs with AgNP
highlights a possible initation event in inflammasome activation involving NF-κB.
Additional mechanisms have also been identified in AgNP mediated inflammasome
activation. ROS, specifically mitochondrial superoxide, have been implicated together
with alteration in K+ efflux channels and cathepsin release causing mitochondrial
dysfunction and ROS generation, all resulting from AgNP exposure (Yang et al, 2012).
Another contributor to inflammasome activation by AgNP was recently identified as
degradation of an endoplasmic reticulum stress sensor (Simard et al, 2015). Further
investigation is required to determine if one or all of these machanisms is responsible
for inflammasome activation and subsequent IL-1β release brought on by exposure to
the specific AgNP investigated in this study.
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The antimicrobial potential of AgNP has led to their application in a variety of areas
ranging from medical devices and drug therapies to cosmetics. The continuing growth
of this industry means that exposure is becoming more common, which has highlighted
a lack of information regarding the toxic potential of AgNP and other nanomaterials.
The results of this study could provide preliminary information relating to the toxic
potential of AgNP and more importantly provide a more realistic picture of their
interaction with biological systems, and how this can influence nanoparticle interaction
with living systems upon exposure. The results presented here also lend themselves to
providing a preliminary insight into the toxic effect of AgNP upon oral exposure, the
modifying effects on toxicity upon interaction with biofluids and the immune response
provoked following absorption into the bloodstream, and finally, highlighting that the
application of nanomaterials into consumer products should be approached with
caution.
This report has highlighted that a certain level of caution should be undertaken when
considering incorporating nanomaterials into consumer products. It is of the upmost
importance that a certain level of care be taken when considering nanomaterials for
consumer use, especially following documentation of the harm caused by these
materials at low doses. When trying to establish the risk of such materials, it is
important to take into account realistic parameters such as concentrationmetrics and
interaction of nanomaterials with the individual components within living systems when
designing experiments. This will provided accurate information on the potential hazards
of nanomaterials towards humans and the environment. This information along with the
results presented in this study will impact a number of sectors across the area of
nanotechnology including, food and agricultural, food packaging, medical and cosmetic.

8.2 Future Work
8.2.1 Effect of AgNP on adaptive immunity
Furthering the investigation into the innate immune response generated in monocytes by
AgNP exposure, an experiment designed to determine AgNP effects on the adaptive
immune response will be investigated. Specifically this experiment seeks to identify the
allosteric T cell response induced by AgNP exposure. This study would determine the
ability of AgNP to induce T cell proliferation, important cells in the immune response
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involved in destruction of infected cells and maturation of other immune cells.
Following whole blood collection, both monocytes and lymphocytes will be extracted,
specifically CD3 cells, from donor blood. Monocytes will be pre-treated with AgNP as
in previous experiments and lymphocytes will be fluorescently labelled. Monocytes will
then be combined with lymphocytes from another donor in a 96 well plate with cell
media containing no cytokines and incubated. Following 3, 4, 5 and 6 days cells will be
stained for CD3 (a marker present on both T helper and T killer cells) CD4 and CD8,
and analysed on a flow cytometer. A histogram illustrating several peaks indicates cell
division and would suggest that AgNP exposure can activate monocytes, which leads to
the activation of T lymphocytes and subsequent cell proliferation, indicative of an
adaptive immune response. The staining of specific CD markers would also identify the
type of T cells induced by AgNP exposure.

8.2.2 Innate immune response of AgNP in an in vivo model
An interesting and important continuation of this work would be to determine if the
response observed in both the monocyte cell line and in primary human monocytes is
similar to the response induced in an in vivo model. Galleria mellonella larvae, a type
of moth, will be used as an in vivo model to determine if a similar innate immune
response to AgNP exposure is induced. G. mellonella are widely used in research for in
vivo investigations into immune responses as the innate immune response is similar to
the human innate immune response. The larvae will be injected with AgNP at a
concentration of 50µg/ml and the hemolymph extracted for cellular extraction, RNA
isolation and subsequent molecular analysis. The same endpoints IL-1, IL-6 and TNF-α
will be analysed to determine cytokine up-regulation induced by AgNP exposure. These
larvae are a useful in vivo model and can provide an important insight into the
mammalian innate immune response following AgNP exposure.

8.2.3 Investigation into the toxicity of other metallic nanoparticles following oral
exposure
This thesis has demonstrated important results regarding the effects of AgNP on
biological systems following oral exposure. While there are still further investigations
remaining to form a complete cytotoxic profile of AgNP exposure, it is important that
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other nanoparticles are considered for similar investigation. Metallic nanoparticles such
as titanium dioxide (TiO2) are also applicable in consumer goods making the risk of
exposure to the public more prevalent. TiO2 is used in powdered foods such as
powdered milk to prevent caking and is also used as a whitening agent in certain
foodstuffs (Lomar et al, 2002; Smolkova et al, 2015). TiO2 provides a good example of
a metallic nanoparticle that should be considered for investigation as they are
consistently used in consumer products especially food products making the risk of
exposure a certainty. As such a complete cytotoxic profile of these nanoparticles must
be performed to determine the potential risks posed following exposure. Similar to the
work undertaken in this thesis, investigations into the possible interaction with various
biological entities and their ability to induce a biological response must be considered.
This work will add to the knowledge available regarding potential hazards of
nanoparticle use in consumer products, not as a barrier to innovation and growth of the
industry, but that the decision to use metallic nanoparticles can be approached with
caution.

8.3 Conclusion
This thesis has clearly demonstrated that AgNP exposure can induce an innate immune
response in both a monocyte cell line and primary human monocytes by up-regulation
of the pro-inflammatory cytokines IL-1, IL-6 and TNF-α. In addition this response was
found to involve innflammasome activation. This report has also highlighted the
induced toxicity of AgNP upon oral exposure and the vital role of individual biological
fluids in modifying toxicity and inflammation. These findings serve to highlight the
importance of considering the varied and dynamic environment met by AgNP upon oral
exposure and the effects individual components can have on the biological response
produced. It also serves to highlight the immunological significance of AgNP following
entry to the circulation and the generation of an innate immune response. These findings
demonstrate that there is still a long way to go in fully understanding the toxic potential
of AgNP following oral exposure and that those responses are varied depending on the
biological environment and can potentially contribute to disease development or
exacerbate already existing conditions.
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Appendix

UV/VIS absorption spectroscopy was performed to identify the features of cell culture
media RPMI and DMEM and of AgNP dispersed in cell culture media and any
alterations following the inclusion of the tested biofluid components UDCA, CA, DCA
and DPPC. This method was employed to explore potential interaction of AgNP with
cell growth medium and its various constituents. The UV/VIS spectrum of cell culture
media consists of a number of features at 360, 410 and 560nm. There was also a feature
at 270nm not illustrated here. The feature at 410nm was attributed to 10% foetal bovine
serum (FBS) added to culture media which also displays another feature at 270nm, the
feature at 360nm is riboflavin, a vitamin present in the medium and finally the feature at
560nm can be attributed to the phenol red indicator.

All features can be seen in the absorbance spectra presented (Fig 4..4.1 (a) and 4.4.1
(b)). Because AgNP are dispersed in cell culture media for toxicity testing it is
important to establish if their presence leads to interactions with growth factors present
in the medium which could play a role in the toxicity of the material. From the data
presented the presence of AgNP appears to alter the spectra with a slight increase in
absorbance observed upon the dispersion of AgNP in the media and also in the presence
of the various biofluid components. Analysis of AgNP alone (dispersed in dH2O) reveal
a feature between the wavelengths of 300 and 400nm which can be attributed to the
silver plasmon. There is no evidence of this feature in the preparations of AgNP in cell
media and with the addition of biofluid components.
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(a)

Figure 4.4.1 (a) Absorption spectra of RPMI only, AgNP (15.6µg/ml) in dH2O,
dispersed in RPMI, AgNP dispersed in RPMI with UDCA (50µM) and RPMI with
DPPC (0.25µg/ml)

Figure 4.4.1 (a) compares the absorption spectrum of the cell culture medium RPMI,
AgNP dispersed in RPMI and AgNP dispersed in RPMI with added DPPC and UDCA.
The features of cell culture media as detailed previously at 360, 410 and 560nm are
clearly observed from the spectra presented. From the data there was a slight decrease in
the peak at 560nm upon the addition of AgNP to RPMI and also with the addition of
UDCA and DPPC. There was also an apparent decrease in the peaks and increase in
absorbance at 360 and 410nm upon addition of AgNP and biofluid components. The
silver plasmon was not apparent upon addition to the different preparations.
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(b)

Figure A4.4.1 (b) Absorption spectra of AgNP (15.6µg/ml), DMEM only, and AgNP
dispersed in DMEM with CA (1mM), DCA (0.125mM) and UDCA (50µM)

Figure 4.4.1 (b) illustrates a similar spectrum to 4.4.1 (a) but with DMEM cell culture
media used as a dispersant. DMEM displays the features at 360, 410 and 560nm,
riboflavin, 10% FBS and phenol red respectively. Unlike RPMI these features,
particularly the phenol red indicator, are more pronounced in DMEM. As with RPMI a
similar alteration to the spectra is observed. A slight reduction in peaks at 360, 410 and
560nm were noted, suggestive of a possible interaction of AgNP with the cell media
components. A change in absorbance spectra was also observed in the presence of the
biofluid components CA, DCA and UDCA. As before the silver plasmon is not
visualised following addition of AgNP to DMEM/ biofluid component preparations.
UV-Vis absorption analysis preparations of AgNP and cell culture media demonstrate
slight changes in the absorption spectra. Alterations in spectra can indicate an
interaction of AgNP with the molecular components of the culture media. Any
interaction could result in a secondary toxicity resulting from depletion of the nutrient
and growth factors of the media due to the presence of AgNP. The presence of particles
may cause absorption of the media constituents making them unavailable to cells. This
has been investigated for other nanomaterials such as carbon nanotubes which resulted
in significant depletion of cell culture media constituents possibly contributing to a
secondary toxicity by making the various supplements and growth constituents
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unavailable to cells. This produced a secondary toxicity as opposed to a primary toxicity
(Casey et al, 2007). The results demonstrated here show only slight changes in peak
width and absorbance values. Although changes in these features can suggest particlemedia interaction the changes are so small that any possibility of an interaction is
negligible and may not impact on the any overall toxicity in further studies.

Appendix A5.2

Figure A5.2.1 (a) Cytotoxicity of AgNP in HepG-2 cells after 24, 48, 72 and 96hr
exposure as determined by the Alamar Blue assay. Data expressed as percentage of
control mean ± SD of three individual experiments. * denotes a statistically significant
(p<0.01) difference from the unexposed control

Figure A5.2.1 represents cytotoxic response of HepG-2 cells to AgNP exposure
determined by the AB assay. In the presence of AgNP cell viability decreases in a
concentrationand time dependant manner. Loss in cell viability is more apparent in the
AB assay which assesses the cytosolic integrity of the cell. A reduction in cell viability
was observed at the lowest exposure concentrations 3.9 and 7.8µg/ml after 24 hours. A
significant reduction in cell viability compared to the unexposed control was observed
at a concentration of 15.6µg/ml and upwards following 24, 72 and 96 hour exposures
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with significant reduction in viability at all exposure time points at concentrations of
31.25µg/ml and above.

Figure A5.2.1 (b) Cytotoxicity of AgNP in HepG-2 cells with added UDCA after 24,
48, 72 and 96hr exposures as determined by the Alamar Blue assay. Data expressed as
percentage of control mean ± SD of three independent experiments. * denotes a
statistically significant (p<0.01) difference from the unexposed control

Figure A5.2.1 (b) illustrates the toxic response of HepG-2 cells following AgNP
exposure in the presence of UDCA determined by the AB assay. A similar
concentrationdependant response was noted as seen with the previous assays, following
exposure to AgNP alone with the response increasing over time. A decline in cell
viability was observed after 24 hours and upwards at concentrations of 3.91 and
7.81µg/ml. A significant decrease in cell viability compared to the unexposed control
occured at all exposure time points at doses of 15.6µg/ml and above. Interestingly the
presence of UDCA appeared to have no effect on cellular response to AgNP exposure,
with almost identical patterns of toxicity observed with and without the addition of
UDCA. This suggests that the presence of UDCA does not modify AgNP toxicity in
HepG-2 cells.
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Figure A5.2.1 (c) Cytotoxicity of AgNP in HepG-2 cells with added CA after 24, 48,
72 and 96hr exposures as determined by the Alamar Blue assay. Data expressed as
percentage of control mean ± SD of three independent experiments. * denotes a
statistically significant (p<0.01) difference from the unexposed control

Figure A5.2.1 (c) represents exposure AgNP exposure to HepG-2 cells in the presence
of CA. A concentrationand time dependant response to AgNP exposure was noted. A
significant decrease in cell survival after 24 hours at a concentration of 3.91µg/ml was
observed. At this concentration a significant decline in cell survival was detected after
48 and 72 hours. The apparent increase in viability after 96 hour exposure may indicate
cell recovery. At this low concentration any surviving cells may begin to replicate as the
doubling time for this cell line is 48 hours. A significant decline in cell viability was
detected at concentrations of 7.81µg/ml and higher compared to the unexposed control
at all exposure time points.
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Figure A5.2.1 (d) Cytotoxicity of AgNP in HepG-2 cells with added DCA after 24, 48,
72 and 96hr exposures as determined by the Alamar Blue assay. Data expressed as
percentage of control mean ± SD of three independent experiments. * denotes a
statistically significant (p<0.01) difference from the unexposed control

Figure A5.2.1 (d) illustrates the toxic response of HepG-2 cells to AgNP exposure in the
presence of DCA. Exposure resulted in a concentrationand time dependant reduction in
viability. Significant loss in cell viability compared to the unexposed control was
observed at all time points and at all exposure doses.
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Figure A5.2.2 (a) Cytotoxicity of AgNP to Hep2 cells after 24, 48, 72 and 96hr
exposure as determined by the Alamar Blue assay. Data expressed as percentage of
control mean ± SD of three independent experiments. * denotes a statistically
significant (p<0.01) difference from the unexposed control

Figure A5.2.2 (a) displays the cytotoxic response of Hep2 cells to AgNP exposure
determined by the AB assay. As with previous cell lines toxicity occured in a
concentrationand time dependant pattern. Significant reduction in viability was
observed at 48 and 72 hours for all exposure concentrations. A significant reduction in
viability compared to the unexposed control after 24 hours was noted at concentrations
of 15.6µg/ml and above with a significant reduction observed for all exposure time
points at concentrations of 62.5µg/ml and upwards. At concentrations of 3.91 to
62.5μg/ml there appeared to be cell recovery at the 96 hour exposure point. This may be
due to remaining particles precipitating out of solution giving any remaining cells an
opportunity to begin replicating. With a rapid doubling time of 23 hours cell viability
appeared to increase at lower AgNP doses after prolonged exposure.
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Figure A5.2.2 (b) Cytotoxicity of AgNP to Hep2 cells with added UDCA after 24, 48,
72 and 96hr exposures as determined by the Alamar Blue assay. Data expressed as
percentage of control mean ± SD of three independent experiments. * denotes a
statistically significant (p<0.01) difference from the unexposed control
Figure A5.2.2 (b) illustrates toxic response of Hep2 cells to AgNP in the presence of
UDCA. In the presence of UDCA a dramatic reduction in cell viability compared to
exposure to AgNP alone was noted. Results demonstrated significant reduction in
viability at 48, 72 and 96 hours at all exposure concentrations with a significant
reduction at all time points at a concentration of 15.6µg/ml and above. Loss in cell
viability was more pronounced following 48, 72 and 96 hour exposures suggesting a
possible delay in toxicity. The data presented illustrate that compared to AgNP exposure
alone the presence of UDCA does modify toxicity.
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Appendix 6.2

Figure A6.2.1 Cytotoxicity of AgNP to A549 cells after 24, 48, 72 and 96hr exposures
as determined by the Alamar Blue assay. Data expressed as percentage of control mean
± SD of three independent experiments. * denotes a statistically significant (p<0.01)
difference from the unexposed control

The cytotoxic response of A549 cells to AgNP demonstrated by the AB assay is
displayed in figure A6.2.1. Decline in cell viability occurred in a concentrationand time
dependent manner with a significant reduction in cell viability following 48 hour
exposures at all AgNP doses. After 72 hour exposure a significant reduction in cell
viability was observed at concentrations of 15.6µg/ml and above with a significant
decline at 31.25µg/ml and upwards at all exposure time points. At 96 hours and 72
hours at lower AgNP doses, cell recovery was noted. It is possible that at this time after
exposure and due to the rapid (22 hour) doubling time of A549 cells, the particles have
fallen out of solution and with toxic effect having taken place within the first 6-12 hours
following exposure. It is possible that any surviving cells begin to replicate at lower
exposure doses and at prolonged exposure times. This was observed at concentrations of
3.91-62.5μg/ml up to 125µg/ml where a slight recovery was noted. It must also be
considered that the sensitivity of viability assays can vary with cell type and while one
assay may be suitable for one type a different assay may be more suited to another type.
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Figure A6.2.2 Cytotoxicity of AgNP to A549 cells with added DPPC after 24, 48, 72
and 96hr exposures as determined by the Alamar Blue assay. Data expressed as
percentage of control mean ± SD of three independent experiments. * denotes a
statistically significant (p<0.01) difference from the unexposed control

The response of A549 cells to AgNP exposure in the presence of DPPC demonstrated
by the AB assay (figure A6.2.2). A concentrationand time dependant reduction in
viability was observed. A significant reduction in cell survival compared to the
unexposed control was observed at concentrations 7.81µg/ml and above following 24
hour exposure and at a concentration of 3.9µg/ml and above after 48 and 72 hours. At
31.25µg/ml and above a significant reduction in cell survival at all exposure time points
was detected. As previously suggested, at lower AgNP doses following 96 hour
exposures, the increase in viability may be attributed to cell recovery.
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Figure A6.2.3 (a) ROS generation in A549 cells after different time points of AgNP
exposure. Data are expressed as percentage of control mean ± SD of six independent
experiments.

(a)

(b)

Figure A6.2.3 (b) Confocal image (x40) of A549 cells exposed to 500µg/ml AgNP
suspended in cell culture media. Image taken on a Zeiss 510 LSM confocal microscope
with an argon ion laser, excitation 488nm using a band pass filter 505-530nm to detect
DCF. (a) LSM image demonstrating intracellular ROS, (b) overlay of LSM and bright
field image.
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The generation of ROS in response to AgNP exposure was determined using 2’, 7’
Dichlorofluorsecin diacetate which detects intracellular hydroperoxides. Results were
expressed as a percentage of the unexposed control. A positive control of 10µM H2O2
was used in this assay.
Figure A6.2.3 (a) demonstrated little to no intracellular ROS production in response to
AgNP exposure. The generation of intracellular hydroperoxides was detected only at the
highest concentration, 500µg/ml with production increasing in a time dependant
manner. ROS production was detected after 15 minutes at the highest AgNP
concentrationwith maximum levels detected after 1 hour. In the hourly readings that
followed ROS production rapidly declined. For this particular cell line it was found that
AgNP were not potent inducers of ROS. Confirmation of ROS induction by AgNP at a
concentration of 500µg/ml was verified by confocal microscopy as illustrated in figure
A6.2.3 (b).

Appendix 7.2

Figure 7.2.1 Fold increase in IL-1, IL-6 and TNF-α gene expression in THP-1 cells
following 8 hour exposure to AgNP, LPS and combined AgNP + LPS compared to
unexposed control ± SD of three independent experiments. *denotes a statistically
significant difference (p<0.05) from the unexposed control
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Figure 7.2.2 Fold increase in IL-1, IL-6 and TNF-α gene expression in THP-1 cells
following 8 hour exposure to AgNP, LPS and combined AgNP + LPS compared to
unexposed control ± SD of three independent experiments. *denotes a statistically
significant difference (p<0.05) from the unexposed control. Polymyxin B (50µg/ml)
employed as an endotoxin inhibitor was pre-treated 1 hour before exposure.

In order to ensure that gene expression was due to AgNP and LPS exposure alone,
polymyxin B an endotoxin inhibitor was pre-treated 1 hour before exposures to ensure
no endotoxin contamination in the system. Figure 7.2.1 illustrates pro-inflammotory
cytokine gene expression following exposure to 50µg/ml AgNP, 1µg/ml LPS and a
combination of AgNP and LPS. A significant up-regulation in gene expression was
observed for all cytokines IL-1, IL-6 and TNF-α following AgNP and LPS exposures. A
significant up-regulation in IL-1 and IL-6 was detected following exposure to combined
AgNP and LPS. With the addition of polymyxin B (figure 7.2.2) no inhibition of gene
expression was observed following exposure to AgNP and combined AgNP and LPS. A
significant up-regulation compared to the unexposed control was noted for all cytokine
targets following exposure to AgNP. LPS induced gene expression was inhibited by
pre-treatment of cells with polymyxin B, however gene expression was still observed
following exposure to a combination of AgNP and LPS with significant up-regulation in
IL-1 and IL-6 compared to the unexposed control detected. These results demonstrate
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no endotoxin contamination in the system and that gene expression is induced by
AgNP, LPS and AgNP-LPS exposure alone.
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